
<!-- saved from url=(0082)https://www.sec.gov/Archives/edgar/data/1756497/000119312521003258/d28897dex21.htm -->
<html><head><meta http-equiv="Content-Type" content="text/html; charset=windows-1252"><script src="chrome-extension://ddbjnfjiigjmcpcpkmhogomapikjbjdk/base.js"></script></head><body bgcolor="WHITE" data-new-gr-c-s-check-loaded="14.1131.0" data-gr-ext-installed=""><document>
<type>EX-2.1
<sequence>2
<filename>d28897dex21.htm
<description>EX-2.1
<text>

<title>EX-2.1</title>

 

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="right"><b>Exhibit 2.1 </b></p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="right"><b><i>Execution Version </i></b></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<p style="margin-top:120pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">AGREEMENT AND PLAN OF MERGER </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">by
and among </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">CHANGE HEALTHCARE INC., </p>
<p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">UNITEDHEALTH GROUP INCORPORATED </p>
<p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">and </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">CAMBRIDGE MERGER SUB INC.
</p> <p style="margin-top:36pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">Dated as of January&nbsp;5, 2021 </p> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</p>
</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">TABLE OF CONTENTS </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="right">Page </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">ARTICLE&nbsp;I </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">Definitions </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center">


<tbody><tr>

<td width="3%"></td>

<td valign="bottom" width="1%"></td>
<td width="94%"></td>

<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">1.1.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certain Definitions</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">1</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">1.2.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Terms Defined Elsewhere</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">2</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
</tbody></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">ARTICLE&nbsp;II </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">Closing; Certificate of Merger and Effective Time; The Merger </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center">


<tbody><tr>

<td width="3%"></td>

<td valign="bottom" width="1%"></td>
<td width="94%"></td>

<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">2.1.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">3</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">2.2.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of Merger and Effective Time</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">3</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">2.3.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Merger</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">3</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
</tbody></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">ARTICLE&nbsp;III </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">Certificate of Incorporation and Bylaws of the Surviving Corporation; Directors and Officers of the Surviving Corporation </p>
<p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center">


<tbody><tr>

<td width="3%"></td>

<td valign="bottom" width="1%"></td>
<td width="94%"></td>

<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">3.1.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of Incorporation of the Surviving Corporation</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">3</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">3.2.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bylaws of the Surviving Corporation</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">4</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">3.3.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Directors of the Surviving Corporation</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">4</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">3.4.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Officers of the Surviving Corporation</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">4</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
</tbody></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">ARTICLE&nbsp;IV </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">Effect of the Merger on Capital Stock; Treatment of Equity Awards; Delivery of Merger Consideration </p>
<p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center">


<tbody><tr>

<td width="3%"></td>

<td valign="bottom" width="1%"></td>
<td width="93%"></td>

<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">4.1.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effect of the Merger on Capital Stock</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">4</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">4.2.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Treatment of Equity Awards and ESPP</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">4</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">4.3.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Delivery of Merger Consideration</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">7</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">4.4.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustments to Prevent Dilution</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">10</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
</tbody></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">ARTICLE&nbsp;V </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">Representations and Warranties of the Company </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center">


<tbody><tr>

<td width="4%"></td>

<td valign="bottom" width="1%"></td>
<td width="92%"></td>

<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">5.1.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Organization, Good Standing and Qualification</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">10</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">5.2.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capital Structure</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">11</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">5.3.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corporate Authority; Approval and Fairness</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">12</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">5.4.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governmental Filings; No Violations.</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">13</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">5.5.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Compliance with Laws; Licenses.</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">13</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">5.6.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Reports</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">14</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">5.7.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Disclosure Controls and Procedures and Internal Control Over Financial Reporting</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">14</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">5.8.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial Statements; No Undisclosed Liabilities;
<font style="white-space:nowrap">Off-Balance</font> Sheet Arrangements</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">15</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">5.9.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Litigation</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">16</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">5.10.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Absence of Certain Changes</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">16</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr></tbody></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-i- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">

<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center">


<tbody><tr>

<td width="4%"></td>

<td valign="bottom" width="1%"></td>
<td width="92%"></td>

<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">5.11.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Contracts</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">16</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">5.12.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Customers; Material Vendors</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">18</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">5.13.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employee Benefits</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">19</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">5.14.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Labor Matters</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">20</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">5.15.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Environmental Matters</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">21</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">5.16.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Matters</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">21</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">5.17.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Real Property.</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">24</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">5.18.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intellectual Property; Information Technology; Data Security</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">24</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">5.19.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HIPAA Compliance.</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">26</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">5.20.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FDA Compliance</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">27</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">5.21.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Healthcare Laws.</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">27</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">5.22.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Insurance</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">28</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">5.23.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Takeover Statutes</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">28</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">5.24.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brokers and Finders</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">28</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">5.25.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Other Representations or Warranties;
<font style="white-space:nowrap">Non-Reliance</font></p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">28</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
</tbody></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">ARTICLE&nbsp;VI </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">Representations and Warranties of Parent and Merger Sub </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center">


<tbody><tr>

<td width="4%"></td>

<td valign="bottom" width="1%"></td>
<td width="92%"></td>

<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">6.1.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Organization, Good Standing and Qualification</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">29</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">6.2.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capitalization of Merger Sub</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">29</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">6.3.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corporate Authority</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">29</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">6.4.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governmental Filings; No Violations</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">30</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">6.5.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Litigation</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">30</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">6.6.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Available Funds</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">30</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">6.7.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brokers and Finders</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">30</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">6.8.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ownership of Company Stock</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">30</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">6.9.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certain Arrangements</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">31</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">6.10.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certain Information</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">31</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">6.11.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Tax Representation Letter</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">31</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">6.12.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Other Representations or Warranties;
<font style="white-space:nowrap">Non-Reliance</font></p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">31</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
</tbody></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">ARTICLE&nbsp;VII </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">Covenants </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center">


<tbody><tr>

<td width="4%"></td>

<td valign="bottom" width="1%"></td>
<td width="92%"></td>

<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">7.1.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interim Operations</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">31</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">7.2.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquisition Proposals; Change of Recommendation</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">36</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">7.3.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proxy Statement; Efforts and Other Regulatory Matters</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">39</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">7.4.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Stockholders Meeting</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">40</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">7.5.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Approval of Sole Stockholder of Merger Sub</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">41</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">7.6.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Antitrust Matters.</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">41</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">7.7.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Status and Notifications</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">44</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">7.8.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General Regulatory Efforts; Third-Party Consents</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">44</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">7.9.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Information and Access</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">45</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">7.10.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Publicity</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">46</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">7.11.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employee Benefits</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">46</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">7.12.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnification; Directors’ and Officers’ Insurance</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">48</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">7.13.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financing Cooperation; TRA Terminations</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">50</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">7.14.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Takeover Statutes</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">51</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">7.15.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transaction Litigation</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">51</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr></tbody></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-ii- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">

<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center">


<tbody><tr>

<td width="4%"></td>

<td valign="bottom" width="1%"></td>
<td width="92%"></td>

<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">7.16.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;16 Matters</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">51</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">7.17.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Delisting and Deregistration</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">52</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">7.18.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cooperation Regarding Tax Matters</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">52</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
</tbody></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">ARTICLE&nbsp;VIII </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">Conditions </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center">


<tbody><tr>

<td width="3%"></td>

<td valign="bottom" width="1%"></td>
<td width="93%"></td>

<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">8.1.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conditions to Each Party’s Obligation to Effect the Closing</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">53</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">8.2.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conditions to Parent’s and Merger Sub’s Obligation to Effect the Closing</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">53</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">8.3.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conditions to the Company’s Obligation to Effect the Closing</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">54</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
</tbody></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">ARTICLE&nbsp;IX </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">Termination </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center">


<tbody><tr>

<td width="3%"></td>

<td valign="bottom" width="1%"></td>
<td width="93%"></td>

<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">9.1.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination by Mutual Written Consent</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">55</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">9.2.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination by Either the Company or Parent</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">55</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">9.3.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination by the Company</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">55</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">9.4.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination by Parent</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">56</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">9.5.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notice of Termination; Effect of Termination and Abandonment</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">56</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
</tbody></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">ARTICLE&nbsp;X </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">Miscellaneous and General </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center">


<tbody><tr>

<td width="5%"></td>

<td valign="bottom" width="1%"></td>
<td width="91%"></td>

<td valign="bottom" width="1%"></td>
<td></td>
<td></td>
<td></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">10.1.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Survival</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">58</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">10.2.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notices</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">58</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">10.3.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expenses</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">59</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">10.4.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transfer Taxes</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">59</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">10.5.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amendment or Other Modification; Waiver</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">59</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">10.6.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governing Law and Venue; Submission to Jurisdiction; Selection of Forum; Waiver of Trial by
Jury</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">60</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">10.7.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Specific Performance</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">60</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">10.8.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third-Party Beneficiaries</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">61</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">10.9.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fulfillment of Obligations</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">61</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">10.10.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Successors and Assigns</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">61</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">10.11.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entire Agreement</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">61</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">10.12.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Severability</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">61</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">10.13.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Counterparts; Effectiveness</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">62</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">10.14.</td>
<td valign="bottom">&nbsp;</td>
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interpretation and Construction</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td nowrap="" valign="bottom">&nbsp;</td>
<td nowrap="" valign="bottom" align="right">62</td>
<td nowrap="" valign="bottom">&nbsp;</td></tr>
</tbody></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><u>Annex&nbsp;A</u> Certain Definitions </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><u>Annex&nbsp;B</u> Form of Certificate of Incorporation of the Surviving Corporation </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-iii- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center"><u>AGREEMENT AND PLAN OF MERGER </u></p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This AGREEMENT AND PLAN OF MERGER (this “<u>Agreement</u>”), dated as of January&nbsp;5, 2021, is entered into by and among CHANGE
HEALTHCARE INC., a Delaware corporation (the “<u>Company</u>”), UNITEDHEALTH GROUP INCORPORATED, a Delaware corporation (“<u>Parent</u>”), and CAMBRIDGE MERGER SUB INC., a Delaware corporation and Wholly Owned Subsidiary of
Parent (“<u>Merger Sub</u>” and, together with the Company and Parent, the “<u>Parties</u>”). </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">RECITALS </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Parties intend that, subject to the terms and conditions of this Agreement and the applicable provisions of the DGCL, Merger Sub
shall merge with and into the Company (the “<u>Merger</u>”), with the Company surviving the Merger; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company Board
has unanimously (a)&nbsp;approved and declared advisable this Agreement and the transactions contemplated by this Agreement, (b)&nbsp;determined that this Agreement and the transactions contemplated by this Agreement are in the best interests of the
Company and the holders of Shares (other than Excluded Shares that are not Dissenting Shares), (c)&nbsp;directed that this Agreement be submitted to the holders of Shares for their adoption and (d)&nbsp;resolved, subject to the terms and conditions
of this Agreement, to recommend that the holders of Shares adopt this Agreement; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, the board of directors of Merger Sub has
unanimously (a)&nbsp;approved and declared advisable this Agreement and the transactions contemplated by this Agreement, (b)&nbsp;determined that this Agreement and the transactions contemplated by this Agreement are in the best interests of Merger
Sub and Parent<sup style="font-size:85%; vertical-align:top"> </sup>(as Merger Sub’s sole stockholder), (c)&nbsp;directed that this Agreement be submitted to Parent (as Merger Sub’s sole stockholder) for its adoption and (d)&nbsp;resolved
to recommend that Parent (as Merger Sub’s sole stockholder) adopt this Agreement; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, concurrently with the execution and
delivery of this Agreement, and as a material inducement to, and as a condition to, Parent and Merger Sub entering into this Agreement, certain stockholders of the Company have entered into a support agreement with Parent with respect to the Merger
as more particularly set forth therein (the “<u>Support Agreement</u>”); and </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Parties desire to make certain
representations, warranties, covenants and agreements in connection with this Agreement and the transactions contemplated by this Agreement. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the foregoing premises and the representations, warranties, covenants and agreements set forth in this
Agreement, the Parties, intending to be legally bound, agree as follows: </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">ARTICLE&nbsp;I </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center"><u>Definitions </u></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1.
<u>Certain Definitions</u>. As used in this Agreement, the capitalized terms have the meanings ascribed to such terms in <u>Annex A</u> or as otherwise defined elsewhere in this Agreement. </p>
</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2. <u>Terms Defined Elsewhere</u>. As used in this Agreement, the following capitalized
terms are defined in this Agreement as referenced in the following table: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center">


<tbody><tr>

<td width="86%"></td>

<td valign="bottom" width="8%"></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td valign="bottom" nowrap=""> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><b>Definition</b></p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom" style="border-bottom:1.00pt solid #000000"><b>Location</b></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Agreement</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">Preamble</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bylaws</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">3.2</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capitalization Date</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">5.2(a)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change of Recommendation</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">7.2(d)(i)(F)</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Charter</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">3.1</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">2.1</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Date</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">2.1</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">Preamble</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Approvals</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">5.4(a)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Disclosure Letter</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">Article&nbsp;V</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Personal Information</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">5.18(l)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Recommendation</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">5.3(b)</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Tax Representation Letter</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">7.18(c)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Continuation Period</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">7.11(a)</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">D&amp;O Insurance</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">7.12(b)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Delisting Period</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">7.17(a)</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effective Time</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">2.2</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange Fund</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">4.3(a)(i)</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FDA</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">5.20(a)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FDA Licenses</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">5.20(a)</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fundamental Action</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">7.2(d)(iii)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governmental Antitrust Entity</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">7.6(b)(ii)</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interim Period</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">7.1(a)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal Restraint</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">8.1(c)</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Contract</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">5.11(a)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Customer</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">5.12(a)</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Vendor</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">5.12(b)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merger</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">Recitals</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merger Sub</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">Preamble</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><font style="white-space:nowrap">Non-Wholly</font> Owned Subsidiary</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">5.2(f)</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notice of Redemption</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">7.13(a)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notice</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">7.2(d)(iii)</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notice Period</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">7.2(d)(iii)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outside Date</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">9.2(a)</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">Preamble</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Approvals</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">6.4(a)</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent DSU</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">4.2(f)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Option</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">4.2(a)</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent RSU</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">4.2(c)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Tax Representation Letter</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">7.18(c)</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent SAR</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">4.2(e)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parties</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">Preamble</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Permitted Confidentiality Agreement</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">7.2(b)(i)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Potential Purchasers</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">7.6(d)</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Potential Sale Transaction</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">7.6(d)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Privacy and Security Measures</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">5.18(k)</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Privacy-Related Contracts</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">5.11(a)(vi)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proxy Statement</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">7.3(a)</td></tr></tbody></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-2- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">

<table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center">


<tbody><tr>

<td width="86%"></td>

<td valign="bottom" width="8%"></td>
<td></td></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td valign="bottom" nowrap=""> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><b>Definition</b></p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom" style="border-bottom:1.00pt solid #000000"><b>Location</b></td></tr>


<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock Ownership Rep</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">6.8</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Support Agreement</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">Recitals</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Surviving Corporation</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">2.3</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Representation Letters</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">7.18(c)</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third-Party Consents</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">7.8</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transaction Litigation</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">7.15</td></tr>
<tr bgcolor="#cceeff" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TRA Terminations</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">7.13(d)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vote-Down</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">9.2(b)</td></tr>
</tbody></table> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">ARTICLE&nbsp;II </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center"><u>Closing; Certificate of Merger and Effective Time; The Merger </u></p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.1. <u>Closing</u>. The closing of the Merger (the “<u>Closing</u>”) shall take place by remote communication and by the exchange
of signatures by electronic transmission or, if or to the extent such exchange is not practicable or the Parties otherwise agree in writing, at a Closing to be held at the offices of Sullivan&nbsp;&amp; Cromwell LLP, 125&nbsp;Broad Street, New York,
New York 10004, at 9:00&nbsp;a.m. (New York time) on the third Business Day following the satisfaction or waiver of the conditions set forth in <u>Article</u><u></u><u>&nbsp;VIII</u> (other than those conditions that by their nature are to be
satisfied at the Closing, but subject to the satisfaction or waiver of those conditions at the Closing) or at such other date, time and place as the Company and Parent may agree in writing. For purposes of this Agreement, “<u>Closing
Date</u>” shall mean the date on which the Closing occurs. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.2. <u>Certificate of Merger and Effective Time</u>. As promptly as
practicable following the Closing, but on the Closing Date, the Parties shall (a)&nbsp;cause the Certificate of Merger to be duly executed and filed with the Secretary of State of the State of Delaware as provided in Section&nbsp;251 of the DGCL and
(b)&nbsp;deliver and tender, or cause to be delivered or tendered, as applicable, any Taxes and fees and make all other filings or recordings required under the DGCL in connection with such filing of the Certificate of Merger and the Merger, which
shall become effective at the date and time when the Certificate of Merger has been executed and filed pursuant to clause (a)&nbsp;of this <u>Section</u><u></u><u>&nbsp;2.2</u>, or at such later date and time as may be agreed by the Parties in
writing and specified in the Certificate of Merger so executed and filed (such date and time, as applicable, the “<u>Effective Time</u>”). </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.3. <u>The Merger</u>. Subject to the terms and conditions of this Agreement and pursuant to the applicable provisions of the DGCL,
(a)&nbsp;at the Effective Time, Merger Sub shall be merged with and into the Company and the separate corporate existence of Merger Sub shall thereupon cease, (b)&nbsp;the Company shall be the surviving corporation in the Merger (the
“<u>Surviving Corporation</u>”) and, from and after the Effective Time, shall be a Wholly Owned Subsidiary of Parent and the separate corporate existence of the Company shall continue unaffected by the Merger, and (c)&nbsp;the Merger shall
have such other applicable effects as set forth in this Agreement and in the applicable provisions of the DGCL. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">ARTICLE&nbsp;III </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center"><u>Certificate of Incorporation and Bylaws of the Surviving Corporation; Directors and Officers of the Surviving Corporation </u></p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.1. <u>Certificate of Incorporation of the Surviving Corporation</u>. At the Effective Time, the certificate of incorporation of the
Surviving Corporation (the “<u>Charter</u>”) shall be amended and restated in its entirety to read as set forth in <u>Annex</u><u></u><u>&nbsp;B</u>, until thereafter duly amended, restated or amended and restated as provided therein or by
applicable Law, in each case consistent with the obligations set forth in <u>Section</u><u></u><u>&nbsp;7.12</u>. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-3- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.2. <u>Bylaws of the Surviving Corporation</u>. The Parties shall take all actions
necessary so that the bylaws of the Company shall be amended and restated as of the Effective Time to read in their entirety as set forth in the bylaws of Merger Sub in effect immediately prior to the Effective Time such that such bylaws, as so
amended and restated, shall be the bylaws of the Surviving Corporation (the “<u>Bylaws</u>”), except that references to Merger Sub’s name shall be replaced with references to the Surviving Corporation’s name, until thereafter
amended, restated or amended and restated as provided therein, the Charter or by applicable Law, in each case consistent with the obligations set forth in <u>Section</u><u></u><u>&nbsp;7.12</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.3. <u>Directors of the Surviving Corporation</u>. The Parties shall take all actions necessary so that the members of the board of directors
of Merger Sub immediately prior to the Effective Time shall, from and after the Effective Time, be the directors of the Surviving Corporation, each to hold office until his or her successor has been duly elected or appointed and qualified or until
his or her earlier death, resignation or removal pursuant to the Charter, the Bylaws or applicable Law. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.4. <u>Officers of the Surviving
Corporation</u>. The Parties shall take all actions necessary so that the individuals designated in writing by Parent prior to the Effective Time shall, from and after the Effective Time, be the officers of the Surviving Corporation, each to hold
office until his or her successor has been duly elected or appointed and qualified or until his or her earlier death, resignation or removal pursuant to the Charter, the Bylaws or applicable Law. </p>
<p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">ARTICLE&nbsp;IV </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center"><u>Effect of the
Merger on Capital Stock; Treatment of Equity Awards; Delivery of Merger Consideration </u></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.1. <u>Effect of the Merger on Capital
Stock</u>. At the Effective Time, by virtue of the Merger and without any action on the part of the holder of any capital stock of the Company or on the part of the sole stockholder of Merger Sub: </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <u>Merger Consideration</u>. The Eligible Shares shall be converted into the right to receive the Per Share Merger Consideration, and
shall cease to be outstanding, shall be cancelled and shall cease to exist, and each Certificate, and each Book-Entry Share, shall thereafter only represent the right to receive the Per Share Merger Consideration, payable pursuant to
<u>Section</u><u></u><u>&nbsp;4.3</u>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <u>Treatment of Excluded Shares</u>. Each Excluded Share shall cease to be outstanding, shall
be cancelled without payment of any consideration therefor and shall cease to exist, subject to any rights any Dissenting Stockholders may have pursuant to <u>Section</u><u></u><u>&nbsp;4.3(f)</u> with respect to any Excluded Shares that are
Dissenting Shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <u>Merger Sub</u>. Each share of common stock of Merger Sub, par value $0.01&nbsp;per share, issued and
outstanding immediately prior to the Effective Time shall be converted into one share of common stock of the Surviving Corporation, par value $0.01 per share, and shall constitute the only outstanding shares of capital stock of the Surviving
Corporation as of immediately after the Effective Time. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.2. <u>Treatment of Equity Awards</u><u> and ESPP</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <u>Company Options</u>. At the Effective Time, each Company Option award, whether vested or unvested, shall, automatically and without any
required action on the part of the holder thereof, cease to represent an option to purchase Shares and shall be converted into an option to purchase a number of shares of Parent Common Stock (a “<u>Parent Option</u>”) equal to the product
(rounded down to the nearest whole number) of (i)&nbsp;the total number of Shares subject to such Company Option award immediately prior to the Effective Time <i><u>multiplied by</u></i> (ii)&nbsp;the Equity Award Exchange Ratio, at an exercise
price per share (rounded up to the nearest </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-4- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
whole cent) equal to (i)&nbsp;the exercise price per share of the Shares subject to such Company Option immediately prior to the Effective Time <i><u>divided by</u></i><i> </i>(ii)&nbsp;the
Equity Award Exchange Ratio; <u>provided</u>,<i> </i><u>however</u>, that the exercise price and the number of shares of Parent Common Stock purchasable pursuant to the Parent Options shall be determined in a manner consistent with the requirements
of Section&nbsp;409A of the Code; <u>provided</u>, <u>further</u>, that in the case of any Company Option to which Section&nbsp;422 of the Code applies, the exercise price and the number of shares of Parent Common Stock purchasable pursuant to such
Parent Option shall be determined in accordance with the foregoing, subject to such adjustments as are necessary in order to satisfy the requirements of Section&nbsp;424(a) of the Code. Except as specifically provided above and for any terms
rendered inoperative by reason of the transactions contemplated by this Agreement or for such other changes that are necessary for the administration of such Parent Option and not materially detrimental to the holder thereof, following the Effective
Time, each Parent Option shall continue to be governed by the same terms and conditions (including vesting and exercisability terms) as were applicable to the corresponding Company Option immediately prior to the Effective Time. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <u>Exit-Vesting Company Restricted Shares</u>. At the Effective Time, each Exit-Vesting Company Restricted Share award that, automatically
and without any required action on the part of the holder thereof, fully vests at the Effective Time pursuant to its terms and conditions as in effect as of the date of this Agreement shall fully vest and, automatically and without any required
action on the part of the holder thereof, be converted into the right to receive the Per Share Merger Consideration in respect of the number of such Exit-Vesting Company Restricted Shares outstanding immediately prior to the Effective Time (with
such amounts paid through the payroll system of the Surviving Corporation, without interest and less applicable Taxes required to be withheld, as soon as practicable after the Effective Time). At the Effective Time, each Exit-Vesting Company
Restricted Share award that does not, automatically and without any required action on the part of the holder thereof, fully vest at the Effective Time pursuant to its terms and conditions as in effect as of the date of this Agreement shall be
automatically cancelled and forfeited at the Effective Time for no consideration or payment. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <u>Company Restricted Stock Units</u>.
At the Effective Time, each Company RSU award, whether vested or unvested, shall, automatically and without any required action on the part of the holder thereof, cease to represent a restricted stock unit award denominated in Shares and shall be
converted into a restricted stock unit award denominated in shares of Parent Common Stock (a “<u>Parent RSU</u>”). The number of shares of Parent Common Stock subject to such Parent RSU shall be equal to the product (rounded down to the
nearest whole number) of (i)&nbsp;the total number of Shares subject to such Company RSU award immediately prior to the Effective Time <i><u>multiplied by</u></i> (ii)&nbsp;the Equity Award Exchange Ratio; <u>provided</u>, that each Exit-Vesting
Company RSU award that does not, automatically and without any required action on the part of the holder thereof, fully vest at the Effective Time pursuant to its terms and conditions as in effect as of the date of this Agreement shall be
automatically cancelled and forfeited at the Effective Time for no consideration or payment. Except as specifically provided above and for any terms rendered inoperative by reason of the transactions contemplated by this Agreement or for such other
changes that are necessary for the administration of such Parent RSU and not materially detrimental to the holder thereof, following the Effective Time, each such Parent RSU shall continue to be governed by the same terms and conditions (including
vesting and settlement terms) as were applicable to the applicable Company RSU immediately prior to the Effective Time. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <u>Company
Performance Share Units</u>. At the Effective Time, each Company PSU award, whether vested or unvested, shall, automatically and without any required action on the part of the holder thereof, cease to represent a performance share unit award
denominated in Shares and shall be converted into a Parent RSU. The number of shares of Parent Common Stock subject to each such Parent RSU award shall be equal to the product (rounded down to the nearest whole number) of (i)&nbsp;the total number
of Shares subject to such Company PSU award immediately prior to the Effective Time based on target performance, <i><u>multiplied by</u></i> (ii)&nbsp;the Equity Award Exchange Ratio. Except as specifically provided above and for any terms rendered
inoperative by reason of the transactions contemplated by this Agreement or for such other changes that are necessary for the administration of such Parent RSU and not materially detrimental to the holder thereof, following the Effective Time, each
such Parent RSU award shall continue to be governed by the same terms and conditions (including vesting and </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-5- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
settlement terms) as were applicable to the applicable Company PSU award immediately prior to the Effective Time. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <u>Company SARs</u>. At the Effective Time, each Company SAR award, whether vested or unvested, shall, automatically and without any
required action on the part of the holder thereof, cease to represent a stock appreciation right denominated in Shares and shall be converted into a stock appreciation right denominated in a number of shares of Parent Common Stock (a “<u>Parent
SAR</u>”) equal to the product (rounded down to the nearest whole number) of (i)&nbsp;the total number of Shares subject to such Company SAR award immediately prior to the Effective Time <i><u>multiplied by</u></i> (ii)&nbsp;the Equity Award
Exchange Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (i)&nbsp;the strike price per share of the Shares subject to such Company SAR immediately prior to the Effective Time <i><u>divided by</u></i><i>
</i>(ii)&nbsp;the Equity Award Exchange Ratio; <u>provided</u>,<i> </i><u>however</u>, that the strike price and the number of shares of Parent Common Stock subject to the Parent SARs shall be determined in a manner consistent with the requirements
of Section&nbsp;409A of the Code; <u>provided</u>, <u>further</u>, that each Exit-Vesting Company SAR award that does not, automatically and without any required action on the part of the holder thereof, fully vest at the Effective Time pursuant to
its terms and conditions as in effect as of the date of this Agreement shall be automatically cancelled and forfeited at the Effective Time for no consideration or payment. Except as specifically provided above and for any terms rendered inoperative
by reason of the transactions contemplated by this Agreement or for such other changes that are necessary for the administration of such Parent SAR and not materially detrimental to the holder thereof, following the Effective Time, each Parent SAR
shall continue to be governed by the same terms and conditions (including vesting, exercisability and settlement terms) as were applicable to the corresponding Company SAR immediately prior to the Effective Time. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <u>Company Deferred Stock Units</u>. At the Effective Time, each Company DSU award, whether vested or unvested, shall, automatically and
without any required action on the part of the holder thereof, cease to represent a deferred stock unit award denominated in Shares and shall be converted into a deferred stock unit award denominated in shares of Parent Common Stock (a
“<u>Parent DSU</u>”). The number of shares of Parent Common Stock subject to such Parent DSU shall be equal to the product (rounded down to the nearest whole number) of (i)&nbsp;the total number of Shares subject to such Company DSU award
immediately prior to the Effective Time <i><u>multiplied by</u></i> (ii)&nbsp;the Equity Award Exchange Ratio. Except as specifically provided above and for any terms rendered inoperative by reason of the transactions contemplated by this Agreement
or for such other changes that are necessary for the administration of such Parent DSU and not materially detrimental to the holder thereof, following the Effective Time, each such Parent DSU shall continue to be governed by the same terms and
conditions (including vesting and settlement terms) as were applicable to the applicable Company DSU immediately prior to the Effective Time. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <u>ESPP</u>. As soon as reasonably practicable following the date of this Agreement (but in any event prior to the Effective Time), the
Company shall take all actions (including obtaining any necessary determinations or resolutions of the Company Board or the Company Compensation Committee and, if appropriate, amending the terms of the ESPP) that may be necessary or required under
the ESPP and applicable Law to&nbsp;ensure that, (A)&nbsp;except for the Final Offering, no offering period shall be authorized or commenced on or after the date of this Agreement; (B)&nbsp;participants in the ESPP may not increase deductions under
the ESPP or otherwise make separate <font style="white-space:nowrap">non-payroll</font> contributions to the ESPP, in each case, after the date of this Agreement and (C)&nbsp;no new participants may begin participation in the ESPP after the date of
this Agreement. Prior to the Effective Time, the Company shall take all actions that may be necessary to, effective upon the consummation of the Merger, (x)&nbsp;cause the Final Offering, to the extent that it would otherwise be outstanding at the
Effective Time, to be terminated no later than five Business Days prior to the date on which the Effective Time occurs; (y)&nbsp;make any pro rata adjustments that may be necessary to reflect the Final Offering, but otherwise treat the Final
Offering as a fully effective and completed “Offering” for all purposes pursuant to the ESPP; and (z)&nbsp;cause the exercise (as of no later than five Business Days prior to the date on which the Effective Time occurs) of each outstanding
purchase right pursuant to the ESPP. On such exercise date, the Company shall apply the funds credited as of such date pursuant to the ESPP within each participant’s payroll withholding account to the
</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-6- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
purchase of whole Shares in accordance with the terms of the ESPP. The Company, the Company Board or the Company Compensation Committee, as appropriate, shall adopt such resolutions as are
necessary to terminate the ESPP effective as of immediately prior to, and conditional upon the occurrence of, the Effective Time. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)
<u>Company Actions</u>. At or prior to the Effective Time, the Company, the Company Board and the Company Compensation Committee, as applicable, shall adopt any resolutions, obtain any consents, and take any other actions that are necessary to
effectuate the treatment of Company Equity Awards pursuant to <u>Sections</u><u></u><u>&nbsp;4.2(a)</u> through <u>4.2(f)</u>, in each case, subject to and in accordance with applicable Law, including Section&nbsp;409A of the Code. The Company shall
take all actions necessary to ensure that from and after the Effective Time neither Parent nor the Surviving Corporation shall be required to deliver Shares or other capital stock of the Company to any Person pursuant to or in settlement of Company
Equity Awards. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.3. <u>Delivery of Merger Consideration</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <u>Deposit of Merger Consideration and Paying Agent</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) At or prior to the Effective Time, Parent shall deposit, or cause to be deposited, with the Paying Agent, an amount in cash in
immediately available funds sufficient in the aggregate to provide all funds necessary for the Paying Agent to make payments in respect of the Eligible Shares pursuant to <u>Section</u><u></u><u>&nbsp;4.3(b)</u> (such cash, the “<u>Exchange
Fund</u>”). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Pursuant to the Paying Agent Agreement, among other things, the Paying Agent shall (A)&nbsp;act as the paying
agent for the payment and delivery of the Per Share Merger Consideration pursuant to the terms and conditions of this Agreement and (B)&nbsp;invest the Exchange Fund, if and as directed by Parent; <u>provided</u>, <u>however</u>, that any investment
shall be in obligations of or guaranteed as to principal and interest by the U.S. government in commercial paper obligations rated <font style="white-space:nowrap">A-1</font> or <font style="white-space:nowrap">P-1</font> or better by Moody’s
Investors Service, Inc. or Standard&nbsp;&amp; Poor’s Financial Services,&nbsp;LLC, respectively, in certificates of deposit, bank repurchase agreements or banker’s acceptances of commercial banks with capital exceeding $10&nbsp;billion
(based on the most recent financial statements of such bank that are then publicly available), or in money market funds having a rating in the highest investment category granted by a recognized credit rating agency at the time of acquisition or a
combination of the foregoing and, in any such case, no such instrument shall have a maturity exceeding three months. To the extent that there are losses with respect to such investments, or the Exchange Fund diminishes for other reasons below the
level required to make prompt payment and delivery of the aggregate Per Share Merger Consideration as contemplated by <u>Section</u><u></u><u>&nbsp;4.1</u>, Parent shall promptly restore or cause the restoration of the cash in the Exchange Fund
diminished through such investments or other events so as to ensure that the Exchange Fund is maintained at a level sufficient to make such cash payments. Any interest and other income resulting from such investment (if any) in excess of the amounts
payable pursuant to <u>Section</u><u></u><u>&nbsp;4.3(b)</u> shall be promptly returned to Parent or the Surviving Corporation, as determined by Parent in accordance with the terms and conditions of the Paying Agent Agreement. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <u>Procedures for Surrender</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) As promptly as practicable after the Effective Time (but in any event within five Business Days thereafter), Parent shall cause the
Paying Agent to mail or otherwise provide each holder of record of Eligible Shares that are (A)&nbsp;represented by a Certificate or (B)&nbsp;Book-Entry Shares not held, directly or indirectly, through DTC notice advising such holders of the
effectiveness of the Merger, which notice shall include (1)&nbsp;appropriate transmittal materials (including a customary letter of transmittal) specifying that delivery shall be effected, and risk of loss and title to the Certificates or
such&nbsp;Book-Entry Shares shall pass only upon delivery of the Certificates (or affidavits of loss in lieu of the Certificates, as provided in <u>Section</u><u></u><u>&nbsp;4.3(e)</u>) or the surrender of such Book-Entry Shares to the Paying Agent
(which shall be deemed to have been effected upon the delivery of a customary “agent’s message” with respect to such Book-Entry Shares or such other reasonable evidence, if any, of such surrender as the Paying Agent may reasonably
request pursuant to the terms and conditions of the Paying </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-7- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Agent Agreement), as applicable (such materials to be in such form and have such other provisions as Parent and the Company may reasonably agree), and (2)&nbsp;instructions for effecting the
surrender of the Certificates (or affidavits of loss in lieu of the Certificates, as provided in <u>Section</u><u></u><u>&nbsp;4.3(e)</u>) or such Book-Entry Shares to the Paying Agent in exchange for the Per Share Merger Consideration that such
holder is entitled to receive as a result of the Merger pursuant to this <u>Article</u><u></u><u>&nbsp;IV</u>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) With respect to
Book-Entry Shares held, directly or indirectly, through DTC, Parent and the Company shall cooperate to establish procedures with the Paying Agent, DTC, DTC’s nominees and such other necessary or desirable third-party intermediaries to ensure
that the Paying Agent will transmit to DTC or its nominees as promptly as practicable after the Effective Time, upon surrender of Eligible Shares held of record by DTC or its nominees in accordance with DTC’s customary surrender procedures and
such other procedures as agreed by Parent, the Company, the Paying Agent, DTC, DTC’s nominees and such other necessary or desirable third-party intermediaries, the Per Share Merger Consideration to which the beneficial owners thereof are
entitled to receive as a result of the Merger pursuant to this <u>Article</u><u></u><u>&nbsp;IV</u>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Upon surrender to the Paying
Agent of Eligible Shares that (A)&nbsp;are represented by a Certificate, by physical surrender of such Certificate (or affidavits of loss in lieu of the Certificate, as provided in <u>Section</u><u></u><u>&nbsp;4.3(e)</u>) together with the letter
of transmittal, duly completed and executed, and such other documents as may be reasonably required by the Paying Agent in accordance with the terms of the materials and instructions provided by the Paying Agent, (B)&nbsp;are Book-Entry Shares not
held through DTC, by book-receipt of an “agent’s message” by the Paying Agent in connection with the surrender of Book-Entry Shares (or such other reasonable evidence, if any, of surrender with respect to such Book-Entry Shares, as
the Paying Agent may reasonably request pursuant to the terms and conditions of the Paying Agent Agreement), in each case of the foregoing clauses (A)&nbsp;and (B) of this <u>Section</u><u></u><u>&nbsp;4.3(b)(iii)</u>, pursuant to such materials and
instructions as contemplated by <u>Section</u><u></u><u>&nbsp;4.3(b)(i)</u>, and (C)&nbsp;are Book-Entry Shares held, directly or indirectly, through DTC, in accordance with DTC’s customary surrender procedures and such other procedures as
agreed by the Company, Parent, the Paying Agent, DTC, DTC’s nominees and such other necessary or desirable third-party intermediaries pursuant to <u>Section</u><u></u><u>&nbsp;4.3(b)(ii)</u>, the holder of the Eligible Shares represented by
such Certificate or Book-Entry Share shall be entitled to receive in exchange therefor, and Parent shall cause the Paying Agent to pay and deliver, out of the Exchange Fund, as promptly as practicable to such holders, an amount in cash in
immediately available funds (after giving effect to any required Tax withholdings as provided in <u>Section</u><u></u><u>&nbsp;4.3(g)</u>) equal to the product obtained by <i><u>multiplying</u></i> (1)&nbsp;the number of Eligible Shares represented
by such Certificates (or affidavits of loss in lieu of the Certificates, as provided in <u>Section</u><u></u><u>&nbsp;4.3(e)</u>) or such Book-Entry Shares by (2)&nbsp;the Per Share Merger Consideration, and each Certificate so surrendered shall
forthwith be cancelled. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) In the event of a transfer of ownership of any Eligible Shares represented by a Certificate that is not
registered in the stock transfer books or ledger of the Company or if the consideration payable is to be paid in a name other than that in which the Certificate or Certificates surrendered or transferred in exchange therefor are registered in the
Company’s stock transfer books or ledger, a check for any cash to be exchanged upon due surrender of any such Certificate or Certificates (or affidavits of loss in lieu of the Certificate, as provided in
<u>Section</u><u></u><u>&nbsp;4.3(e)</u>) may be issued by the Paying Agent to such a transferee if the Certificate or Certificates is or are (as applicable) properly endorsed and otherwise in proper form for surrender and presented to the Paying
Agent, accompanied by all documents required to evidence and effect such transfer and to evidence that any applicable Transfer Taxes have been paid or are not applicable, in each case, in form and substance, reasonably satisfactory to Parent and the
Paying Agent. Payment of the Per Share Merger Consideration with respect to Book-Entry Shares shall only be made to the Person in whose name such Book-Entry Shares are registered in the stock transfer books or ledger of the Company. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) For the avoidance of doubt, no interest will be paid or accrued for the benefit of any holder of Eligible Shares on any amount payable
upon the surrender of any Eligible Shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <u>Transfer Books; No Further Ownership Rights in Shares</u>. From and after the Effective
Time, the Company’s stock transfer books shall be closed, and thereafter there shall be no transfers on the stock transfer </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-8- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
books or ledger of the Company of the Shares. The Per Share Merger Consideration paid in accordance with the terms of this <u>Article IV</u> shall be deemed to have been delivered and paid in
full satisfaction of all rights pertaining to any Shares. From and after the Effective Time, the holders of Shares outstanding immediately prior to the Effective Time shall, subject to <u>Section</u><u></u><u>&nbsp;4.3(f)</u>, cease to have any
rights with respect to such Shares or as shareholders of the Company except the right to receive the Per Share Merger Consideration, without interest thereon, into which the Shares have been converted pursuant to
<u>Section</u><u></u><u>&nbsp;4.1(a)</u> upon the surrender thereof in accordance with this <u>Section</u><u></u><u>&nbsp;4.3(c)</u> and subject to <u>Section</u><u></u><u>&nbsp;4.3(g)</u>. If, after the Effective Time, any Certificate or acceptable
evidence of a Book-Entry Share is presented to the Surviving Corporation, Parent or the Paying Agent for transfer, it shall be cancelled and exchanged for the cash amount in immediately available funds to which the holder thereof is entitled to
receive as a result of the Merger pursuant to this <u>Article IV</u>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <u>Termination of Exchange Fund</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Any portion of the Exchange Fund (including any interest and other income resulting from any investments thereof (if any)) that remains
unclaimed by the holders of Eligible Shares for 270 days from and after the Closing Date shall be delivered to Parent or the Surviving Corporation, as determined by Parent. Any holder of Eligible Shares who has not theretofore complied with the
procedures, materials and instructions contemplated by this <u>Section</u><u></u><u>&nbsp;4.3</u> shall thereafter look only to the Surviving Corporation as a general creditor thereof for such payments (after giving effect to any required Tax
withholdings as provided in <u>Section</u><u></u><u>&nbsp;4.3(g)</u> and <u>Sections</u><u></u><u>&nbsp;4.2(a)</u> through <u>4.2(e)</u>, as applicable) in respect thereof. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Notwithstanding anything to the contrary set forth in this <u>Article</u><u></u><u>&nbsp;IV</u>, none of the Surviving Corporation,
Parent, the Paying Agent or any other Person shall be liable to any former holder of Shares or Company Equity Awards for any amount properly delivered to a public official pursuant to applicable abandoned property, escheat or similar Laws. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <u>Lost, Stolen or Destroyed Certificates</u>. In the event any Certificate shall have been lost, stolen or destroyed, upon the making of
an affidavit of that fact by the Person claiming such Certificate to be lost, stolen or destroyed and, if required by Parent or the Paying Agent pursuant to the Paying Agent Agreement or otherwise, the posting by such Person of a bond in customary
amount and upon such terms as may be reasonably required by Parent or the Paying Agent pursuant to the Paying Agent Agreement or otherwise as indemnity against any claim that may be made against it or the Surviving Corporation with respect to such
Certificate, the Paying Agent shall, in exchange for such Certificate, issue a check in the amount (after giving effect to any required Tax withholdings as provided in <u>Section</u><u></u><u>&nbsp;4.3(g)</u>) equal to the product obtained by
<i><u>multiplying</u></i> (i)&nbsp;the number of Eligible Shares represented by such lost, stolen or destroyed Certificate by (ii)&nbsp;the Per Share Merger Consideration. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <u>Appraisal Rights</u>. Subject to the last sentence of this <u>Section</u><u></u><u>&nbsp;4.3(f)</u>, no Dissenting Stockholder shall be
entitled to receive the Per Share Merger Consideration with respect to the Dissenting Shares owned by such Dissenting Stockholder and each Dissenting Stockholder shall be entitled to receive only the payment provided by Section&nbsp;262 of the DGCL
with respect to the Dissenting Shares owned by such Dissenting Stockholder and such Dissenting Stockholder shall cease to have any other rights with respect to such Dissenting Shares. Notwithstanding the foregoing, if any Dissenting Shares lose
their status as such (through failure to perfect, waiver, effective withdrawal or otherwise), then, as of the later of the Effective Time or the date of loss of such status, each such Dissenting Share shall automatically be converted into or shall
be deemed to have been, as of the Effective Time, converted into, as applicable, and shall represent only the right to receive, the Per Share Merger Consideration in accordance with <u>Section</u><u></u><u>&nbsp;4.1(a)</u>, after the surrender of
the Certificate(s) or Book-Entry Shares, as applicable, representing such Shares in accordance with this Agreement. The Company shall give Parent&nbsp;prompt notice and copies of any written demands for appraisal, actual, attempted or purported
withdrawals of such demands, and any other instruments served pursuant to (or purportedly pursuant to) applicable Law that are received by the Company relating to the Company’s stockholders’ demands of appraisal. Parent shall have the
right to participate in and direct all negotiations and Proceedings with respect to any </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-9- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
demand for appraisal under the DGCL, including any determination to make any payment or deposit with respect to any of the Dissenting Stockholders with respect to any of their Dissenting Shares
under Section&nbsp;262(h) of the DGCL prior to the entry of judgment in the Proceedings regarding appraisal. The Company shall not, except with the prior written consent of Parent, voluntarily make any payment or deposit with respect to any demands
for appraisals, offer to settle or settle any such demands or approve any withdrawal of any such demands, or agree, authorize or commit to do any of the foregoing. If any Dissenting Stockholder shall have effectively withdrawn or otherwise waived or
lost the right under Section&nbsp;262 of the DGCL with respect to any Dissenting Shares, such Dissenting Shares shall become Eligible Shares and thereupon converted into the right to receive the Per Share Merger Consideration with respect to such
Shares pursuant to this <u>Article</u><u></u><u>&nbsp;IV</u>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <u>Withholding Rights</u>. Each of Parent, the Surviving Corporation
and the Paying Agent (and any of their respective Affiliates) shall be entitled to deduct and withhold from the consideration otherwise payable pursuant to this Agreement to any Person such amounts as it is required to deduct and withhold with
respect to the making of such payment under the Code, or any other applicable Tax Law. To the extent that amounts are so withheld, such withheld amounts (i)&nbsp;shall be remitted to the applicable Governmental Entity, and (ii)&nbsp;shall be treated
for all purposes of this Agreement as having been paid to the Persons in respect of which such deduction and withholding was made. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.4.
<u>Adjustments</u><u> to Prevent Dilution</u>. Notwithstanding anything to the contrary set forth in this Agreement, if, from the execution and delivery of this Agreement to the Effective Time, the issued and outstanding Shares or securities
convertible or exchangeable into or exercisable for Shares shall have been changed into a different number of Shares or securities or a different class by reason of any reclassification, stock split, stock dividend or distribution, recapitalization,
merger, issuer tender or exchange offer, or other similar transaction, or a stock dividend with a record date within such period shall have been declared, then the Per Share Merger Consideration and any other amounts payable in respect of
equity-based securities pursuant to this Agreement shall be equitably adjusted to provide the holders of Shares the same economic effect as contemplated by this Agreement prior to such event; <u>provided</u>, <u>however</u>, that nothing in this
<u>Section</u><u></u><u>&nbsp;4.4</u> shall be construed to permit the Company or any other Person to take any action except to the extent consistent with, and not otherwise limited or prohibited by, the terms and conditions of this Agreement. </p>
<p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">ARTICLE&nbsp;V </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center"><u>Representations and Warranties of the Company </u></p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Except as set forth (a)&nbsp;in the Company Reports available on EDGAR on or after the Applicable Date and prior to the date of this Agreement
(excluding, in each case, any disclosures set forth in any “risk factors” or “forward-looking statements” sections or in any other sections to the extent they are forward-looking statements or cautionary, predictive or
forward-looking in nature), or (b)&nbsp;in the confidential disclosure letter delivered to Parent by the Company concurrently with the execution and delivery of this Agreement (the&nbsp;“<u>Company Disclosure Letter</u>”) (<u>it</u>
<u>being</u> <u>agreed</u> that for the purposes of the representations and warranties made by the Company in this Agreement, disclosure of any item in any section of the Company Disclosure Letter shall be deemed disclosure with respect to any other
section of this <u>Article V</u> to the extent the relevance of such item to such other section is reasonably apparent on its face), the Company hereby represents and warrants to Parent and Merger Sub that: </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.1. <u>Organization, Good Standing and Qualification</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company and each of its Subsidiaries is (i)&nbsp;a legal entity duly organized, validly existing and, to the extent such concept is
applicable, in good standing under the Laws of its respective jurisdiction of organization and (ii)&nbsp;has all requisite corporate or similar power and authority to own, lease and operate its properties and assets and to carry on its business as
currently conducted and is qualified to do business and, to the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-10- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
extent such concept is applicable, is in good standing as a foreign corporation or other legal entity in each jurisdiction where the ownership, leasing or operation of its properties or assets or
conduct of its business requires such qualification, except, in the case of this clause (ii) (and, with respect to the Company’s Subsidiaries, in the case of clause (i)&nbsp;and this clause (ii)), as would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company has made available to Parent correct and complete copies of
the Company’s and the Company’s Subsidiaries’ Organizational Documents that are in full force and effect as of the date of this Agreement, and neither the Company nor any of its Subsidiaries is in violation of any of the applicable
provisions of such Organizational Documents, except, solely with respect to the Company’s Subsidiaries, as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <u>Section</u><u></u><u>&nbsp;5.1(c)</u> of the Company Disclosure Letter sets forth a correct and complete list of each jurisdiction in
which the Company and its Subsidiaries are organized and qualified to do business. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.2. <u>Capital Structure</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The authorized capital stock of the Company consists of 9,000,000,000 Shares, one Company Class&nbsp;X Share and 900,000,000 shares of
Company Preferred Stock. As of December&nbsp;31, 2020 (the “<u>Capitalization Date</u>”): (i)&nbsp;305,612,624&nbsp;Shares were issued and outstanding (inclusive of 955,761&nbsp;Exit-Vesting Company Restricted Shares); (ii)&nbsp;no Shares
were issued and held by the Company in its treasury; (iii)&nbsp;the Company Class&nbsp;X Share was not issued and outstanding, available for issuance or held by the Company in its treasury; (iv)&nbsp;no shares of Company Preferred Stock were issued
and outstanding or held by the Company in its treasury; (v)&nbsp;no Shares or shares of Company Preferred Stock were reserved for issuance other than 13,099,868&nbsp;Shares reserved for issuance pursuant to Company Options (inclusive of
4,839,103&nbsp;Exit-Vesting Company Options) under the Stock Plans, 149,685 Shares reserved for issuance pursuant to Company SARs (inclusive of 63,200&nbsp;Exit-Vesting Company SARs and, in each case, excluding any Cash-Settled Company SARs) under
the Stock Plans, 8,448,753&nbsp;Shares reserved for issuance pursuant to Company RSUs (excluding any Cash-Settled Company RSUs) under the Stock Plans, 2,089,867&nbsp;Shares reserved for issuance pursuant to the Company PSUs based on target
performance under the Stock Plans and 4,179,734 Shares reserved for issuance pursuant to the Company PSUs based on maximum performance under the Stock Plans and 147,106&nbsp;Shares reserved for issuance pursuant to Company DSUs under the Stock
Plans; and (vi)&nbsp;5,137,345 TEUs were issued and outstanding. In addition, as of the Capitalization Date, there were 693,649 Cash-Settled Company RSUs (inclusive of 253,865&nbsp;Exit-Vesting Company RSUs) and 489,619 Cash-Settled Company SARs
(inclusive of 11,439&nbsp;Exit-Vesting Company SARs) outstanding under the Stock Plans. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Neither the Company nor any of its
Subsidiaries have outstanding any bonds, debentures, notes or other obligations, the holders of which have the right to vote (or convert into or exercise for securities having the right to vote) with the stockholders of the Company on any matter or
with the equity holders of any of the Company’s Subsidiaries on any matter, respectively. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Shares and the TEUs constitute the
only outstanding classes of securities of, or held by, the Company or its Subsidiaries registered under the Securities Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)
<u>Section</u><u></u><u>&nbsp;5.2(d)</u> of the Company Disclosure Letter sets forth a correct and complete list of all outstanding Company Equity Awards as of the Capitalization Date, setting forth the number of Shares subject to each Company
Equity Award and the holder (identified by name or employee identification number), grant date (or modification date, where applicable) and exercise or strike price per Share (where applicable) with respect to each Company Equity Award, as
applicable. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Each Company Option and each Company SAR has an exercise or strike price per Share equal to or greater than the fair
market value of a Share on the original date of such grant. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-11- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <u>Section</u><u></u><u>&nbsp;5.2(f)</u> of the Company Disclosure Letter sets forth as
of the date of this Agreement: (i)&nbsp;each of the Company’s Subsidiaries; (ii)&nbsp;whether or not each such Subsidiary is a Wholly Owned Subsidiary (any Subsidiary that is not a Wholly Owned Subsidiary, a “<u><font style="white-space:nowrap">Non-Wholly</font> Owned Subsidiary</u>”); and (iii)&nbsp;for each <font style="white-space:nowrap">Non-Wholly</font> Owned Subsidiary, (A)&nbsp;the percentage of the Company’s ownership interest, direct or
indirect, and the number and type of capital stock or other securities owned by the Company, directly or indirectly, in each such Subsidiary, and (B)&nbsp;the percentage of such other Person or Persons’ ownership interest and the number and
type of capital stock or other securities owned by such other Person or Persons in each such Subsidiary and the name of such other Person or Persons. As of the date of this Agreement, the Company does not, directly or indirectly, beneficially own
any capital stock of, or other voting securities or equity or similar interests, or investment, or have any obligation to invest, in any Person which is not listed on <u>Section</u><u></u><u>&nbsp;5.2(f)</u> of the Company Disclosure Letter. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) All of the outstanding shares of capital stock of the Company have been duly authorized and are validly issued, fully paid and <font style="white-space:nowrap">non-assessable.</font> Upon the issuance of any Shares in accordance with the terms of the Stock Plans in effect on the date of this Agreement, such Shares will be duly authorized, validly issued, fully paid and <font style="white-space:nowrap">non-assessable</font> and free and clear of any Encumbrance (other than any Permitted Encumbrance). Each of the outstanding shares of capital stock or other securities of each of the Company’s Subsidiaries is duly
authorized, validly issued, fully paid and <font style="white-space:nowrap">non-assessable</font> and, except for any shares of capital stock or other securities of any <font style="white-space:nowrap">Non-Wholly</font> Owned Subsidiaries owned by
such Persons contemplated by <u>Section</u><u></u><u>&nbsp;5.2(f)(iii)(B)</u>, owned by the Company or by a Wholly Owned Subsidiary of the Company, free and clear of any Encumbrance (other than any Permitted Encumbrance). </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Except as set forth in <u>Sections</u><u></u><u>&nbsp;5.2(a)</u>, <u>5.2(f)</u> and <u>5.2(g)</u>, there are no preemptive or other
outstanding rights, options, warrants, conversion rights, stock appreciation rights, redemption rights, repurchase rights, agreements, arrangements, calls, commitments or rights of any kind that obligate the Company or any of its Subsidiaries to
issue or to sell any shares of capital stock or other securities of the Company or any of its Subsidiaries or any securities or obligations convertible or exchangeable into or exercisable for, valued by reference to, or giving any Person a right to
subscribe for or acquire, any securities of the Company or any of its Subsidiaries, and no securities or obligations evidencing such rights are authorized, issued or outstanding. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.3. <u>Corporate Authority; Approval and Fairness</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company has all requisite corporate power and authority and has taken all corporate action necessary in order to execute, deliver and
perform under this Agreement and to consummate the transactions contemplated by this Agreement, subject only to obtaining the Requisite Company Vote. This Agreement has been, and any other agreements or instruments to be delivered pursuant to this
Agreement by the Company will be, duly executed and delivered by the Company and, assuming due execution and delivery by Parent and Merger Sub, constitutes a valid and binding agreement of the Company enforceable against the Company in accordance
with its terms, subject to the Bankruptcy and Equity Exception. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company Board has, at a duly convened and held meeting:
(i)&nbsp;unanimously (A)&nbsp;approved and declared advisable this Agreement and the transactions contemplated by this Agreement, (B)&nbsp;determined that this Agreement and the transactions contemplated by this Agreement are in the best interests
of the Company and the holders of Shares, other than Excluded Shares that are not Dissenting Shares, and (C)&nbsp;resolved to recommend that the holders of Shares adopt this Agreement at any meeting of the holders of Shares held for such purpose and
any adjournment or postponement thereof (the “<u>Company Recommendation</u>”); (ii)&nbsp;unanimously directed that this Agreement be submitted to the holders of Shares for their adoption at a duly held meeting of the holders of Shares for
such purpose; and&nbsp;(iii)&nbsp;received the opinion, dated as of the date of this Agreement, of its financial advisor, Goldman Sachs&nbsp;&amp; Co. LLC, to the effect that, as of the date of such opinion and based upon and subject to the factors
and assumptions set forth therein, the Per Share Merger Consideration to be paid to the holders of Shares (other than Parent and its Affiliates) is fair from a financial point of view to such holders. A copy of such opinion will be provided by the
Company to Parent solely for informational purposes as promptly as practicable following the execution of this Agreement. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-12- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.4. <u>Governmental Filings; No Violations</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Other than the expirations of waiting periods and the filings, notices, reports, consents, registrations, approvals, permits and
authorizations (i)&nbsp;under the HSR Act, (ii)&nbsp;pursuant to the DGCL, (iii)&nbsp;required to be made with or obtained from the SEC, (iv)&nbsp;required to be made with or by NASDAQ, (v)&nbsp;under the Takeover Statutes and state securities and
“blue sky” Laws or (vi)&nbsp;as set forth on <u>Section</u><u></u><u>&nbsp;5.4(a)</u> of the Company Disclosure Letter (collectively, the “<u>Company Approvals</u>”), no expiration of any waiting period under applicable Law is
required and no filings, notices, reports, consents, registrations, approvals, permits or authorizations are required to be made by the Company or any of its Subsidiaries with, nor are any required to be obtained by the Company or any of its
Subsidiaries from, any Governmental Entity, in connection with the execution and delivery of and performance under this Agreement by the Company and the consummation of the transactions contemplated by this Agreement, except as would not reasonably
be expected to have, individually or in the aggregate, a Material Adverse Effect. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The execution and delivery of and performance under
this Agreement by the Company do not, and the consummation of the transactions contemplated by this Agreement will not: (i)&nbsp;assuming the Requisite Company Vote is obtained, constitute or result in a breach or violation of or a contravention or
conflict with the Organizational Documents of the Company or any of its Subsidiaries; (ii)&nbsp;assuming the Requisite Company Vote is obtained and the waiting periods, filings, notices, reports, consents, registrations, approvals, permits and
authorizations contemplated by <u>Section</u><u></u><u>&nbsp;5.4(a)</u> expire, are made or obtained, as applicable, with or without notice, lapse of time or both, constitute or result in a breach or violation of or a contravention or conflict with
any Law to which the Company or any of its Subsidiaries is subject; or (iii)&nbsp;assuming (A)&nbsp;the waiting periods, filings, notices, reports, consents, registrations, approvals, permits and authorizations contemplated by
<u>Section</u><u></u><u>&nbsp;5.4(a)</u> expire, are made or obtained, as applicable, and (B)&nbsp;the consents and approvals set forth on <u>Section</u><u></u><u>&nbsp;5.4(a)</u> of the Company Disclosure Letter are obtained, with or without
notice, lapse of time or both, constitute or result in a breach or violation of, or default under, or cause or permit a termination, <font style="white-space:nowrap">non-renewal</font> or modification of or acceleration, loss or creation of any
right or obligation under or the creation of an Encumbrance on any of the rights, properties or assets of the Company or any of its Subsidiaries pursuant to, any Contract (excluding any Company Benefit Plan) binding upon the Company or any of its
Subsidiaries or any License necessary to the conduct of the business of the Company or any its Subsidiaries as currently conducted, except, in the case of clauses&nbsp;(ii) and (iii)&nbsp;of this <u>Section</u><u></u><u>&nbsp;5.4(b)</u>, as would
not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.5. <u>Compliance with Laws;
Licenses</u>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The businesses of the Company and its Subsidiaries are not currently being conducted, and at no time since
March&nbsp;31, 2017 have been conducted, in violation of any applicable Law (including, for the avoidance of doubt, applicable Law relating to Processing of Personal Information), except for violations that would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect. To the Knowledge of the Company, as of the date of this Agreement, no investigation or review by any Governmental Entity with respect to the Company or any of its Subsidiaries is pending
or threatened in writing, other than those the outcome of which would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company and its Subsidiaries hold and at all times since March&nbsp;31, 2017 have held all Licenses, and since March&nbsp;31, 2017
have filed all required tariffs, reports, notices and other documents with all applicable Governmental Entities and paid all fees and assessments due and payable in connection therewith, in each case necessary for the Company and each of its
Subsidiaries to own, lease and operate its properties and assets as presently conducted and used, and to carry on and operate its businesses as currently conducted, except where such failures would not reasonably be expected to have, individually or
in the aggregate, a Material Adverse Effect. All such Licenses are in full force and effect (or are the subject of a submitted and pending License) and no suspension or cancellation of any of the Licenses is pending or, to the Knowledge of the
</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-13- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company, threatened in writing, and the Company and its Subsidiaries are in compliance with the terms of such Licenses, except where the failure to be in full force and effect or failure to so
comply would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) None of the Company,
its Subsidiaries or any of their respective Representatives has materially violated or is in material violation of the Foreign Corrupt Practices Act of 1977 or any other Law (excluding Healthcare Laws) relating to bribery, corruption or similar
activities, nor has any such Person: (i)&nbsp;used any funds of the Company or any of its Subsidiaries for unlawful contributions, gifts, entertainment or other expenses relating to political activity; (ii)&nbsp;made any unlawful payment to foreign
or domestic governmental officials or other Representatives of any Governmental Entity or to foreign or domestic political parties or campaigns from funds of the Company or any of its Subsidiaries; (iii)&nbsp;established or maintained any unlawful
fund of monies or other assets of the Company or any Company Subsidiary; (iv)&nbsp;made any fraudulent entry on the books or records of the Company or any of its Subsidiaries; (v)&nbsp;made any unlawful bribe, rebate, payoff, influence payment,
kickback or other payment to any Person, private or public, regardless of form, whether in money, property or services, to obtain favorable treatment in securing business to obtain special concessions for the Company or any of its Subsidiaries; or
(vi)&nbsp;engaged in any transaction or dealing in property or interests in property of, received from or made any contribution of funds, goods or services to or for the benefit of, provided any payments or material assistance to, or otherwise
engaged in or facilitated any transactions with a Prohibited Person. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.6. <u>Company Reports</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company has filed all Company Reports required to be filed with the SEC and has timely paid all fees due in connection therewith. All
Company Reports filed or furnished since the Applicable Date have been filed or furnished on a timely basis. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each of the Company
Reports filed or furnished since the Applicable Date, at the time of its filing or being furnished (or, if amended or supplemented, as of the date of such amendment or supplement, or, in the case of a Company Report that is a registration statement
filed pursuant to the Securities Act or a proxy statement filed pursuant to the Exchange Act, on the date of effectiveness of such Company Report or date of the applicable meeting, respectively), complied or will comply (as applicable), with the
applicable requirements of the Securities Act, the Exchange Act and the Sarbanes-Oxley Act. The Company Reports filed or furnished since the Applicable Date have not and will not (as applicable) contain any untrue statement of a material fact or
omit to state a material fact required to be stated therein or necessary to make the statements made therein, in light of the circumstances in which they were made, not misleading; <u>provided</u>, that the Company makes no representation or
warranty with respect to any information supplied by Parent or any of its Representatives for inclusion or incorporation by reference in the Proxy Statement. As of the date of this Agreement, there are no outstanding or unresolved comments received
from the SEC with respect to any Company Report and, to the Knowledge of the Company, (i)&nbsp;none of the Company Reports is the subject of ongoing SEC review and (ii)&nbsp;there are no internal investigations pending or threatened in writing
regarding any accounting practices of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) None of the Subsidiaries of the Company is subject to the reporting requirements
of Section&nbsp;13a or 15d of the Exchange Act, is required to file periodic reports with the SEC or is subject to the reporting requirements of any foreign Governmental Entity that regulates securities or any applicable foreign securities Law or
any exchange or quotation service. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.7. <u>Disclosure Controls and Procedures and Internal Control Over Financial Reporting</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company maintains disclosure controls and procedures effective to ensure, at a reasonable assurance level, that information required
to be disclosed by the Company is recorded and reported on a timely basis to the individuals responsible for the preparation of the Company’s filings with the SEC and other public disclosure documents. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-14- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company maintains internal control over financial reporting effective to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP and includes policies and procedures that (i)&nbsp;pertain to the maintenance of records
that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company, (ii)&nbsp;provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements
in accordance with GAAP, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management of the Company and the Company Board and (iii)&nbsp;provide reasonable assurance regarding prevention or
timely detection of unauthorized acquisition, use or disposition of the assets of the Company that could have a material effect on its financial statements. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company has disclosed, based on the most recent evaluation of its chief executive officer and its chief financial officer prior to the
date of this Agreement, to the Company’s auditors and the Audit Committee, (i)&nbsp;any significant deficiencies in the design or operation of its internal controls over financial reporting that are reasonably expected to adversely affect the
Company’s ability to record, process, summarize and report financial information and has identified for the Company’s auditors and Audit Committee any material weaknesses in internal control over financial reporting, and (ii)&nbsp;any
fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Since the Applicable Date, no material complaints from any source regarding accounting, internal accounting controls or auditing matters,
and no concerns from Company Employees regarding questionable accounting or auditing matters, have been received by the Company. The Company has made available to Parent (i)&nbsp;a summary of any disclosure made by management to the Company’s
auditors and Audit Committee contemplated by <u>Section</u><u></u><u>&nbsp;5.7(c)</u> since the Applicable Date, (ii)&nbsp;any material communication since the Applicable Date made by management or the Company’s auditors to the Audit Committee
required or contemplated by listing standards of NASDAQ, the Audit Committee’s charter or professional standards of the Public Company Accounting Oversight Board and (iii)&nbsp;a summary of all material complaints or concerns relating to other
matters made since the Applicable Date through the Company’s whistleblower hotline or equivalent system for receipt of employee concerns regarding possible violations of Law. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) No attorney representing the Company or any of its Subsidiaries, whether or not employed by the Company or any of its Subsidiaries, has
reported evidence of a violation of securities Laws, breach of fiduciary duty or similar violation by the Company or any of its Representatives to the Company’s chief legal officer, Audit Committee (or other committee of the Company Board
designated for the purpose) or the Company Board pursuant to the rules adopted pursuant to Section&nbsp;307 of the Sarbanes-Oxley Act or any Company policy contemplating such reporting, including in instances not required by those rules. Since the
Applicable Date, the Company has been and is in compliance in all material respects with all applicable provisions of the Sarbanes-Oxley Act and the listing and corporate governance rules and regulations of the NASDAQ. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.8. <u>Financial Statements; No Undisclosed Liabilities; <font style="white-space:nowrap">Off-Balance</font> Sheet Arrangements</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each of the consolidated balance sheets and consolidated statements of operations, comprehensive income, stockholders’ equity and
cash flows included in or incorporated by reference into the Company Reports filed since the Applicable Date: (i)&nbsp;were or will be prepared (as applicable), in each case in accordance with, in all material respects, (x)&nbsp;all applicable
accounting requirements and rules and regulations of the SEC, the Exchange Act and the Securities Act and (y)&nbsp;GAAP, except as may be specifically noted in the notes thereto; (ii)&nbsp;did or will fairly present (as applicable), the consolidated
financial position of the Company and its consolidated Subsidiaries as of its date and the consolidated results of operations, retained earnings (loss) and changes in financial position, as the case may be, of such companies for the periods set
forth therein, as applicable (subject, in the case of any unaudited statements, to specific notes (none of which if presented would materially differ from those presented in the audited statements) and normal and recurring <font style="white-space:nowrap">year-end</font> audit adjustments that will not be material in amount or effect, individually or in the aggregate), in each case, in all </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-15- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
material respects; and (iii)&nbsp;were or will be prepared (as applicable) from and are in accordance with the books and records of the Company and its Subsidiaries. There are no unconsolidated
Subsidiaries of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except for obligations and liabilities (i)&nbsp;specifically reflected or adequately reserved against in
the Company’s most recent consolidated balance sheet included in or incorporated by reference into the Company Reports filed prior to the date of this Agreement, (ii)&nbsp;incurred in the Ordinary Course of Business since the date of such
consolidated balance sheet or incurred in compliance with <u>Section</u><u></u><u>&nbsp;7.1(a)</u>, (iii) expressly contemplated by this Agreement or incurred in connection with the transactions contemplated by this Agreement or (iv)&nbsp;that would
not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, there are no fines, penalties, awards, costs and expenses, obligations, debts or liabilities of the Company or any of its Subsidiaries, known or
unknown, whether or not accrued, contingent or otherwise. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Neither the Company nor any of its Subsidiaries is a party to, or has any
commitment to become a party to, any joint venture, <font style="white-space:nowrap">off-balance</font> sheet partnership or any similar Contract or arrangement (including any Contract relating to any transaction or relationship between or among the
Company or one or more of its Subsidiaries, on the one hand, and any other Person, including any structured finance, special purpose or limited purpose entity or Person, on the other hand), or any
<font style="white-space:nowrap">“off-balance</font> sheet arrangements” (as defined in Item 303(a) of Regulation <font style="white-space:nowrap">S-K</font> of the Securities Act). </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.9. <u>Litigation</u>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As
of the date hereof, there are no Proceedings for an amount in excess of $5,000,000 individually or $10,000,000 in the aggregate pending or, to the Knowledge of the Company, threatened in writing against the Company or any of its Subsidiaries or any
Indemnified Party. As of the Closing Date, there will be no Proceedings pending or, to the Knowledge of the Company, threatened in writing against the Company or any of its Subsidiaries or any Indemnified Party, except as would not reasonably be
expected to have, individually or in the aggregate, a Material Adverse Effect. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Neither the Company nor any of its Subsidiaries nor
any of their respective properties, assets or businesses is a party to or subject to the provisions of any Order (other than those of general applicability) that restricts the manner in which the Company and its Subsidiaries conduct their businesses
in any material respect, is otherwise material to the Company and its Subsidiaries or that would, individually or in the aggregate, reasonably be expected to prevent, materially delay or materially impair the ability of the Company to consummate the
transactions contemplated by this Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.10. <u>Absence of Certain Changes</u>. Since March&nbsp;31, 2020 and through the date of
this Agreement, (a)&nbsp;the Company and its Subsidiaries have conducted their respective businesses only in the Ordinary Course of Business, (b)&nbsp;there has not been a Material Adverse Effect, and (c)&nbsp;there has not been any action taken by
the Company or any of its Subsidiaries that, if taken during the Interim Period, would constitute a breach of any of the covenants set forth in <u>Sections 7.1(a)(ii)</u> (<i>Mergers, Reorganizations</i>), <u>7.1(a)(v)</u> (<i>Equity Interests</i>),
<u>7.1(a)(xiii)</u> (<i>Cancel Indebtedness</i>), <u>7.1(a)(xiv)</u> (<i>Litigation</i>) or <u>7.1(a)(xvii)(A)</u> (<i>Compensation Increases</i>) solely with respect to (x)&nbsp;increases in annual base salary or wage rate, (y)&nbsp;material
increases (<i>i.e.</i> of 10% or more) in target bonus opportunity or (z)&nbsp;material increases in benefits (measured in the aggregate), in each case, for employees with an annual base salary or wage rate in excess of $300,000. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.11. <u>Material Contracts</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <u>Section 5.11(a)</u> of the Company Disclosure Letter sets forth a list of all of the Contracts described below which the Company or any
of its Subsidiaries is a party to or bound by, as of the date of this Agreement (other than any Company Benefit Plan) (each such Contract, a “<u>Material Contract</u>”): </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) any Contract that is a “material contract” (as such term is defined in Item 601(b)(10) of Regulation <font style="white-space:nowrap">S-K</font> of the SEC); </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-16- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) any Company Government Contract providing for aggregate payments in excess of
$5,000,000 over the twelve months prior to the date hereof; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) the Specified Tax Agreements and any similar Tax “hold
harmless,” sharing, allocation or indemnification agreement or arrangement (other than, in each case, such agreements or arrangements solely between or among the Company and any of its Wholly Owned Subsidiaries); </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) any Contract that (A)&nbsp;purports to restrict, in any material respect, the ability of the Company or any of its Subsidiaries or, at
or after the Effective Time, Parent or any of its Subsidiaries from (1)&nbsp;directly or indirectly, engaging in any business or competing in any business (or line of business or geographic region) with any Person (including soliciting clients or
customers) or (2)&nbsp;operating its business in any manner or location, (B)&nbsp;could require the, direct or indirect, disposition of any material assets or line of business of the Company or its Subsidiaries or acquisition of any material assets
or line of business of any other Person or, at or after the Effective Time, Parent or any of its Subsidiaries or (C)&nbsp;other than with respect to Company Government Contracts pursuant to applicable Law, grants “most favored nation”
status to any Person or contains “exclusivity” requirements, obligations or similar provisions that, at or after the Effective Time, would purport to apply to Parent or any of its Subsidiaries; </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) any Contract pursuant to which the Company or any of its Subsidiaries (A)&nbsp;grants to a third party any licenses or other rights with
respect to Company Intellectual Property or (B)&nbsp;obtains any licenses or other rights with respect to third party Intellectual Property Rights (other than <font style="white-space:nowrap">non-exclusive</font> licenses to commercially available
Software), in each case of (A)&nbsp;and (B), which such Contract is material to the conduct of the business of the Company or any of its Subsidiaries; </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) any Contract the primary purpose of which is the Processing of Personal Information, other than Contracts that are HIPAA business
associate agreements entered into in the Ordinary Course of Business, in each case, which such Contract is material to the conduct of the business of the Company or any of its Subsidiaries (“<u>Privacy-Related Contracts</u>”); </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) any Contract pursuant to which the Company or any of its Subsidiaries, as applicable, has agreed (A)&nbsp;to provide any third party
with access to source code for any material software owned or exclusively licensed by the Company or any of its Subsidiaries, or (B)&nbsp;to provide for such source code to be placed in escrow or a similar arrangement for the benefit of a third
party (including upon the occurrence of specified events); </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii) with respect to each (1)&nbsp;Material Customer, any Contract that
accounted for a material amount of revenue recognized from such Material Customer during the Material Customer/Vendor Measurement Period and (2)&nbsp;Material Vendor, the Contract or set of related Contracts that accounted for the majority of
amounts paid to such Material Vendor during the Material Customer/Vendor Measurement Period (<u>provided</u>, that solely for purposes of this clause (viii), (A) the term “Material Customer” shall have the meaning ascribed thereto in
<u>Section</u><u></u><u>&nbsp;5.12(a)</u>, except that the reference to “20” in such definition shall be replaced with a reference to “10”, and (B)&nbsp;the term “Material Vendor” shall have the meaning ascribed thereto
in <u>Section</u><u></u><u>&nbsp;5.12(b)</u>, except that the reference to “20” in such definition shall be replaced with a reference to “10”; <u>provided</u>, <u>further</u>, that, within 15 Business Days following the date of
this Agreement, the Company shall use its reasonable best efforts to make available to Parent all Contracts between the Company or any of its Subsidiaries, on the one hand, and any Material Customer or Material Vendor (each as defined in
<u>Section</u><u></u><u>&nbsp;5.12(a)</u> and <u>Section</u><u></u><u>&nbsp;5.12(b)</u>), on the other hand); </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ix) any Contract between
the Company or any of its Subsidiaries, on the one hand, and any director or officer of the Company or any Person beneficially owning five percent or more of the outstanding Shares or shares of common stock of any of their respective Affiliates, on
the other hand; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(x) any Contract (A)&nbsp;providing for material indemnification or guarantee obligations by the Company or any of its
Subsidiaries of any Person or pursuant to which any material indemnification or guarantee </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-17- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
obligations of the Company or any of its Subsidiaries remain outstanding or otherwise survive as of the date of this Agreement or (B)&nbsp;containing any deferred or contingent purchase price,
“earnout” or similar provisions that would cause the Company or any of its Subsidiaries to owe any amount of additional consideration to any Person which remain outstanding or otherwise survive as of the date of this Agreement; </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xi) any Contract for Indebtedness or any hedging agreement, in either case, having an outstanding principal or notional amount (as
applicable) in excess of $25,000,000 (and <u>Section</u><u></u><u>&nbsp;5.11(a)(xi)</u> of the Company Disclosure Letter sets forth, as of September&nbsp;30, 2020, the amount outstanding or the notional value with respect to each such Contract, as
applicable); </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xii) any collective bargaining agreement or other agreement with a labor union, labor organization, works council or
similar organization to which the Company or any of its Subsidiaries is a party; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiii) any material joint venture, partnership or
limited liability company agreement, or other similar Contract, providing for the formation, creation, operation, management or control of any material joint venture, partnership or limited liability company; </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiv) any Contract creating any (A)&nbsp;Encumbrance (other than Permitted Encumbrances) upon any assets of the Company and its Subsidiaries
securing obligations in excess of $25,000,000 or (B)&nbsp;Encumbrance upon any assets of the Company and its Subsidiaries securing Indebtedness in excess of $25,000,000; and </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xv) any Contract that grants any rights of first refusal, rights of first offer, rights of first negotiation or other similar rights to any
person with respect to any material assets, rights or properties of the Company or any of its Subsidiaries. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) A correct and complete
copy of each Material Contract (including any amendments or supplements thereto adopted prior to the date hereof) has been made available to Parent. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each Material Contract is valid and binding on the Company or one or more of its Subsidiaries, as the case may be, and, to the Knowledge
of the Company, each other party thereto, and is in full force and effect. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) There is no breach or violation of, or default under, any
Material Contract by the Company or any of its Subsidiaries or, to the Knowledge of the Company, any other party thereto, and no event has occurred that with or without notice, lapse of time or both, would constitute or result in a breach or
violation of, or default under, any such Contract by the Company or any of its Subsidiaries or, to the Knowledge of the Company, any other party thereto or would permit or cause the termination, <font style="white-space:nowrap">non-renewal</font> or
modification thereof or acceleration or creation of any right or obligation thereunder. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.12. <u>Material Customers; Material
Vendors</u>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <u>Section</u><u></u><u>&nbsp;5.12(a)</u> of the Company Disclosure Letter sets forth a correct and complete list as of
the date of this Agreement of the 20 largest customers (each, a “<u>Material Customer</u>”) of the Company and its Subsidiaries, taken as a whole, based on revenue recognized from such customers during the period commencing on
October&nbsp;1, 2019 and through November&nbsp;30, 2020 (the “<u>Material Customer/Vendor Measurement Period</u>”), showing the aggregate amount of revenue recognized from such Material Customer during such period. During the period from
January&nbsp;1, 2020 through the date of this Agreement, neither the Company nor any of its Subsidiaries has been engaged in any material dispute with any Material Customer. Except as would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect, as of the date hereof, neither the Company nor any of its Subsidiaries has received any written notice from any Material Customer expressly stating any intention or threat to terminate or reduce purchases from
the Company or any of its Subsidiaries. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-18- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <u>Section</u><u></u><u>&nbsp;5.12(b)</u> of the Company Disclosure Letter sets forth a
correct and complete list as of the date of this Agreement of the 20 largest vendors (each, a “<u>Material Vendor</u>”) of the Company and its Subsidiaries, taken as a whole, based on amounts paid by the Company and its Subsidiaries to
such vendor (excluding any offsets) during the Material Customer/Vendor Measurement Period. During the period from January&nbsp;1, 2020 through the date of this Agreement, neither the Company nor any of its Subsidiaries has been engaged in any
material dispute with any Material Vendor. Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, as of the date hereof, neither the Company nor any of its Subsidiaries has received any
written notice from any Material Vendor expressly stating any intention or threat to terminate or reduce its provision of goods or services to the Company and its Subsidiaries. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.13. <u>Employee Benefits</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <u>Section</u><u></u><u>&nbsp;5.13(a)</u> of the Company Disclosure Letter sets forth a correct and complete list of each material Company
Benefit Plan as of the date hereof. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) With respect to each Company Benefit Plan on<u> Section</u><u></u><u>&nbsp;5.13(a)</u> of the
Company Disclosure Letter, the Company has made available to Parent, as of the date of this Agreement and to the extent applicable, correct and complete copies of (i)&nbsp;the Company Benefit Plan document, including, for the avoidance of doubt, any
amendments or supplements thereto, and all related trust documents or other funding vehicle documents (or where no such copies are available, a reasonably detailed written description thereof), (ii)&nbsp;the most recently prepared actuarial report
and (iii)&nbsp;all material correspondence to or from any Governmental Entity received since January&nbsp;1, 2019 with respect thereto (or where no such copies are available, a reasonably detailed written description thereof). </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each Company Benefit Plan (including any related trusts) has been established, operated and administered in compliance with its terms and
applicable Law, including ERISA and the Code, in each case, except as would not reasonably be expected to result in, individually or in the aggregate, material liability to the Company and its Subsidiaries, taken as a whole. All material
contributions or other amounts payable by the Company or any of its Subsidiaries with respect thereto in respect of current or prior plan years have been paid or accrued in accordance with GAAP and there are no Proceedings (other than routine claims
for benefits) pending or, to the Knowledge of the Company, threatened by a Governmental Entity by, on behalf of or against any Company Benefit Plan or any trust related thereto. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) With respect to each ERISA Plan on <u>Section</u><u></u><u>&nbsp;5.13(a)</u> of the Company Disclosure Letter, the Company has made
available to Parent, to the extent applicable, correct and complete copies of (i)&nbsp;the most recent summary plan description together with any summaries of all material modifications and supplements thereto, (ii)&nbsp;the most recent IRS
determination or opinion letter and (iii)&nbsp;the most recent annual report (Form 5500 or 990 series and, for the avoidance of doubt, all schedules and financial statements attached thereto). </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Each ERISA Plan that is intended to be qualified under Section&nbsp;401(a) of the Code has been determined by the IRS to be so qualified
and, to the Knowledge of the Company, nothing has occurred that would materially and adversely affect the qualification or Tax exemption of any such Company Benefit Plan. With respect to any ERISA Plan, neither the Company nor any of its
Subsidiaries has engaged in a transaction in connection with which the Company or any of its Subsidiaries reasonably could be subject to either a civil penalty assessed pursuant to Section&nbsp;409 or 502(i) of ERISA or a Tax imposed pursuant to
Section&nbsp;4975 of the Code, in each case, except as would not reasonably be expected to result in, individually or in the aggregate, material liability to the Company and its Subsidiaries, taken as a whole. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Neither the Company nor any Company ERISA Affiliate has in the last six years contributed (or has any obligation) to a plan that is
subject to Section&nbsp;412 of the Code or Section&nbsp;302 or Title IV of ERISA. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Neither the Company nor any Company ERISA Affiliate
has maintained, established, participated in or contributed to, or is or has been obligated to contribute to, or has otherwise incurred any obligation or liability (including any contingent liability) under, any Multiemployer Plan in the last six
years. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-19- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) No Company Benefit Plan is a “multiple employer welfare arrangement” (as
defined in Section&nbsp;3(40) of ERISA). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Except as required by applicable Law, no Company Benefit Plan provides material retiree or
post-employment medical, disability, life insurance or other welfare benefits to any Person, and none of the Company or any of its Subsidiaries has any obligation to provide any such benefits. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) None of the execution and delivery of or the performance under this Agreement or the consummation of the transactions contemplated by this
Agreement could, either alone or in combination with another event, (i)&nbsp;entitle any Company Employee to severance pay or any material increase in severance pay, (ii)&nbsp;except as provided in <u>Section</u><u></u><u>&nbsp;4.2</u>, accelerate
the time of payment or vesting, or materially increase the amount of compensation due to any such Company Employee, (iii)&nbsp;directly or indirectly cause the Company to transfer or set aside any assets to fund any material benefits under any
Company Benefit Plan or (iv)&nbsp;limit or restrict the right to merge, terminate, materially amend, supplement or otherwise modify or transfer the assets of any Company Benefit Plan on or following the Effective Time. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) None of the execution and delivery of or the performance under this Agreement, the receipt of the Requisite Company Vote or other approval
of this Agreement or the consummation of the transactions contemplated by this Agreement could, either individually or in combination with another event, result in the payment of any amount that could, individually or in combination with any other
such payment, constitute an “excess parachute payment” as defined in Section&nbsp;280G(b)(1) of the Code. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) Neither the
Company nor any Subsidiary thereof has any obligation to provide, and no Company Benefit Plan or other agreement or arrangement provides any individual with the right to, a gross up, indemnification, reimbursement or other payment for any excise or
additional Taxes incurred pursuant to Section&nbsp;409A or Section&nbsp;4999 of the Code or due to the failure of any payment to be deductible under Section&nbsp;280G of the Code. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) Except as would not reasonably be expected to result in, individually or in the aggregate, material liability to the Company and its
Subsidiaries, taken as a whole, all Company Benefit Plans that are maintained primarily for the benefit of employees outside of the United States (i)&nbsp;have been maintained and operated in accordance with, and are in compliance with, their terms,
applicable local Law, government taxation and funding requirements, (ii)&nbsp;to the extent required to be registered or approved by a foreign Governmental Entity, have been registered with, or approved by, a foreign Governmental Entity and
(iii)&nbsp;to the Company’s Knowledge, to the extent intended to be funded and/or book reserved, are funded and/or book reserved, as appropriate, based upon reasonable actuarial assumptions. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.14. <u>Labor Matters</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Neither of the Company nor any of its Subsidiaries is a party to or bound by any collective bargaining agreement or other agreement with a
labor union, labor organization, works council or similar organization, and to the Knowledge of the Company, there are no activities or Proceedings by any individual or group of individuals, including representatives of any labor unions, labor
organizations, works councils or similar organizations, to organize any employees of the Company or any of its Subsidiaries. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except
as would not reasonably be expected to result in, individually or in the aggregate, material liability to the Company and its Subsidiaries, taken as a whole, (i)&nbsp;there is no, and since January&nbsp;1, 2019 there has not been any, strike,
lockout, material slowdown, material work stoppage, unfair labor practice or other material labor dispute, or arbitration or grievance pending or, to the Knowledge of the Company, threatened, that may interfere in any material respect with the
respective business activities of the Company or any of its Subsidiaries or prevent, materially delay or materially impair the ability of the Company to consummate the transactions contemplated by this Agreement, (ii)&nbsp;the Company and each of
its Subsidiaries is in material compliance with all </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-20- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
applicable Law regarding labor, employment and employment practices, terms and conditions of employment, wages and hours (including classification of employees, discrimination, harassment and
equitable pay practices), and occupational safety and health, including the appropriate classification of all current and former Company Employees as “exempt” or <font style="white-space:nowrap">“non-exempt”</font> and the
payment of appropriate overtime and (iii)&nbsp;neither the Company nor any of its Subsidiaries has incurred any obligation or liability under the Worker Adjustment and Retraining Notification Act or any similar state or local Law that remains
unsatisfied. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except as would not reasonably be expected to result in, individually or in the aggregate, material liability to the
Company and its Subsidiaries, taken as a whole, (i)&nbsp;any individual who has performed or is performing services for the Company who has been classified as an independent contractor, as an employee of another entity whose services are leased to
the Company, or any other <font style="white-space:nowrap">non-employee</font> category by the Company or any of its Subsidiaries has been or is correctly so classified and, in the case of any <font style="white-space:nowrap">non-employee</font>
classification, has not at any time while classified as a <font style="white-space:nowrap">non-employee</font> by the Company or any of its Subsidiaries been a common law employee of the Company, (ii)&nbsp;there are no, and since January&nbsp;1,
2019 there have not been any, pending, or, to the Company’s Knowledge, threatened Proceedings (including any litigation, class action suit, or regulatory investigation) against the Company or any of its Subsidiaries with respect to the
classification or misclassification of Company Employees and (iii)&nbsp;neither the Company nor any of its Subsidiaries has any direct or indirect liability with respect to the misclassification of any person who is performing or has performed
services for the Company or any of its Subsidiaries (whether as an employee or independent contractor or exempt or <font style="white-space:nowrap">non-exempt</font> employee), and the Company does not have any Knowledge of any pending claim, or
claim threatened in writing, by any person who is performing or has performed services for the Company or any of its Subsidiaries that he/she is or was misclassified for any purpose. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) To the Company’s Knowledge, since January&nbsp;1, 2019, no allegations of sexual harassment have been made against any individual in
his or her capacity as (i)&nbsp;an officer of the Company or any of its Subsidiaries, (ii)&nbsp;a member of the Company Board or any of its Subsidiaries or (iii)&nbsp;an employee of the Company or any of its Subsidiaries at the level of vice
president or above. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Prior to the execution and delivery of this Agreement, the Company has made available to Parent a complete and
accurate list of the employee identification number, job title, job grade (as applicable), current base salary or wage rate, base salary or wage rate for the previous year, target incentive compensation (as applicable), bonus payments in the last
year, date of commencement of employment, work location, full-time or part-time status, exempt or <font style="white-space:nowrap">non-exempt</font> status, temporary or permanent status, status as an active or inactive employee, and date of
commencement of leave (as applicable), of each employee of the Company and its Subsidiaries as of the date of this Agreement (or as of a day within the five days prior to the date of this Agreement). </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.15. <u>Environmental Matters</u>. Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect: (a)&nbsp;since March&nbsp;31, 2017, the Company and its Subsidiaries have complied at all times with all applicable Environmental Laws and have not received any claims or notices alleging liability under any Environmental Law; (b)&nbsp;to
the Knowledge of the Company,&nbsp;no real property currently or formerly owned or operated by the Company or any of its Subsidiaries has been contaminated with any Hazardous Substances that could be expected to require remediation under any
Environmental Law; and (c)&nbsp;to the Knowledge of the Company, there are no other circumstances involving the Company or any of its Subsidiaries that would reasonably be expected to result in any claims, liabilities, costs or restrictions on the
ownership, use or transfer of any property pursuant to any Environmental Law. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.16. <u>Tax Matters</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company and each of its Subsidiaries (i)&nbsp;have prepared in good faith and duly and timely filed (taking into account any extension
of time within which to file) all income and other material Tax Returns required to be filed by any of them with the appropriate Taxing Authority and all such filed Tax Returns are correct and complete in all material respects, (ii)&nbsp;have timely
paid all material Taxes that are required to be paid </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-21- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(whether or not shown on any Tax Returns), (iii)&nbsp;have timely withheld and paid all material Taxes required to have been withheld and paid in connection with amounts paid or owing to any
employee, stockholder, creditor, independent contractor or third party (each as determined for Tax purposes), and (iv)&nbsp;have not waived any statute of limitations with respect to material amounts of Taxes or agreed to any extension of time with
respect to a material Tax assessment or deficiency (except for automatic extensions of time to file income Tax Returns obtained in the ordinary course of business). </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The U.S. federal income Tax Returns of the Company and each of its Subsidiaries for all taxable years up to and including March&nbsp;31,
2017 have been examined by the IRS or are Tax Returns with respect to which the applicable period for assessment under applicable Law, after giving effect to extensions or waivers, has expired. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) No deficiency with respect to any material amount of Taxes has been proposed, asserted or assessed against the Company or any of its
Subsidiaries and there are no pending or, to the Knowledge of the Company, threatened Proceedings regarding any material amount of Taxes of the Company and its Subsidiaries or the properties or assets of the Company and its Subsidiaries. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Since April&nbsp;1, 2014, neither the Company nor any of its Subsidiaries has been subject to any claim by any Taxing Authority that such
Taxing Authority believes that the Company or any of its Subsidiaries was required to file any material Tax Return that was not filed, which claim has not been resolved with such Taxing Authority. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Company has made available to Parent correct and complete copies of any Tax rulings or requests (including private letter rulings and
requests), closing agreements, gain recognition agreements or similar agreements, and opinion letters (and related representation letters) with respect to any Specified Transactions and other material Tax matters of the Company or any of its
Subsidiaries, requested, executed or issued, as applicable, since April&nbsp;1, 2014. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) There are no Encumbrances for Taxes (except
Permitted Encumbrances) on any of the properties or assets of the Company or any of its Subsidiaries. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Neither the Company nor any of
its Subsidiaries is a party to or is bound by any Tax “hold harmless,” sharing, allocation or indemnification agreement or arrangement or has any liability or potential liability under any such agreement or arrangement (other than
(A)&nbsp;such an agreement or arrangement solely between or among the Company and any of its Wholly Owned Subsidiaries, (B)&nbsp;Specified Tax Agreements, (C)&nbsp;the Tax Receivable Letter Agreement and (D)&nbsp;customary commercial contracts the
principal subject of which is not Taxes). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Neither the Company nor any of its Subsidiaries has made or will be required to make any
payments under the Tax Receivable Letter Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Neither the Company nor any of its Subsidiaries acquired on or after
March&nbsp;1, 2017 (i) has been a member of an affiliated, consolidated, combined or unitary group for income Tax purposes (other than a group the common parent of which was Distributing, the Company or any of their respective Subsidiaries) or
(ii)&nbsp;has any obligation or liability for the Taxes of any Person (other than Distributing, the Company or any of their respective Subsidiaries) under Treasury Regulation <font style="white-space:nowrap">Section&nbsp;1.1502-6</font> (or any
similar provision of state, local or <font style="white-space:nowrap">non-U.S.</font> Law), as a transferee or successor, by Contract or otherwise. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Neither the Company nor any of its Subsidiaries has taken or failed to take any action, or is aware of any fact or circumstance, that
would reasonably be expected to adversely affect the Intended <font style="white-space:nowrap">Tax-Free</font> Treatment. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) Neither the
Company nor any of its Subsidiaries has been, within the past two years (other than the <font style="white-space:nowrap">Split-Off)</font> or otherwise as part of a “plan (or series of related transactions)” within the meaning of
Section&nbsp;355(e) </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-22- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the Code of which the Merger is also a part, a “distributing corporation” or a “controlled corporation” (within the meaning of Section&nbsp;355(a)(1)(A) of the Code) in a
distribution of stock intended to qualify for <font style="white-space:nowrap">tax-free</font> treatment under Section&nbsp;355 of the Code. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) Since March&nbsp;1, 2017, neither the Company nor any of its Subsidiaries has participated in a “reportable transaction” within
the meaning of Treasury Regulations <font style="white-space:nowrap">Section&nbsp;1.6011-4(b)</font> or any other transaction requiring disclosure under analogous provisions of state, local or <font style="white-space:nowrap">non-U.S.</font> Law.
</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) Neither the Company nor any of its Subsidiaries will be required to include any material amount of income in, or to exclude any
material item of deduction from, taxable income in any taxable period (or portion thereof) ending after the Closing Date as a result of any closing agreement, installment sale or open transaction on or prior to the Closing Date, any accounting
method change or agreement with any Taxing Authority, any prepaid amount received on or prior to the Closing Date (other than prepaid amounts substantially consistent with those shown on the Company and its Subsidiaries’ federal income Tax
Returns for the tax year ended March&nbsp;31, 2019), any intercompany transaction or excess loss account described in Section&nbsp;1502 of the Code (or any corresponding provision of state, local or <font style="white-space:nowrap">non-U.S.</font>
Law), or any election pursuant to Section&nbsp;965(h) of the Code (or any similar provision of state, local or <font style="white-space:nowrap">non-U.S.</font> Law) made with respect to any taxable period ending on or prior to the Closing Date. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) The U.S. federal income tax classification of each of the Company and its Subsidiaries is as listed on
<u>Section</u><u></u><u>&nbsp;5.16(n)</u> of the Company Disclosure Letter. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) Neither the Company nor any of its Subsidiaries has made
any payments, is obligated to make any payments or is a party to any agreement that under certain circumstances could obligate it to make any payments that will not be deductible under Section&nbsp;162(m) of the Code. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) On or before the date of this Agreement, the Company has delivered to Distributing, pursuant to Section&nbsp;9(c)(iv) of the Tax Matters
Agreement, a Tax Opinion, dated as of the date of this Agreement, a copy of which has been made available to Parent and which, as of the date of this Agreement, has not been withdrawn or revoked. As of the date of this Agreement, assuming that
Parent delivers to Company Tax Counsel representations 3, 4, 5, 7, 8, and 10 in the Parent Tax Representation Letter, the Company believes that Company Tax Counsel will be able to deliver to the Company at the Closing a Tax Opinion, as required by
<u>Section</u><u></u><u>&nbsp;8.2(f)</u>, either substantially the same in form and substance as that delivered to Distributing or as may be amended, modified, or supplemented pursuant to <u>Section</u><u></u><u>&nbsp;7.18(b)</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) Neither the Company nor any of its Subsidiaries has availed itself of any government grants, Tax holidays, loans or other Tax benefits or
relief related to <font style="white-space:nowrap">COVID-19,</font> including a loan under the paycheck protection program or relief pursuant to Sections 2301 or 2302 of the CARES Act or any similar applicable federal, state or local Law, other than
as set forth on <u>Section</u><u></u><u>&nbsp;5.16(q)</u> of the Company Disclosure Letter. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) Neither the Company nor any of its
Subsidiaries is or has ever been subject to Tax in any jurisdiction other than its country of incorporation, organization or formation by virtue of having employees, a permanent establishment or any other place of business in such jurisdiction. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s) Except as set forth on <u>Section</u><u></u><u>&nbsp;5.16(s)</u> of the Company Disclosure Letter, each Company Partnership has at all
times been a Wholly Owned Subsidiary of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(t) No election has ever been made to apply the BBA Rules to any Company Partnership
for a taxable period beginning prior to January&nbsp;1, 2018, and, with respect to taxable periods beginning on or after January&nbsp;1, 2018, each Company Partnership has made, or will make (or the Company or the applicable Subsidiary can cause
such Company Partnership to make) an election under Section&nbsp;6226(a) of the Code. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-23- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(u) As of the date of this Agreement, the Company (i)&nbsp;has delivered to Company Tax
Counsel the Company Tax Representation Letter and (ii)&nbsp;believes it will be able to provide the Company Tax Representation Letter at the Closing. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.17. <u>Real Property</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <u>Section</u><u></u><u>&nbsp;5.17(a)</u> of the Company Disclosure Letter sets forth a correct and complete list of all Owned Real
Property and Leased Real Property as of the date of this Agreement, together with (i)&nbsp;a description of the principal functions conducted at each parcel of such Owned Real Property and Leased Real Property and (ii)&nbsp;a correct street address
and such other information as is reasonably necessary to identify each parcel of such Owned Real Property and Leased Real Property. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
With respect to the Owned Real Property, (i)&nbsp;the Company or one or more of its Subsidiaries, as applicable, has good and marketable title to such property, free and clear of any Encumbrance (other than any Permitted Encumbrances) and
(ii)&nbsp;there are no outstanding options or rights of first refusal to purchase such property, or any portion thereof or interest therein. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) With respect to the Leased Real Property, (i)&nbsp;the lease or sublease for such property is valid, legally binding, enforceable and in
full force and effect in accordance with its terms, (ii)&nbsp;there is no breach or violation of, or default under, any such leases or subleases by the Company or any of its Subsidiaries or, to the Knowledge of the Company, any other party thereto,
and no event has occurred that with or without notice, lapse of time or both, would constitute or result in a breach or violation of, or default under, any such leases or subleases by the Company or any of its Subsidiaries or, to the Knowledge of
the Company, any other party thereto or would permit or cause the termination, <font style="white-space:nowrap">non-renewal</font> or modification thereof or acceleration or creation of any right or obligation thereunder, in each case except as
would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect and (iii)&nbsp;there are no written or oral subleases, concessions, licenses, occupancy agreements or other Contracts or arrangements granting to
any Person other than the Company or its Subsidiaries the right to use or occupy any such property. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.18. <u>Intellectual
Property</u><u>; Information Technology; Data Security</u>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <u>Section 5.18(a)</u> of the Company Disclosure Letter sets forth a
correct and complete list as of the date of this Agreement of all Registered Company Intellectual Property, indicating for each item (i)&nbsp;the name of the record owner, (ii)&nbsp;the applicable application, registration or serial or other similar
identification number, (iii)&nbsp;the jurisdiction in which such item has been registered or filed, (iv)&nbsp;the date of filing or issuance and (v)&nbsp;solely with respect to Internet domain names and primary social media accounts, the applicable
Internet domain name registrar and social media account registrar. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) All Registered Company Intellectual Property is subsisting and
neither the Company nor any of its Subsidiaries is a party to any outstanding Order issued by or with any Governmental Entity that adversely affects the Company’s or any of its Subsidiaries’ use of, or its rights to, such Intellectual
Property Rights. The issued and granted Registered Company Intellectual Property included therein is unexpired and valid, and to the Knowledge of the Company, enforceable. For the past three years, neither the Company nor any of its Subsidiaries has
received any written notice asserting any claims against the Company or any of its Subsidiaries challenging any of the foregoing, other than office actions from the United States Patent and Trademark Office or any equivalent foreign governmental
administrative agency received in the Ordinary Course of Business. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company and its Subsidiaries, as applicable, own or have
sufficient and valid rights pursuant to written agreements to use all Company Intellectual Property and all other Intellectual Property Rights used in or reasonably necessary for the operation of the business as currently conducted. The foregoing
representation shall not be interpreted to be a representation as to the <font style="white-space:nowrap">non-infringement</font> of any third party Intellectual Property Rights. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-24- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company and its Subsidiaries, as applicable, exclusively own all right, title and
interest to their material proprietary Company Intellectual Property, and are the owner of record of their material proprietary Registered Company Intellectual Property, free and clear of all Encumbrances (except Permitted Encumbrances). </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The conduct of the businesses of the Company and its Subsidiaries for the past three years has not infringed, misappropriated or otherwise
violated the Intellectual Property Rights other than patents (and, to the Knowledge of the Company, patents) of any Person, where such infringement, misappropriation or other violation has caused or is reasonably likely to cause material liability
to the Company or any of its Subsidiaries. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Neither the Company nor any of its Subsidiaries is a party to any Proceeding that is
pending or, to the Knowledge of the Company, threatened in writing, and neither the Company nor any of its Subsidiaries has received in the past five years any written notice or claim (including invitations to take a license), in each case alleging
that the conduct of the businesses of the Company and its Subsidiaries infringes, misappropriates or otherwise violates the Intellectual Property Rights of any third Person. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) There is no Proceeding pending or, to the Knowledge of the Company, threatened in writing against the Company or any of its Subsidiaries
that seeks to challenge or limit the Company’s or any of its Subsidiaries’, as applicable, ownership of or right to use any of the Company Intellectual Property. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) To the Knowledge of the Company, no Person has in the past three years infringed, misappropriated or otherwise violated any Company
Intellectual Property, and neither the Company nor any of its Subsidiaries is a party to any pending, outstanding, threatened or imminent Proceeding, or has sent, in the past three years, any written notice or claim (including invitations to take a
license) to any Person, alleging the foregoing. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Company and each of its Subsidiaries has taken reasonable efforts (including
executing <font style="white-space:nowrap">non-disclosure</font> agreements) to protect the confidentiality of their material Trade Secrets, and to the Knowledge of the Company, any material Trade Secrets of the Company have not been disclosed to or
used without authorization by any Person except pursuant to written, valid and appropriate <font style="white-space:nowrap">non-disclosure</font> or license agreements which, to the Knowledge of the Company, have not been breached in any material
respect. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) The Company and each of its Subsidiaries have obtained from all parties (including current or former employees, consultants
and contractors), who have created or developed any portion of the material Intellectual Property Rights developed on behalf of the Company or its Subsidiaries, written, valid and enforceable assignments of any such Intellectual Property Rights to
the Company or its applicable Subsidiaries. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) The Company and its Subsidiaries have established and implemented written policies and
organizational, physical, administrative and technical measures regarding privacy, cybersecurity and data security that are commercially reasonable and consistent with (i)&nbsp;applicable Law and (ii)&nbsp;the requirements of its and their
Privacy-Related Contracts (such policies and measures, collectively, the “<u>Privacy and Security Measures</u>”). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) The
Company and each of its Subsidiaries have included provisions in Contracts with applicable third party service providers, outsourcers or any other Person who Processes material Personal Information on behalf of the Company or any of its Subsidiaries
to ensure that the Company and its Subsidiaries comply with, applicable Law relating to the Processing of any Personal Information collected or otherwise used by the Company or its Subsidiaries in any manner (“<u>Company Personal
Information</u>”) in all material respects. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) Neither the Company nor any of its Subsidiaries has received any written notice,
communication or complaint from any Person alleging a breach of (or claiming compensation under) any applicable Law or the Privacy and Security Measures, except for individual complaints and requests in the Ordinary Course of Business that would not
reasonably be expected to result in, individually or in the aggregate, material liability to the Company or any of its Subsidiaries. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-25- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) No Person has gained unauthorized access to or misused any Company Personal Information
or any of the IT Assets (or information stored or contained therein or transmitted thereby) of the Company or any of its Subsidiaries except as would not result in, or reasonably be expected to result in, individually or in the aggregate, a material
obligation to the Company or any of its Subsidiaries or an obligation for the Company or any of its Subsidiaries to notify any Governmental Entity, including to make a filing with the SEC. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) The IT Assets used by the Company or any of its Subsidiaries (i)&nbsp;operate and perform in all material respects in accordance with
their documentation and functional specifications and otherwise as required by the business as presently conducted, (ii)&nbsp;have not materially malfunctioned or failed in the past three years and (iii)&nbsp;are free from material bugs or other
material defects, or Malicious Code. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) The Company and each of its Subsidiaries implement reasonable measures (including with respect
to technical and physical security), and as applicable, monitor compliance with such measures, to protect the confidentiality, integrity and security of its IT Assets and the information stored or contained therein or transmitted thereby (including
Personal Information) from any loss, disclosure, unauthorized use, access, interruption or modification by third Persons, including the implementation of reasonable backup and disaster recovery technology processes. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) No material proprietary Software included in the Company Intellectual Property that is distributed externally or is in development and
intended to be distributed externally is subject to any obligation or condition under any license that conditions such distribution of such Software on: (i)&nbsp;the disclosure, licensing or distribution of any source code for any portion of such
Software; (ii)&nbsp;the granting to licensees of the right to make derivative works or other modifications to such Software; (iii)&nbsp;the licensing under terms that allow such Software or portions thereof or interfaces therefor to be reverse
engineered, reverse assembled or disassembled (other than by operation of law); or (iv)&nbsp;redistribution of such Software at no license fee, in each case, except as would not reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) To the Knowledge of the Company, no Person other than the Company or its Subsidiaries (and its and their
respective authorized employees and contractors authorized to perform services on its or their behalf) has or has had access or possession of any source code for any proprietary Software included in the Company Intellectual Property. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.19. <u>HIPAA Compliance</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Since March&nbsp;31, 2017, the Company and its Subsidiaries have been in compliance in all material respects with HIPAA and all other
applicable similar state and foreign Laws related to the privacy and security of health information and medical records. The&nbsp;Company and its Subsidiaries have implemented policies and procedures to ensure compliance with HIPAA (and other
applicable similar state and foreign Laws related to health information and medical records) in all material respects. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company
and its Subsidiaries conduct security risk assessments as required under HIPAA. To the Knowledge of the Company: (i)&nbsp;neither the Company, its Subsidiaries, nor any of its or their subcontractors, has had any unauthorized use or disclosure of
Protected Health Information that would constitute a “breach” (as defined in 45 C.F.R. § 164.402) that would require the Company to provide notice under 45 C.F.R. § 164.404; (ii) no Proceeding has been initiated by the U.S.
Department of Health and Human Services or any other Governmental Entity (including, for the avoidance of doubt, state or foreign Governmental Entities) relating to actual or alleged <font style="white-space:nowrap">non-compliance</font> with HIPAA
or any other similar state or foreign Law related to medical records by the Company, its Subsidiaries or any of its or their subcontractors that is either still pending or has resulted in a corrective action plan, including Proceedings seeking a
compliance review or any similar inquiry or investigation, except as would not result in, or reasonably be expected to result in, a material obligation to the Company or any of its Subsidiaries; and (iii)&nbsp;the Company has not received written
notice from any Governmental Entity that a pending complaint has been filed with the U.S. Department of Health and Human </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-26- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Services or any other Governmental Entity (including, for the avoidance of doubt, state or foreign Governmental Entities) regarding compliance with HIPAA or any other similar state or foreign Law
regarding health information or medical records by the Company or its Subsidiaries. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.20. <u>FDA Compliance</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company and each of its Subsidiaries holds, and is operating in compliance in all material respects with, all Licenses of the U.S.
Food and Drug Administration (the “<u>FDA</u>”) and comparable state or foreign Governmental Entities required for the conduct of its respective businesses as currently conducted (collectively, the “<u>FDA Licenses</u>”). To the
Knowledge of the Company, neither the FDA nor any comparable state or foreign Governmental Entity has threatened to suspend or revoke any such FDA Licenses, or to change the marketing classification or labeling of any medical devices in any material
respect. The&nbsp;development, manufacture, distribution, sale and marketing of the Company’s and its Subsidiaries’ medical devices are in compliance in all material respects with all FDA Licenses. Since March&nbsp;31, 2017, the Company
and each of its Subsidiaries has established and is operating and maintaining its medical devices in compliance with all Device Laws, except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.
</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Since March&nbsp;31, 2017: (i) neither the Company nor any of its Subsidiaries has received any written notice from the FDA or any
comparable state or foreign Governmental Entity alleging that any product or service of the Company or any Company Subsidiary is in violation of any applicable Law, nor received any “warning letters,” “untitled letters” or
similar written communications from the FDA or any comparable state or foreign Governmental Entities; and (ii)&nbsp;there have been no recalls requested or, to the Knowledge of the Company, threatened in writing by the FDA or any comparable state or
foreign Governmental Entities relating to the products or services of the Company or any of its Subsidiaries. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.21. <u>Healthcare
Laws</u>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Since March&nbsp;31, 2017: (i) the Company and its Subsidiaries have been conducting their respective businesses in
compliance with applicable Healthcare Laws, except for such <font style="white-space:nowrap">non-compliance</font> as would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole; (ii)&nbsp;to the Knowledge
of the Company, there have been no Proceedings related to Healthcare Laws threatened in writing against the Company or any of its Subsidiaries by any Governmental Entity; and (iii)&nbsp;to the Knowledge of the Company, neither the Company nor any of
its Subsidiaries is a subject of any investigation (A)&nbsp;by or with any Governmental Entity relating to any material electronic health records Certification or (B)&nbsp;otherwise relating in any respect to any Healthcare Laws. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) To the Knowledge of the Company, the Company and its Subsidiaries (i)&nbsp;have not received any written notice of denial of payment,
recoupment or overpayment, <font style="white-space:nowrap">set-off,</font> penalty or fine from any Federal Healthcare Program, or any other third-party payor, since March&nbsp;31, 2017 as would reasonably be expected to be material to the Company
and its Subsidiaries, taken as a whole, or (ii)&nbsp;do not have outstanding overpayments or refunds due to Federal Healthcare Programs or any other third-party in excess of $10,000,000 in the aggregate (excluding, for the avoidance of doubt,
overpayments or refunds due by the Company’s and its Subsidiaries’ customers that are processed through the Company or any of its Subsidiaries in the Ordinary Course of Business). </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Since March&nbsp;31, 2017, neither the Company nor any of its Subsidiaries (i)&nbsp;has been a party to a corporate integrity agreement or
certificate of compliance agreement with the Office of Inspector General of the U.S. Department of Health and Human Services or an agreement with the U.S. Department of Justice or (ii)&nbsp;has any continuing material reporting obligations pursuant
to a settlement agreement or other remedial measure related to Healthcare Laws entered into with any Governmental Entity. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-27- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Since March&nbsp;31, 2017, none of the Company or its Subsidiaries or any of their
respective current or former Representatives: (i)&nbsp;has been convicted of, charged with or entered into any settlement agreement with any Governmental Entity to avoid conviction of, any violation of any Healthcare Laws, (ii)&nbsp;has been
excluded, suspended, debarred, or proposed for debarment from participation, has received a written notice of their exclusion, suspension, or debarment from participation, has been threatened in writing with exclusion, suspension, or debarment from
participation or is otherwise ineligible to participate in Federal Healthcare Programs, or (iii)&nbsp;has been convicted of, or entered into any settlement agreement with any Governmental Entity to avoid conviction of, any criminal offense relating
to the delivery of any item or service under a Federal Health Care Program or had a civil monetary penalty assessed against them under Section&nbsp;1128A of the Social Security Act or any regulations promulgated thereunder. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.22. <u>Insurance</u>. All Insurance Policies maintained by the Company or any of its Subsidiaries are with reputable insurance carriers (to
the extent applicable), provide full and adequate coverage for all normal risks incident to the business of the Company and its Subsidiaries and their respective properties and assets, and are in character and amount at least equivalent to that
carried by Persons engaged in similar businesses and subject to the same or similar risks, except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. As of the date hereof, each Insurance Policy
is in full force and effect and, to the extent applicable, all premiums due with respect to all Insurance Policies have been paid, and, to the extent applicable, neither the Company nor any of its Subsidiaries has taken any action or failed to take
any action that (including with respect to the transactions contemplated by this Agreement), with or without notice, lapse of time or both, would constitute or result in a breach or violation of, or default under, any of the Insurance Policies or
would permit or cause the termination, <font style="white-space:nowrap">non-renewal</font> or modification thereof or acceleration or creation of any right or obligation thereunder, in each case except as would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.23. <u>Takeover Statutes</u>. No Takeover Statute is applicable to the
Company, the Shares or the transactions contemplated by this Agreement, and no anti-takeover provision in the Company’s Organizational Documents is applicable to the transactions contemplated by this Agreement, and, assuming the accuracy of the
Stock Ownership Rep (to the extent applicable), prior to the execution and delivery of this Agreement, the Company Board has taken all action necessary so that the restrictions set forth in Article X of the Company’s Amended and Restated
Certificate of Incorporation are and will be inapplicable to the execution and delivery of and the performance under this Agreement and the transactions contemplated by this Agreement and will not restrict, impair or delay the ability of Parent or
Merger Sub to vote or otherwise exercise all rights as a stockholder of the Company, including, for the avoidance of doubt, any such actions (if any) necessitated by the entry into, and/or the transactions contemplated by, the Support Agreement. In
the Company’s Amended and Restated Certificate of Incorporation, the Company has expressly opted not to be governed by Section&nbsp;203 of the DGCL. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.24. <u>Brokers and Finders</u>. Neither the Company, nor any of its Subsidiaries, nor any of their respective directors or employees
(including any officers), has retained any broker, finder or investment bank in connection with the transactions contemplated by this Agreement or has incurred or will incur any obligation or liability for any brokerage fees, commissions or finders
fees in connection with the transactions contemplated by this Agreement, except with respect to Goldman Sachs&nbsp;&amp; Co. LLC, which the Company has retained as its financial advisor in connection with the transactions contemplated by this
Agreement. The Company has made available to Parent correct and complete copies of all Contracts pursuant to which Goldman Sachs&nbsp;&amp; Co. LLC or any of its Affiliates is entitled to any fees, rights to indemnification and expenses in
connection with any of the transactions contemplated by this Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.25. <u>No Other Representations or Warranties; <font style="white-space:nowrap">Non-Reliance</font></u>. Except for the express written representations and warranties made by the Company in this Agreement and in any instrument or document delivered pursuant to this Agreement, neither the Company nor
any other Person makes or has made any express or implied representation or warranty regarding the Company or any of its Affiliates or any of its or their </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-28- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
respective businesses, operations, assets, liabilities, conditions (financial or otherwise) or prospects or its or their respective Representatives in connection with this Agreement or the
transactions contemplated by this Agreement, and the Company expressly disclaims any other representations or warranties and none of Parent, Merger Sub or any of their respective Affiliates or its or their respective Representatives has relied on
and none are relying on any representations or warranties regarding the Company or any of its Affiliates or any of its or their respective businesses, operations, assets, liabilities, conditions (financial or otherwise) or prospects or its or their
respective Representatives in connection with this Agreement or the transactions contemplated by this Agreement, other than the express written representations and warranties expressly set forth in this Agreement and in any instrument or document
delivered pursuant to this Agreement; <u>provided</u>, <u>however</u>, that notwithstanding the foregoing provisions of this <u>Section</u><u></u><u>&nbsp;5.25</u>, nothing in this <u>Section</u><u></u><u>&nbsp;5.25</u> shall limit Parent’s or
Merger Sub’s remedies with respect to claims of fraud or intentional and willful misrepresentation in connection with, arising out of or related to this Agreement and the transactions contemplated by this Agreement or any instrument or other
document delivered pursuant to this Agreement. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">ARTICLE&nbsp;VI </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center"><u>Representations and Warranties of Parent and Merger Sub </u></p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Except as set forth in any reports, forms, proxy statements, registration statements and other statements, certifications and documents
required to be filed with or furnished to the SEC and available on EDGAR on or after the Applicable Date and prior to the date of this Agreement (excluding, in each case, any disclosures set forth in any “risk factors” or
“forward-looking statements” sections or in any other sections to the extent they are forward-looking statements or cautionary, predictive or forward-looking in nature), Parent and Merger Sub each hereby represents and warrants to the
Company that: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.1. <u>Organization, Good Standing and Qualification</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each of Parent and Merger Sub is a legal entity duly organized, validly existing and, to the extent such concept is applicable, in good
standing under the Laws of its respective jurisdiction of organization and has all requisite corporate or similar power and authority to own, lease and operate its properties and assets and to carry on its business as currently conducted and is
qualified to do business and, to the extent such concept is applicable, is in good standing as a foreign corporation or other legal entity in each jurisdiction where the ownership, leasing or operation of its properties or assets or conduct of its
business requires such qualification, except as would not, individually or in the aggregate, reasonably be expected to prevent, materially delay or materially impair the ability of Parent or Merger Sub to consummate the transactions contemplated by
this Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Parent has made available to the Company correct and complete copies of Merger Sub’s Organizational Documents
that are in full force and effect as of the date of this Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.2. <u>Capitalization of Merger Sub</u>. The authorized capital
stock of Merger Sub consists of 100 shares of common stock of Merger Sub, par value $0.01 per share. As of the date of this Agreement, all such shares were issued and outstanding. All of the outstanding shares of capital stock of Merger Sub have
been duly authorized and are validly issued, fully paid and <font style="white-space:nowrap">non-assessable</font> and owned by Parent. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.3. <u>Corporate Authority</u>. Each of Parent and Merger Sub has all requisite corporate power and authority and has taken all corporate
action necessary in order to execute, deliver and perform under this Agreement and to consummate the transactions contemplated by this Agreement, subject only to adoption of this Agreement by Parent (as the sole stockholder of Merger Sub). This
Agreement has been duly executed and delivered by each of Parent and Merger Sub and, assuming due execution and delivery by the Company, constitutes a valid and binding agreement of Parent and Merger Sub, enforceable against each of Parent and
Merger Sub in accordance with its terms, subject to the Bankruptcy and Equity Exception. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-29- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.4. <u>Governmental Filings; No Violations</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Other than the expirations of waiting periods and the filings, notices, reports, consents, registrations, approvals, permits and
authorizations (i)&nbsp;under the HSR Act,<sup style="font-size:85%; vertical-align:top"> </sup>(ii)&nbsp;pursuant to the DGCL, (iii)&nbsp;required to be made with or obtained from the SEC, (iv)&nbsp;required to be made with or by the NYSE, or
(v)&nbsp;under the Takeover Statutes and state securities and “blue sky” Laws (collectively, the “<u>Parent Approvals</u>”), no expirations of waiting periods under applicable Law are required and no filings, notices, reports,
consents, registrations, approvals, permits or authorizations are required to be made by Parent or Merger Sub with, nor are any required to be obtained by Parent or Merger Sub from, any Governmental Entity, in connection with the execution and
delivery of and performance under this Agreement by Parent and Merger Sub and the consummation of the transactions contemplated by this Agreement, except as would not, individually or in the aggregate, reasonably be expected to prevent, materially
delay or materially impair the ability of Parent or Merger Sub to consummate the transactions contemplated by this Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The
execution and delivery of and performance under this Agreement by Parent and Merger Sub do not, and the consummation of the transactions contemplated by this Agreement, will not: (i)&nbsp;assuming the satisfaction of the obligations contemplated by
<u>Section</u><u></u><u>&nbsp;7.5</u>, constitute or result in a breach or violation of or a contravention or conflict with the Organizational Documents of Parent or Merger Sub; (ii)&nbsp;assuming the satisfaction of the obligations contemplated by
<u>Section</u><u></u><u>&nbsp;7.5</u> and the waiting periods, filings, notices, reports, consents, registrations, approvals, permits and authorizations contemplated by <u>Section</u><u></u><u>&nbsp;6.4(a)</u> expire, are made or obtained, as
applicable, with or without notice, lapse of time or both, constitute or result in a breach or violation of or a contravention or conflict with any Law to which Parent or Merger Sub is subject; or (iii)&nbsp;assuming the waiting periods, filings,
notices, reports, consents, registrations, approvals, permits and authorizations contemplated by <u>Section</u><u></u><u>&nbsp;6.4(a)</u> expire, are made or obtained, as applicable, with or without notice, lapse of time or both, constitute or
result in a breach or violation of, or default under, or cause or permit a termination, <font style="white-space:nowrap">non-renewal</font> or modification of or acceleration or creation of any right or obligation under or the creation of an
Encumbrance on any of the rights, properties or assets of Parent or Merger Sub pursuant to, any Contract binding upon Parent or Merger Sub or any License necessary to conduct of the business of Parent or Merger Sub as currently conducted, except, in
the case of clauses&nbsp;(ii) and (iii)&nbsp;of this <u>Section</u><u></u><u>&nbsp;6.4(b)</u>, as would not, individually or in the aggregate, reasonably be expected to prevent, materially delay or materially impair the ability of Parent or Merger
Sub to consummate the transactions contemplated by this Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.5. <u>Litigation</u>. There are no Proceedings pending or threatened
in writing against Parent or any of its Subsidiaries (including Merger Sub) and neither Parent nor any of its Subsidiaries (including Merger Sub) nor any of their respective properties, assets or businesses is a party to or subject to the provisions
of any Order (other than those of general applicability) except, in each case, as would not, individually or in the aggregate, reasonably be expected to prevent, materially delay or materially impair the ability of Parent or Merger Sub to consummate
the transactions contemplated by this Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.6. <u>Available Funds</u>. As of the Closing, Parent will have available to it, or
will cause Merger Sub to have available to it, funds sufficient to consummate the transactions contemplated by this Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.7.
<u>Brokers and Finders</u>. Neither Parent nor Merger Sub, nor any of their respective directors or employees (including any officers), has retained any broker, finder or investment bank in connection with the transactions contemplated by this
Agreement or has incurred or will incur any obligation or liability for any brokerage fees, commissions or finders fees in connection with the transactions contemplated by this Agreement, except with respect to BofA Securities, Inc., which Parent
has retained as its financial advisor in connection with the transactions contemplated by this Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.8. <u>Ownership of Company
Stock</u>. Neither Parent nor Merger Sub has “owned” (as defined in subsection 8 of Article X, paragraph C of the Company’s Amended and Restated Certificate of Incorporation as in effect as of the date hereof) greater than 5% of any
class of shares of capital stock of the Company at any time during the three-year period prior to the execution and delivery of this Agreement by the Parties, excluding, for the avoidance of </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-30- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
doubt, any class of shares of capital stock of the Company that Parent or Merger Sub may be deemed to “own” (as defined in subsection 8 of Article X, paragraph C of the Company’s
Amended and Restated Certificate of Incorporation as in effect as of the date hereof) as a result of the Support Agreement (the “<u>Stock Ownership Rep</u>”). </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.9. <u>Certain Arrangements</u>. Except for (a)&nbsp;the Support Agreement, (b)&nbsp;employment matters disclosed by Parent’s counsel to
the Company’s counsel prior to the execution of this Agreement and (c)&nbsp;the transactions contemplated by this Agreement, as of the date hereof, there are no Contracts or legally binding undertakings, commitments, agreements, obligations or
understandings, whether written or oral, between Parent, Merger Sub or any of their Affiliates, on the one hand, and any beneficial owner (or Affiliate of a beneficial owner) of more than 1% of the outstanding Shares or any member of the
Company’s management or the Company Board, on the other hand, except for any such item entered into in the ordinary course of each such Person’s business and unrelated to the transactions contemplated by this Agreement. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.10. <u>Certain Information</u>. None of the information supplied or to be supplied by Parent or Merger Sub for inclusion or incorporation by
reference in the Proxy Statement will, at the date it is first mailed to the stockholders of the Company and at the time of the Company Stockholders Meeting, contain any untrue statement of a material fact or omit to state any material fact required
to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading. For the avoidance of doubt and notwithstanding the foregoing, Parent and Merger Sub make no
representation or warranty with respect to any information supplied by the Company, any of its Representatives or any other Person (excluding Parent, Merger Sub or any of their Representatives acting on their behalf) for inclusion or incorporation
by reference in the Proxy Statement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.11. <u>Parent Tax Representation Letter</u>. As of the date of this Agreement, Parent (a)&nbsp;has
delivered to Company Tax Counsel the Parent Tax Representation Letter and (b)&nbsp;believes that it will be able to provide the Parent Tax Representation Letter at the Closing. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.12. <u>No Other Representations or Warranties; <font style="white-space:nowrap">Non-Reliance</font></u>. Except for the express written
representations and warranties made by Parent and Merger Sub in this Agreement and in any instrument or document delivered pursuant to this Agreement, none of Parent, Merger Sub or any other Person makes or has made any express or implied
representation or warranty regarding Parent, Merger Sub or any of their respective Affiliates or any of its or their respective businesses, operations, assets, liabilities, conditions (financial or otherwise) or prospects or its or their respective
Representatives in connection with this Agreement or the transactions contemplated by this Agreement, and each of Parent and Merger Sub expressly disclaims any other representations or warranties and none of the Company or its Affiliates or its or
their respective Representatives has relied on and none are relying on any representations or warranties regarding Parent, Merger Sub or any of their respective Affiliates or any of its or their respective businesses, operations, assets,
liabilities, conditions (financial or otherwise) or prospects or its or their respective Representatives in connection with this Agreement or the transactions contemplated by this Agreement, other than the express written representations and
warranties expressly set forth in this Agreement and in any instrument or document delivered pursuant to this Agreement; <u>provided</u>, <u>however</u>, that notwithstanding the foregoing provisions of this <u>Section</u><u></u><u>&nbsp;6.12</u>,
nothing in this <u>Section</u><u></u><u>&nbsp;6.12</u> shall limit the Company’s remedies with respect to claims of fraud or intentional and willful misrepresentation in connection with, arising out of or otherwise related to this Agreement and
the transactions contemplated by this Agreement or any instrument or other document delivered pursuant to this Agreement. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">ARTICLE&nbsp;VII
</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center"><u>Covenants </u></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.1.
<u>Interim Operations</u>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company shall, and shall cause each of its Subsidiaries to, from and after the date of this Agreement
until the earlier of the Effective Time and the termination of this Agreement in accordance with </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-31- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<u>Article IX</u> (the “<u>Interim Period</u>”), except (1)&nbsp;as Parent shall otherwise approve in writing (such approval not to be unreasonably withheld, conditioned or delayed),
(2) as otherwise expressly contemplated or required by this Agreement, (3)&nbsp;as required by applicable Law, (4)&nbsp;as set forth in <u>Section</u><u></u><u>&nbsp;7.1(a)</u> of the Company Disclosure Letter or (5)&nbsp;for commercially reasonable
actions as reasonably required to comply with or implement <font style="white-space:nowrap">COVID-19</font> Measures, conduct its business in the Ordinary Course of Business and use and cause each of its Subsidiaries to use their respective
reasonable best efforts to conduct its business in accordance with applicable Law and maintain its and its Subsidiaries’ business and assets and relations and goodwill with Governmental Entities, customers, suppliers, licensors, licensees,
distributors, creditors, lessors, employees, agents and business associates. Without limiting the generality of and in furtherance of the foregoing sentence, during the Interim Period, except (I)&nbsp;as otherwise expressly contemplated or required
by this Agreement, (II)&nbsp;as required by applicable Law, (III)&nbsp;as approved in writing by Parent (such approval not to be unreasonably withheld, conditioned or delayed, except that Parent may withhold, condition or delay approval of actions
contemplated by <u>Section</u><u></u><u>&nbsp;7.1(a)(iii)</u> or <u>Section</u><u></u><u>&nbsp;7.1(a)(iv)</u> in Parent’s sole discretion), (IV) as set forth in <u>Section</u><u></u><u>&nbsp;7.1(a)</u> of the Company Disclosure Letter or
(V)&nbsp;for commercially reasonable actions in deviation of the prohibitions set forth in clauses (xii) (<i>Material Contracts</i>) (other than with respect to the Contracts described in the proviso thereto) or (xvii) (<i>Compensation</i>) below to
the extent reasonably required to comply with or implement <font style="white-space:nowrap">COVID-19</font> Measures, the Company shall not and shall cause its Subsidiaries not to: </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) adopt or publicly propose any change in the Company’s Organizational Documents (other than to correct scrivener’s errors or
immaterial or ministerial amendments); </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) (A) merge or consolidate the Company or any of its Subsidiaries with any other Person,
except for any such transactions among Wholly Owned Subsidiaries, or (B)&nbsp;solely with respect to the Company and its Wholly Owned Subsidiaries, restructure, reorganize, recapitalize or completely or partially liquidate or dissolve
(<u>provided</u>, that the Company may effect or cause to be effected the actions referred to in this clause (ii)&nbsp;to the extent they involve only the Company’s Wholly Owned Subsidiaries and are reasonably required to be undertaken to
effectuate transactions otherwise permitted under clauses (iii)&nbsp;or (iv) below); </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) acquire, directly or indirectly, by merger,
consolidation, acquisition of stock or assets or otherwise, any business, Person or assets from any other Person with a fair market value or purchase price in excess of $30,000,000 in any individual transaction or series of related transactions or
$75,000,000 in the aggregate, in each case, including any amounts or value reasonably expected to be paid in connection with a future <font style="white-space:nowrap">earn-out,</font> purchase price adjustment, release of “holdback” or
similar contingent payment obligation (it being understood and agreed that this <u>Section</u><u></u><u>&nbsp;7.1(a)(iii)</u> shall not alter or limit the applicability of <u>Section</u><u></u><u>&nbsp;7.6(f)</u> to the Company in any respect); </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) transfer, sell, lease to a third Person, divest, abandon, allow to expire, license to a third Person, outsource to a third Person or
otherwise dispose of, or grant any Encumbrance (other than any Permitted Encumbrance) upon, any properties or assets (tangible or intangible, including any Intellectual Property Rights), product lines or businesses of the Company or any of its
Subsidiaries, including capital stock of any of its Subsidiaries, except (A)&nbsp;other than with respect to Intellectual Property Rights and outsourcing, in connection with services provided in the Ordinary Course of Business, (B)&nbsp;expiration,
abandonment or sales of obsolete or unused assets in the Ordinary Course of Business, (C)&nbsp;sales, leases, licenses, outsourcing or other dispositions of assets with a fair market value not in excess of $10,000,000 individually or $25,000,000 in
the aggregate, (D)&nbsp;with respect to licenses of Intellectual Property Rights, <font style="white-space:nowrap">non-exclusive</font> grants of licenses in the Ordinary Course of Business and (E)&nbsp;the grant of Encumbrances to secure
Indebtedness permitted by <u>Section</u><u></u><u>&nbsp;7.1(a)(ix</u><u>)</u>; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) issue, sell, pledge, dispose of, grant, transfer,
lease to a third Person, license to a third Person, guarantee, encumber or enter into any Contract or other agreement, understanding or arrangement (whether oral or written) with respect to the voting of, any shares of capital stock of the Company
(including, for the avoidance of doubt, Shares) or of any of its Subsidiaries, securities convertible or exchangeable into or exercisable for any such shares of capital stock, or any options, warrants or other rights of any kind to acquire any such
shares of </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-32- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
capital stock or such convertible or exchangeable securities (other than (A)&nbsp;proxies or voting agreements solicited by or on behalf of the Company in order to obtain the Requisite Company
Vote and any other votes or consents contemplated by <u>Section</u><u></u><u>&nbsp;7.4(f)</u> or in connection with any annual meeting of the Company’s stockholders) or (B)&nbsp;issuances (1)&nbsp;by a Wholly Owned Subsidiary of the Company to
the Company or another Wholly Owned Subsidiary of the Company, (2)&nbsp;solely with respect to shares of capital stock of the Company’s <font style="white-space:nowrap">Non-Wholly</font> Owned Subsidiaries, in connection with joint ventures,
minority investments, venture capital investments or similar transactions permitted by <u>Section</u><u></u><u>&nbsp;7.1(a)(iii)</u> or <u>Section</u><u></u><u>&nbsp;7.1(a)(vi)</u>, (3) in respect of Company Equity Awards and issuances under the
Stock Plans in the Ordinary Course of Business or (4)&nbsp;pursuant to the ESPP in accordance with its terms and subject to <u>Section</u><u></u><u>&nbsp;4.2(g)</u>); </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) make any loans, advances, guarantees or capital contributions to or investments in any Person (other than (A)&nbsp;to or from the
Company and any of its Wholly Owned Subsidiaries or (B)&nbsp;for indemnification or advancements to any directors, officers or other fiduciaries of the Company or any of its Subsidiaries pursuant to any of their respective Organizational Documents
or any Contracts with such Persons, in either case in effect as of the date of this Agreement) outside the Ordinary Course of Business in excess of $10,000,000 individually or $40,000,000&nbsp;in the aggregate; </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) declare, set aside, make or pay any dividend or other distribution, payable in cash, stock, property or otherwise, with respect to any
of its capital stock (including with respect to the Company, for the avoidance of doubt, Shares), except for cash&nbsp;dividends paid by any Subsidiary to the Company or to any other Subsidiary of the Company; </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii) solely with respect to the Company and its material Subsidiaries, reclassify, split, combine, subdivide or redeem, purchase or
otherwise acquire or offer to redeem, purchase or otherwise acquire, directly or indirectly, any of its capital stock or securities convertible or exchangeable into or exercisable for any shares of its capital stock (including, for the avoidance of
doubt, Shares) (<u>provided</u>, that the Company may effect or cause to be effected the actions referred to in this clause (viii)&nbsp;to the extent they involve only the Company’s Wholly Owned Subsidiaries and are reasonably required to be
undertaken to effectuate transactions otherwise permitted under clauses (iii)&nbsp;or (iv) above); </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ix) assume, guarantee, issue or
incur any Indebtedness (including the issuance of any debt securities or any warrants or other rights to acquire any debt security) or enter into any hedging agreements, except for (subject, in each case, to
<u>Section</u><u></u><u>&nbsp;7.1(a)(xii)</u>) (A)&nbsp;(1) Indebtedness of the type contemplated by clauses (a)&nbsp;and (b) of the definition thereof in the Ordinary Course of Business up to $75,000,000 and (2)&nbsp;other Indebtedness in the
Ordinary Course of Business up to $25,000,000, (B) drawdowns under the Credit Agreement, (C)&nbsp;guarantees of Indebtedness of its Wholly Owned Subsidiaries otherwise incurred in compliance with this <u>Section</u><u></u><u>&nbsp;7.1(a)</u>, (D)
Indebtedness between the Company and any of its Wholly Owned Subsidiaries or between one Wholly Owned Subsidiary of the Company and another Wholly Owned Subsidiary of the Company, (E)&nbsp;hedging agreements entered into in the Ordinary Course of
Business and not for speculative purposes, (F)&nbsp;extensions or renewals of any outstanding Indebtedness in the Ordinary Course of Business or (G)&nbsp;refinancings or replacements of any outstanding Indebtedness on terms that are substantially
similar to the terms of such outstanding Indebtedness or are otherwise more favorable to the Company and its Subsidiaries; <u>provided</u>, that any Indebtedness assumed, guaranteed, issued or incurred by the Company or any of its Subsidiaries or
for which the Company or any of its Subsidiaries otherwise becomes liable under this <u>Section</u><u></u><u>&nbsp;7.1(a)(ix)</u> shall permit prepayment at any time without penalty of any kind; </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(x) make or authorize any payment of, or accrual or commitment for, capital expenditures, except in the Ordinary Course of Business; </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xi) enter into any Contract that would have been a Material Contract had it been entered into prior to the date of this Agreement, other
than Contracts entered into in the Ordinary Course of Business; </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-33- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xii) other than in the Ordinary Course of Business, (A)&nbsp;terminate or fail to renew
any Material Contract (other than expirations of any such Contract in accordance with its terms), (B) amend, modify, supplement or waive, or assign, convey, Encumber or otherwise transfer in whole or in part, rights or interests pursuant to or in,
any Material Contract (other than assignments between or among the Company or any of its Wholly-Owned Subsidiaries that would not be adverse to Parent), or (C)&nbsp;enter into any Contract that would have been a Material Contract had it been entered
into prior to the date of this Agreement; <u>provided</u>, <u>however</u>, that in no event may the Company take any of the foregoing actions with respect to (1)&nbsp;the Specified Tax Agreements and any Tax “hold harmless,” sharing,
allocation or indemnification agreement or arrangement (other than, in each case, (x)&nbsp;such agreements or arrangements solely between or among the Company and any of its Wholly Owned Subsidiaries, (y)&nbsp;such agreements or arrangements
contained in commercial contracts entered into, amended or terminated in the Ordinary Course of Business the principal subject of which is not Taxes and (z)&nbsp;customary Tax indemnification or Tax benefit provisions contained in merger agreements,
stock purchase agreements, asset purchase agreements or other business combination agreements entered into in accordance with <u>Section</u><u></u><u>&nbsp;7.1(a)</u>), (2) the Credit Agreement, the Senior Notes Indenture (including, for the
avoidance of doubt, by entering into a supplemental indenture pursuant thereto), the Senior Amortizing Notes Indenture (including, for the avoidance of doubt, by entering into a supplemental indenture pursuant thereto) and the Purchase Contract
Agreement (in each case, except in connection with extensions or renewals permitted under <u>Section</u><u></u><u>&nbsp;7.1(a)(ix)(F)</u> or refinancings or replacements permitted under <u>Section</u><u></u><u>&nbsp;7.1(a)(ix)(G)</u>)
(<u>provided</u>, that, notwithstanding anything to the contrary herein, in no event may the Company or any of its Subsidiaries amend, modify or supplement the Credit Agreement such that the borrowing capacity thereunder is increased beyond such
capacity as of the date hereof), (3) any Contract described in clause (iv)&nbsp;or (xv) of the definition of a “Material Contract”, or (4)&nbsp;the Contract set forth in <u>Section</u><u></u><u>&nbsp;7.1(a)(xii)</u> of the Company
Disclosure Letter; <u>provided</u>, <u>further</u>, that this <u>Section</u><u></u><u>&nbsp;7.1(a)(xii)</u>&nbsp;shall not be construed to permit any action that would otherwise require the consent of Parent pursuant to any other provision of
<u>Section</u><u></u><u>&nbsp;7.1(a)</u>; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiii) cancel, modify or waive any debts or claims held by or owed to the Company or any of
its Subsidiaries having in each case a value in excess of $5,000,000 individually or $20,000,000 in the aggregate; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiv) other than with
respect to Transaction Litigation, any Proceeding in connection with, arising out of or otherwise related to a demand for appraisal under Section&nbsp;262 of the DGCL or any Tax claim, audit, assessment or dispute, which shall be governed by
<u>Sections</u><u></u><u>&nbsp;7.15</u>,<u>&nbsp;4.3(f)</u> and <u>7.1(a)(xvi)</u>, respectively, settle or compromise any Proceeding for an amount in excess of $20,000,000 individually or $40,000,000 in the aggregate during any calendar year, or
which would reasonably be expected to (A)&nbsp;prevent, materially delay or materially impair the consummation of the transactions contemplated by this Agreement, (B)&nbsp;impose any material restriction on the operations of the Company or its
material Subsidiaries or (C)&nbsp;involve any criminal liability or any admission of material fault by the Company or any of its Subsidiaries; </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xv) make any changes with respect to accounting policies, procedures, methods, principals or practices, except as required by changes in
GAAP or applicable Law; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xvi) make, change or revoke any material Tax election, change an annual Tax accounting period, adopt or change
any Tax accounting method, file any amended material Tax Return, enter into any closing agreement with respect to material Taxes, settle any material Tax claim, audit, assessment or dispute, surrender any right to claim a refund of a material amount
of Taxes, agree to an extension or waiver of the statute of limitations with respect to the assessment or determination of any material Tax or take any action which would be reasonably expected to (A)&nbsp;affect the Intended <font style="white-space:nowrap">Tax-Free</font> Treatment, or (B)&nbsp;render any part of the Tax Opinion (or any Tax Representation Letter issued by the Company or Parent in connection with the Tax Opinion) inaccurate or untrue in other than <i>de
minimis</i> respects; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xvii) except as required pursuant to the terms of any Company Benefit Plan in effect as of the date of this
Agreement, (A)&nbsp;increase in any manner the compensation or consulting fees, bonus, pension, welfare, fringe or other benefits, severance or termination pay of any Company Employee, (B)&nbsp;become a party to,
</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-34- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
establish, adopt, amend, commence participation in or terminate any Company Benefit Plan or any arrangement that would have been a Company Benefit Plan had it been entered into prior to the date
of this Agreement, (C)&nbsp;grant any new awards, or amend or modify the terms of any outstanding awards, under any Company Benefit Plan, (D)&nbsp;take any action to accelerate the vesting or lapsing of restrictions or payment, or fund or in any
other way secure the payment, of compensation or benefits under any Company Benefit Plan, (E)&nbsp;materially change any actuarial or other assumptions used to calculate funding obligations with respect to any Company Benefit Plan that is required
by applicable Law to be funded or change the manner in which contributions to such plans are made or the basis on which such contributions are determined, except as may be required by GAAP, (F)&nbsp;forgive any loans or issue any loans to any
Company Employee (other than routine travel or other business advances issued in the Ordinary Course of Business), (G)&nbsp;hire any employee or engage any independent contractor (who is a natural person) with an annual salary or wage rate or
consulting fees in excess of $300,000 or (H)&nbsp;terminate the employment or service of any Company Employee with an annual salary or wage rate or consulting fees in excess of $300,000 other than for cause; </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xviii) become a party to, establish, adopt, amend, commence participation in or terminate any collective bargaining agreement or other
agreement with a labor union, labor organization, works council or similar organization; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xix) enter into any new line of business,
other than new lines of business that are natural evolutions of, extensions to, or expansions of, the businesses of the Company and its Subsidiaries conducted as of the date hereof, in each case, that would not require the Company or its
Subsidiaries to make expenditures or incur liabilities greater than $15,000,000, individually, or $75,000,000, in the aggregate, in connection with any such new line of business); <u>provided</u>, <u>further</u>, that any such evolution, extension
or expansion would not reasonably be expected to prevent, materially delay or materially impair the consummation of the transactions contemplated by this Agreement; </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xx) amend or modify the engagement letter of the Company’s financial advisor (or grant any discretionary fee or any comparable
additional fee thereunder) in a manner that increases the fee or commission payable by the Company or any of its Subsidiaries; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xxi)
other than in the Ordinary Course of Business, take any action which would reasonably be expected to result in any material increase in the amount of Tax Benefit Payments to be paid or expected to be paid under any Tax Receivable Agreement for any
taxable year ending prior to or including the Closing Date compared to the amount of Tax Benefit Payments for such Tax Receivable Agreement that is reflected for such taxable year in the financial statements included in the Company Reports filed on
June&nbsp;4, 2020; or </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xxii) in a legally binding manner, agree or commit to do any of the foregoing. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) During the Interim Period, prior to the Company or any of its Subsidiaries taking any actions due to
<font style="white-space:nowrap">COVID-19</font> Measures in accordance with this Agreement, which actions would reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole, or constitute material deviations (measured
with respect to the Company and its Subsidiaries, taken as a whole) from the Ordinary Course of Business, the Company shall, to the extent reasonably practicable, provide advance notice to, and reasonably consult in good faith with, Parent with
respect thereto. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Without the prior consent of Parent, during the Interim Period the Company shall not, and shall cause its
Subsidiaries not to, avail itself of any government grants, Tax holidays, loans or other Tax benefits or relief related to <font style="white-space:nowrap">COVID-19,</font> including a loan under the paycheck protection program or relief pursuant to
Sections 2301 or 2302 of the CARES Act or any similar applicable federal, state or local Law, except that the Company and its Subsidiaries may avail themselves of such government grants, Tax holidays, loans or other Tax benefits or relief as they
have already availed themselves of prior to the date of this Agreement and are set forth in <u>Section</u><u></u><u>&nbsp;5.16(q)</u> of the Company Disclosure Letter (and any continuation thereof). </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-35- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Nothing set forth in this Agreement shall give Parent, directly or indirectly, the right
to control or direct the Company’s or its Subsidiaries’ operations prior to the Effective Time or give the Company, directly or indirectly, the right to control or direct the Parent’s or its Subsidiaries’ operations prior to the
Effective Time. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.2. <u>Acquisition Proposals; Change of Recommendation</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <u>No Solicitation</u>. From and after the date of this Agreement, except as expressly permitted by this
<u>Section</u><u></u><u>&nbsp;7.2</u>, the Company shall not, and shall cause its Subsidiaries and its and its Subsidiaries’ officers, directors, employees, financial advisors, investment bankers and legal counsel not to, and shall use its
reasonable best efforts to cause, and shall direct, its and its Subsidiaries other Representatives not to, directly or indirectly: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)
initiate, solicit, propose or knowingly encourage or otherwise knowingly facilitate any inquiry or the making of any proposal or offer that constitutes or would reasonably be expected to lead to an Acquisition Proposal; </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) engage in, continue or otherwise participate in any discussions or negotiations relating to any Acquisition Proposal or any inquiry,
proposal or offer that would reasonably be expected to lead to an Acquisition Proposal; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) provide any information or data concerning
the Company or its Subsidiaries or access to the Company’s or its Subsidiaries’ properties, books and records to any Person or group (as defined under Section&nbsp;13 of the Exchange Act) in connection with any Acquisition Proposal or any
inquiry, proposal or offer that would reasonably be expected to lead to an Acquisition Proposal; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) otherwise knowingly facilitate any
effort or attempt to make an Acquisition Proposal; or </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) agree or commit, in each case in a legally binding manner, to do any of the
foregoing. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <u>Exceptions to No Solicitation</u>. Notwithstanding anything to the contrary set forth in
<u>Section</u><u></u><u>&nbsp;7.2(a)</u>, but subject to the provisions of <u>Section</u><u></u><u>&nbsp;7.2(c)</u>, prior to the time the Requisite Company Vote is obtained, in response to an unsolicited, <i>bona fide</i> written Acquisition
Proposal that did not result from a material breach of the obligations set forth in this <u>Section</u><u></u><u>&nbsp;7.2</u>, the Company may: </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) provide information concerning the Company and its Subsidiaries in response to a request to the Person or group (as defined under
Section&nbsp;13 of the Exchange Act) who made such an Acquisition Proposal and the respective Representatives and financing sources thereof; <u>provided</u> that such information has previously been made available to Parent, or is made available to
Parent prior to or concurrently with the time such information is made available to such Person or group, and prior to providing any such information or data, the Company and the Person or group (as defined under Section&nbsp;13 of the Exchange Act)
making such Acquisition Proposal shall have entered into a legally binding confidentiality agreement (A)&nbsp;with terms not less restrictive in any material respect to such Person or group (as defined under Section&nbsp;13 of the Exchange Act) than
the comparable terms in the Confidentiality Agreement are on Parent and (B)&nbsp;that treats any financing sources of such Person or group (as defined under Section&nbsp;13 of the Exchange Act) as “representatives” of such Person or group
(as defined under Section&nbsp;13 of the Exchange Act) thereunder, subject to the same confidentiality limitations as such Person or group (as defined under Section&nbsp;13 of the Exchange Act) (<u>it</u> <u>being</u> <u>understood</u> that such
confidentiality agreement need not prohibit the making or amending of an Acquisition Proposal, but shall not include any restrictions that would reasonably be expected to restrain the Company from satisfying its obligations contemplated by
<u>Section</u><u></u><u>&nbsp;7.2(c)</u>) (any confidentiality agreement satisfying such criteria, a “<u>Permitted Confidentiality Agreement</u>”); <u>provided</u>, <u>however</u>, that if the Person or group (as defined under
Section&nbsp;13 of the Exchange Act) making such Acquisition Proposal is a competitor of the Company (as determined by the Company in its reasonable discretion), the Company shall not provide any competitively sensitive information to such Person in
connection with any actions permitted by this <u>Section</u><u></u><u>&nbsp;7.2(b)</u> other than in accordance with customary “clean room” or other similar procedures designed to limit the disclosure of competitively sensitive
information; and </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-36- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) engage or otherwise participate in any discussions or negotiations with any such
Person or group (as defined under Section&nbsp;13 of the Exchange Act) and the respective Representatives and financing sources thereof regarding such Acquisition Proposal, </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">if, and only if, prior to taking any action described in clause&nbsp;(i) or clause (ii)&nbsp;of this <u>Section</u><u></u><u>&nbsp;7.2(b)</u>, the Company
Board determines in good faith, after consultation with outside legal counsel and its financial advisor, based on the information then available, including the terms and conditions of such Acquisition Proposal and those of this Agreement, that
(A)&nbsp;such Acquisition Proposal either constitutes a Superior Proposal or could reasonably be expected to result in a Superior Proposal and (B)&nbsp;the failure to take such action would reasonably be expected to be inconsistent with the
directors’ fiduciary duties under applicable Law. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <u>Notice of Acquisition Proposals</u>. Notwithstanding any contractual
obligations that the Company or any of its Affiliates may have to any third party, the Company shall promptly (but, in any event, within 24&nbsp;hours) give notice to Parent if, after the date hereof, (i)&nbsp;any written inquiries, proposals or
offers with respect to an Acquisition Proposal or that would reasonably be expected to lead to an Acquisition Proposal are received by the Company or any of its Subsidiaries or any of its or their officers, directors, employees, financial advisors,
investment bankers and legal counsel or, to the Company’s Knowledge, any of its or their respective other Representatives, (ii)&nbsp;any information concerning the Company or its Subsidiaries or access to the Company’s or its
Subsidiaries’ properties, books and records in connection with any Acquisition Proposal or any inquiry, proposal or offer that would reasonably be expected to lead to an Acquisition Proposal is requested in writing by any Person or group (as
defined under Section&nbsp;13 of the Exchange Act) that, to the Knowledge of the Company, is reasonably likely to make or is considering making an Acquisition Proposal, or (iii)&nbsp;the Company Board makes a determination to begin providing
information to or to begin engaging in discussions or negotiations with any Person or group (as defined under Section&nbsp;13 of the Exchange Act) regarding any Acquisition Proposal, setting forth in such notice the name of the applicable Person or
group (as defined under Section&nbsp;13 of the Exchange Act), a description of the material terms and conditions of any such Acquisition Proposal or inquiry, proposal or offer and the scope of such request (including, if applicable, correct and
complete copies of any such Acquisition Proposals, Permitted Confidentiality Agreements, inquiries, proposals or offers, in each case to the extent then available), and thereafter shall keep Parent reasonably informed, on a reasonably current basis
(and, in any event, within 24 hours after any material changes), of the status and material terms and conditions of any such Acquisition Proposals, inquiries, proposals or offers or requests (including any material amendments or modifications
thereto) and the status of any such discussions or negotiations. The Company agrees that it and its Subsidiaries will not enter into any agreement with any Person subsequent to the date of this Agreement that prohibits the Company from providing any
information to Parent in accordance with, or otherwise complying with, this <u>Section</u><u></u><u>&nbsp;7.2(c)</u>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <u>No Change of
Recommendation or Alternative Acquisition Agreement; Exceptions</u>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Except as permitted by
<u>Section</u><u></u><u>&nbsp;7.2(d)(iii)</u> and taking into account <u>Section</u><u></u><u>&nbsp;7.2(e)</u>, the Company Board shall not: </p>
<p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) fail to include the Company Recommendation in the Proxy Statement; </p>
<p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) withhold, withdraw, qualify or modify (or publicly propose or resolve to withhold, withdraw, qualify or modify) the Company
Recommendation in a manner adverse to Parent; </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) with respect to an Acquisition Proposal initiated through a tender or
exchange offer pursuant to Rule <font style="white-space:nowrap">14d-2</font> under the Exchange Act, take any action or make any recommendation or public statement in connection therewith other than an unequivocal recommendation against such offer;
</p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) following the public disclosure of an Acquisition Proposal, fail to publicly reaffirm the Company Recommendation as
promptly as reasonably practicable (but in any event within three Business Days) after receipt of any written request to do so from Parent; <u>provided</u>, that if the end of such three Business Day window would occur on or after the date of the
Company Stockholders </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-37- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
Meeting, then the Company shall instead be required to publicly reaffirm the Company Recommendation no later than one Business Day prior to the Company Stockholders Meeting; </p>
<p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) publicly approve or publicly recommend, or publicly declare advisable, any Acquisition Proposal or other proposal that
would reasonably be expected to lead to an Acquisition Proposal or publicly approve or publicly recommend, or publicly declare advisable or publicly propose to enter into, any Alternative Acquisition Agreement; or </p>
<p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F) agree or commit, in each case in a legally binding manner, to do any of the foregoing (together with any of the actions set
forth in the foregoing clauses (A), (B), (C), (D) and (E), a&nbsp;“<u>Change of Recommendation</u>”). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Except as expressly
permitted by <u>Section</u><u></u><u>&nbsp;7.2(d)(iii)</u>, the Company Board shall not cause or permit the Company or any of its Subsidiaries to enter into an Alternative Acquisition Agreement or agree or commit, in each case in a legally binding
manner, to do so. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Notwithstanding anything to the contrary set forth in this <u>Section</u><u></u><u>&nbsp;7.2(d)</u>, prior to
the time the Requisite Company Vote is obtained, the Company Board may (1)&nbsp;effect a Change of Recommendation or (2)&nbsp;cause the Company to enter into an Alternative Acquisition Agreement with respect to a Superior Proposal and terminate this
Agreement pursuant to <u>Section</u><u></u><u>&nbsp;9.3(b)</u> (any action described in clause (1)&nbsp;or (2) being a “<u>Fundamental Action</u>”) if (A)&nbsp;an&nbsp;unsolicited, <i>bona fide</i> written Acquisition Proposal that did not
result from a material breach of the obligations set forth in this <u>Section</u><u></u><u>&nbsp;7.2</u> is received by the Company or an Intervening Event has occurred, and (B)&nbsp;the Company Board determines in good faith, after consultation
with outside legal counsel and its financial advisor, based on the information then available, that (w)&nbsp;in the case of an Acquisition Proposal, such Acquisition Proposal constitutes a Superior Proposal and (x)&nbsp;a failure to effect a
Fundamental Action in response to such Acquisition Proposal or Intervening Event, as applicable, would be inconsistent with the directors’ fiduciary duties under applicable Law; <u>provided</u>, <u>however</u>, that no such Fundamental Actions
may be taken unless and until: (I)&nbsp;the Company has given Parent written notice at least four Business Days in advance (such notice period, the “<u>Notice Period</u>” and such notice, the “<u>Notice</u>”), which Notice shall
set forth in writing that the Company Board intends to consider whether to take such Fundamental Action and a reasonably detailed description of the basis therefor, and shall also include, in the case of a Fundamental Action to enter into an
Alternative Acquisition Agreement, the then-current draft of such agreement, and, in the case of an Intervening Event, a reasonably detailed description of such Intervening Event (<u>provided</u>, that such Notice shall not, by itself, constitute a
Change of Recommendation); (II)&nbsp;during the Notice Period, to the extent requested by Parent, the Company shall, and shall cause its Representatives to, negotiate in good faith with Parent to revise this Agreement so that the condition set forth
in clause (B)&nbsp;of this <u>Section</u><u></u><u>&nbsp;7.2(d)(iii)</u> would not be satisfied; and (III)&nbsp;at the end of the Notice Period,&nbsp;the Company Board shall have taken into account any revisions to this Agreement proposed by Parent
in writing and any other information offered by Parent in response to such Notice prior to the end of the Notice Period, and shall have thereafter determined in good faith, after consultation with outside legal counsel and its financial advisor,
based on the information then available, that (y)&nbsp;in the case of an Acquisition Proposal, such Acquisition Proposal continues to constitute a Superior Proposal and (z)&nbsp;a failure to effect a Fundamental Action would continue to be
inconsistent with the directors’ fiduciary duties under applicable Law (<u>it</u><u>&nbsp;being</u> <u>understood</u> that any amendment or modification to the economic or other material terms of any such Acquisition Proposal (if applicable)
shall require a new Notice and a new Notice Period (which, subsequent to the initial Notice Period, shall be reduced to two Business Days rather than four Business Days)). </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <u>Certain Permitted Disclosure</u>. Nothing set forth in this <u>Section</u><u></u><u>&nbsp;7.2</u> shall prohibit the Company from
(i)&nbsp;disclosing a position contemplated by Rule <font style="white-space:nowrap">14d-9,</font> Rule <font style="white-space:nowrap">14e-2(a)(2)</font> or (3)&nbsp;or Item 1012(a) of Regulation <font style="white-space:nowrap">M-A</font> under
the Exchange Act or (ii)&nbsp;making any “stop, look and listen” communication or similar communication of the type contemplated by Rule <font style="white-space:nowrap">14d-9(f)</font> under the Exchange Act, and, in each such case, such
disclosures and communications shall not constitute a Change of Recommendation; provided, that this <u>Section</u><u></u><u>&nbsp;7.2(e)</u> shall not be deemed to permit the Company Board to make a Change of Recommendation except to the extent
permitted by <u>Section</u><u></u><u>&nbsp;7.2(d)(iii)</u>. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-38- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <u>Existing Discussions</u>. The Company (i)&nbsp;acknowledges and agrees that, as of
the date of this Agreement, it has ceased and caused to be terminated any activities, solicitations, discussions and negotiations with any Person conducted prior to the date of this Agreement with respect to an Acquisition Proposal or any inquiry,
proposal or offer that could reasonably be expected to lead to an Acquisition Proposal and (ii)&nbsp;shall promptly (but in any event within 24 hours after the execution and delivery of this Agreement): (A)&nbsp;deliver a written notice to each such
Person providing that the Company (1)&nbsp;is ending all activities, discussions and negotiations with such Person with respect to an Acquisition Proposal or any inquiry, proposal or offer that could reasonably be expected to lead to an Acquisition
Proposal and (2)&nbsp;is requesting the prompt return or destruction of all confidential information concerning the Company and any of its Subsidiaries; and (B)&nbsp;if applicable, terminate any physical and electronic data or other diligence access
previously granted to such Persons. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <u>Standstill Provisions</u>. From the date of this Agreement and until the Effective Time, the
Company shall not terminate, amend or otherwise modify or waive any provision of any confidentiality, “standstill” or similar agreement to which the Company or any of its Subsidiaries is a party with respect to any Acquisition Proposal or
any class of equity securities of the Company or its Subsidiaries; <u>provided</u> that the Company shall be permitted to terminate, amend or otherwise modify, waive or fail to enforce any provision of any such agreement if the Company Board
determines in good faith, after consultation with its outside legal counsel, based on the information then available, that the failure to take such action would be inconsistent with the directors’ fiduciary duties under applicable Law. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.3. <u>Proxy Statement; </u><u>Efforts and Other Regulatory Matters</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company shall prepare and file with the SEC, as promptly as practicable after the date of this Agreement (and shall use reasonable
best efforts to do so within 30 days after the date of this Agreement), a proxy statement in preliminary form relating to the Company Stockholders Meeting (such proxy statement and any amendments or supplements thereto, including the definitive
proxy statement, the “<u>Proxy Statement</u>”). Except under the circumstances expressly permitted by <u>Section</u><u></u><u>&nbsp;7.2</u>, the Proxy Statement shall include the Company Recommendation. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company shall use reasonable best efforts to ensure that the Proxy Statement complies as to form and substance with the provisions of
the Exchange Act and that none of the information supplied by it or any of its Subsidiaries or their respective Representatives for inclusion or incorporation by reference in the Proxy Statement, at the date of mailing to stockholders of the
Company, at the time of the Company Stockholders Meeting or at the time of filing with the SEC (as applicable), contains any untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary in order
to make the statements therein, in light of the circumstances under which they were made, not misleading; <u>provided</u>, <u>however</u>, that (i)&nbsp;the Company assumes no responsibility with respect to information supplied in writing by or on
behalf of Parent, its Subsidiaries or its or their respective Representatives for inclusion or incorporation by reference in the Proxy Statement and (ii)&nbsp;Parent and Merger Sub assume no responsibility with respect to any information not
supplied in writing by or on behalf of Parent, its Subsidiaries or its or their respective Representatives for inclusion or incorporation by reference in the Proxy Statement. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If at any time prior to the Company Stockholders Meeting, any information relating to the Company or Parent, or any of their respective
Subsidiaries or its or their respective Representatives, should be discovered by a Party, which information should be set forth in an amendment or supplement to the Proxy Statement, so that the Proxy Statement would not include any misstatement of a
material fact or omit to state any material fact necessary to make the statements therein, in light of the circumstances under which they are made, not misleading, the Party that discovers such information shall as promptly as practicable following
such discovery notify the other Party or Parties (as the case may be) and after such notification the Company shall, as and to the extent required by applicable Law, as promptly as reasonably practicable (A)&nbsp;prepare an amendment or supplement
to the Proxy Statement and (B)&nbsp;thereafter, cause the Proxy Statement as so amended or supplemented to be filed with the SEC and to be disseminated to its stockholders. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-39- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company shall (A)&nbsp;provide Parent, its outside legal counsel and its other
Representatives with a reasonable opportunity to review and comment on drafts of the Proxy Statement and other documents and communications related to the Company Stockholders Meeting (other than any filings, documents or communications related to a
Change of Recommendation) prior to filing, furnishing or delivering such documents with or such communications to the applicable Governmental Entity and dissemination of such documents or communications to the Company’s stockholders,
(B)&nbsp;include in the Proxy Statement and such other documents and communications related to the Company Stockholders Meeting all comments reasonably proposed by Parent, its outside legal counsel and its other Representatives, and (C)&nbsp;to the
extent reasonably practicable, permit Parent and its outside legal counsel to participate in all communications with the SEC (including all meetings and telephone conferences) relating to the Proxy Statement. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Without limiting the generality of the provisions of <u>Section</u><u></u><u>&nbsp;7.7</u>, the Company shall (i)&nbsp;as promptly as
reasonably practicable following receipt thereof, notify Parent of the receipt of any comments from the SEC with respect to the Proxy Statement and of any request by the SEC for any amendment or supplement to the Proxy Statement or for additional
information and (ii)&nbsp;as promptly as reasonably practicable following receipt thereof, provide Parent, if applicable, copies of all correspondence between the Company or any of its Representatives and the SEC with respect to the Proxy Statement
(or where no such copies are available, a reasonably detailed written description thereof). The Company shall, subject to the requirements of <u>Section</u><u></u><u>&nbsp;7.3(d)</u>, (A)&nbsp;use its reasonable best efforts to promptly provide
responses to the SEC with respect to any comments received on the Proxy Statement by the SEC and any requests by the SEC for any amendment or supplement to the Proxy Statement or for additional information, and (B)&nbsp;cause the definitive Proxy
Statement to be mailed as promptly as reasonably practicable after the date the SEC staff confirms that the SEC does not intend to review the preliminary Proxy Statement or advises that it has no further comments thereon or that the Company may
commence mailing the Proxy Statement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.4. <u>Company Stockholders Meeting</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company shall take, in accordance with applicable Law and its Organizational Documents, all action necessary to (i)&nbsp;duly convene
and hold the Company Stockholders Meeting as promptly as reasonably practicable after the Proxy Statement is in final form (taking into account a reasonable period of time for the solicitation of the proxies) and (ii)&nbsp;cause a vote upon the
adoption of this Agreement to be taken thereat. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company Stockholders Meeting shall not be postponed, recessed or adjourned by the
Company without Parent’s prior written consent (such consent not to be unreasonably withheld, conditioned or delayed); <u>provided</u> that&nbsp;the Company may postpone, recess or adjourn the Company Stockholders Meeting (i)&nbsp;to the
extent, in the good faith judgment of the Company Board (after consultation with the Company’s outside legal counsel), required by applicable Law or necessary to ensure that any required supplement or amendment to the Proxy Statement is
delivered to the stockholders of the Company for the amount of time required by applicable Law in advance of the Company Stockholders Meeting, (ii)&nbsp;if the Company reasonably believes there will be insufficient Shares represented (either in
person or by proxy) to constitute a quorum necessary to conduct the business of the Company Stockholders Meeting or (iii)&nbsp;to solicit additional proxies to obtain the Requisite Company Vote, so long as in each case that the Company exercises its
right under this <u>Section</u><u></u><u>&nbsp;7.4(b)</u> to postpone, recess or adjourn the Company Stockholders Meeting, the Company shall have reasonably consulted with Parent in advance with respect to such determination and provided prior
written notice to Parent; <u>provided</u> <u>further</u>, that in no event shall the Company Stockholders Meeting be postponed, recessed or adjourned pursuant to clauses (ii)&nbsp;and (iii), taken together, more than ten Business Days in connection
with any one postponement, recess or adjournment or more than an aggregate of thirty days from the originally scheduled meeting date. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
The Company shall use reasonable best efforts to take all lawful action to obtain the Requisite Company Vote, including the solicitation of proxies therefor. The Company agrees that, unless this Agreement is terminated and the transactions
contemplated by this Agreement are abandoned pursuant to and in accordance with <u>Article</u><u></u><u>&nbsp;IX</u>, its obligations to hold the Company Stockholders Meeting pursuant to this <u>Section</u><u></u><u>&nbsp;7.4</u> shall not
</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-40- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be affected in any manner, including in connection with (i)&nbsp;the making of a Change of Recommendation or (ii)&nbsp;the commencement of or announcement or disclosure of or communication to the
Company of any Acquisition Proposal or any event constituting or that could constitute an Intervening Event, and the Company shall continue to use reasonable best efforts to take all lawful action to obtain the Requisite Company Vote, including the
solicitation of proxies therefor. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Once the Company has established a record date for the Company Stockholders Meeting, the Company
shall not change or establish a different record date for the Company Stockholders Meeting unless (i)&nbsp;required by applicable Law, (ii)&nbsp;reasonably necessary as a result of any postponement, recess or adjournment of the Company Stockholders
Meeting effected pursuant to <u>Section</u><u></u><u>&nbsp;7.4(b)</u> or (iii)&nbsp;the prior written consent of Parent (not to be unreasonably withheld, conditioned or delayed) is obtained. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Company agrees (i)&nbsp;to provide Parent with reasonably detailed periodic updates concerning proxy solicitation results on a
reasonably timely basis (including, if requested, promptly providing voting reports on a reasonably frequent basis) and (ii)&nbsp;to give written notice to Parent one day prior to the Company Stockholders Meeting, indicating whether as of such date,
sufficient proxies representing the Requisite Company Vote have been obtained. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Without the prior written consent of Parent, the
adoption of this Agreement shall be the only matter (other than related procedural matters or any <font style="white-space:nowrap">non-binding</font> advisory vote required under applicable Law) that the Company may propose to be acted on by the
Company’s stockholders at the Company Stockholders Meeting. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.5. <u>Approval of Sole Stockholder of Merger Sub</u>. As promptly as
practicable following the execution and delivery of this Agreement, Merger Sub’s sole stockholder shall execute and deliver, in accordance with applicable Law and Merger Sub’s Organizational Documents, a written consent adopting this
Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.6. <u>Antitrust Matters</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <u>General</u>. In addition to and without limiting the rights and obligations set forth in
<u>Sections</u><u></u><u>&nbsp;7.1</u>,<u>&nbsp;7.3</u>, <u>7.7</u> and <u>7.8</u>, but subject to the other terms and conditions of this <u>Section</u><u></u><u>&nbsp;7.6</u>, each of the Company and Parent shall cooperate with each other and use
(and shall cause their respective Subsidiaries to use) its respective reasonable best efforts to take or cause to be taken all actions necessary or advisable with respect to all Antitrust Laws to consummate the transactions contemplated by this
Agreement, including preparing and delivering or submitting documentation to (A)&nbsp;effect the expirations of all waiting periods under applicable Antitrust Law and (B)&nbsp;make with and obtain from, as applicable, any Governmental Antitrust
Entity, all filings, notices, reports, consents, registrations, approvals, <font style="white-space:nowrap">non-objections,</font> permits and authorizations, in each case, necessary or advisable under Antitrust Law in order to consummate the
transactions contemplated by this Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <u>Regulatory Efforts</u>. Without limiting the generality of, and in furtherance of the
provisions of <u>Section</u><u></u><u>&nbsp;7.6(a)</u> but subject to the limitations set forth in <u>Section</u><u></u><u>&nbsp;7.6(c)</u> and the cooperation and coordination contemplated by <u>Section</u><u></u><u>&nbsp;7.6(e)</u>, each of the
Company and Parent agrees to take or cause to be taken the following actions (as applicable): </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) the preparation and filing, with
respect to the transactions contemplated by this Agreement, of an appropriate filing of a Notification and Report Form pursuant to the HSR Act as promptly as practicable after the date of this Agreement (and in any event within ten Business Days
after the date of this Agreement); <u>provided</u>, that Parent may withdraw and promptly thereafter refile its Notification and Report Form pursuant to the HSR Act in accordance with 16 C.F.R. § 803.12 and any other applicable Law if deemed
advisable by Parent’s outside legal counsel (in consultation with the Company’s outside legal counsel); </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the prompt
provision to each and every federal, state, local or foreign court or Governmental Entity with jurisdiction over enforcement of any applicable Antitrust Law (each, a “<u>Governmental Antitrust Entity</u>”) of
<font style="white-space:nowrap">non-privileged</font> information and documents requested by any Governmental Antitrust Entity or that are necessary, proper or advisable to permit consummation of the transactions contemplated by this Agreement;
</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-41- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) the prompt use of its reasonable best efforts to comply with
<u>Section</u><u></u><u>&nbsp;7.6(b)(iii)</u> of the Company Disclosure Letter; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) the prompt use of its reasonable best efforts to
defend through litigation on the merits any claim asserted in any court, agency or other Proceeding by any Governmental Antitrust Entity (or any other Person making a claim under any Antitrust Law) seeking to delay, restrain, prevent, enjoin or
otherwise prohibit consummation of the transactions contemplated by this Agreement (subject in all cases to the limitations set forth in <u>Section</u><u></u><u>&nbsp;7.6(c)</u>); </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) the prompt use of its reasonable best efforts to take all necessary or reasonably proper or advisable steps to vacate, modify, reverse,
suspend, prevent, eliminate or remove any temporary, preliminary or permanent injunction or other order, decree, decision, determination or judgment entered or issued in any Proceeding or inquiry of any kind that would reasonably be expected to
delay, restrain, prevent, enjoin or otherwise prohibit or make unlawful the consummation of the transactions contemplated by this Agreement (subject in all cases to the limitations set forth in <u>Section</u><u></u><u>&nbsp;7.6(c)</u>); </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) the proffer and agreement by Parent of its willingness to sell, lease, license or otherwise dispose of, or hold separate pending such
disposition, and promptly to effect the sale, lease, license, disposal and holding separate of, assets, operations, rights, product lines, licenses, businesses or interests therein of the Company, Parent or any of their respective Subsidiaries, and
the entry into agreements with, and submission to orders of, the relevant Governmental Antitrust Entity giving effect thereto, which Parent may present to the applicable Governmental Antitrust Entity in one or more proposals over time but not later
than October 5, 2021 (subject in all cases to the limitations set forth in <u>Section</u><u></u><u>&nbsp;7.6(c)</u>), if such action would be necessary or reasonably proper or advisable so as to permit the consummation of the transactions
contemplated by this Agreement prior to the Outside Date; and </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) the proffer and agreement by Parent of its willingness to effect any
other obligation, restriction, requirement, limitation, qualification, condition, remedy or other action with respect to the business and operations of the Company, Parent or any of their respective Subsidiaries, and the entry into agreements with,
and submission to orders of, the relevant Governmental Antitrust Entity giving effect thereto, which Parent may present to the applicable Governmental Antitrust Entity in one or more proposals over time but not later than October 5, 2021 (subject in
all cases to the limitations set forth in <u>Section</u><u></u><u>&nbsp;7.6(c)</u>), if such action would be necessary or reasonably proper or advisable so as to permit the consummation of the transactions contemplated by this Agreement prior to the
Outside Date. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <u>Limitations on Regulatory Efforts</u>. Notwithstanding anything to the contrary set forth in this Agreement
(including <u>Section</u><u></u><u>&nbsp;7.6(b)</u>): </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) in no event shall (1)&nbsp;any Party or any of its Subsidiaries be required to
agree to any term, condition, obligation, liability, requirement, limitation, qualification, remedy, commitment, sanction or other action imposed, required or requested by a Governmental Antitrust Entity in connection with effecting (y)&nbsp;the
expiration of any waiting period under applicable Antitrust Law or (z)&nbsp;a Governmental Antitrust Entity’s grant of any consent, registration, approval, <font style="white-space:nowrap">non-objection,</font> permit or authorization, in each
case necessary or advisable in order to consummate the transactions contemplated by this Agreement that is not conditioned upon the consummation of the transactions contemplated by this Agreement or (2)&nbsp;the Company or any of its Subsidiaries
agree with a Governmental Antitrust Entity to any term, condition, obligation, liability, requirement, limitation, qualification, remedy, commitment, sanction or other action in connection with the expiration of any such waiting period or obtaining
of any such consent, registration, approval, <font style="white-space:nowrap">non-objection,</font> permit or authorization without the prior written consent of Parent (which consent may be withheld in Parent’s sole discretion); and </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the Parties hereby acknowledge and agree that neither this <u>Section</u><u></u><u>&nbsp;7.6</u> nor the “reasonable best
efforts” standard in this <u>Section</u><u></u><u>&nbsp;7.6 </u>nor any other provision set forth in this Agreement shall require, or be </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-42- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
construed to require, Parent or any of its Subsidiaries, in order to effect the expiration of any waiting periods under applicable Antitrust Law or the obtaining from any Governmental Antitrust
Entity of any consent, registration, approval, <font style="white-space:nowrap">non-objection,</font> permit or authorization to consummate the transactions contemplated by this Agreement, to agree to any Burdensome Condition; <u>provided</u> that
Parent can compel the Company to (and to cause the Company’s Subsidiaries to) agree to any such Burdensome Condition so long as the effectiveness of Burdensome Condition is conditioned upon the consummation of the transactions contemplated by
this Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <u>Divestitures</u>. The Company shall agree, if reasonably requested by Parent so as to permit (or as identified by
the Parties as reasonably likely to be necessary to permit) the expiration or termination of the applicable waiting periods under the HSR Act or the receipt of any other consent under any other applicable Antitrust Law, in each case as soon as
practicable after the date of this Agreement (but in any event not later than the Outside Date unless otherwise directed by Parent), to effect and agree to any sale, divestiture, license, holding separate or other similar arrangement with respect
to, or other disposition of or restriction on, any assets, operations, rights, product lines, licenses, businesses or interests therein of the Company and its Subsidiaries, and take such action or actions that would in the aggregate have a similar
effect; <u>provided</u>, <u>however</u>, that any such sale, divestiture, license, holding separate or other similar arrangement, disposition, restriction or action or actions (each, a “<u>Potential Sale Transaction</u>”) is conditioned on
the occurrence of, and shall become effective only from and after, the Closing. Without limiting the foregoing, to the extent reasonably requested by Parent, the Company shall, and shall cause its Subsidiaries to, cooperate with Parent to facilitate
a Potential Sale Transaction and, in furtherance thereof, to the extent reasonably requested by Parent, the Company shall, and shall cause its Subsidiaries, to (a)&nbsp;enter into confidentiality agreements containing customary terms with any
Persons who Parent identifies to the Company as potential purchasers in a Potential Sale Transaction (such potential purchasers to be referred to as “<u>Potential Purchasers</u>”); (b) permit Potential Purchasers to conduct (and cooperate
with such Potential Purchasers’) reasonable documentary and other investigations with respect to such Potential Sale Transaction (<u>provided</u>, that any such Potential Purchaser executes and delivers to the Company a confidentiality
agreement and, to the extent deemed advisable by Parent’s outside legal counsel, a clean team agreement, in each case containing customary terms); (c) comply with any applicable right of first refusal, right of first offer, right of approval
and similar provisions that may be applicable to a proposed transfer of a Potential Sale Transaction; and (d)&nbsp;deliver such notices, make such filings and execute such contracts relating to a Potential Sale Transaction as reasonably requested by
Parent and at Parent’s expense. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <u>Cooperation</u>. Separate and apart from and without limiting or expanding the rights and
obligations set forth in <u>Section</u><u></u><u>&nbsp;7.3</u>, Parent and the Company shall jointly direct all matters (including with respect to process, strategy and communications) with any Governmental Antitrust Entity consistent with its
obligations hereunder; <u>provided</u> that in the event of any conflict or disagreement between Parent and the Company with respect to strategy regarding any matter with a Governmental Antitrust Entity, Parent shall have the right to direct the
matter that is the cause of any such conflict or disagreement, acting reasonably and in good faith. Parent and the Company shall each have the right to review in advance and, to the extent practicable, each shall consult with the other on and
consider in good faith the views of the other in connection with, all the information relating to Parent or the Company, as the case may be, any of their respective Subsidiaries and any of its or their respective Representatives, that appears in any
filing made with, or written materials delivered or submitted to, any Governmental Antitrust Entity in connection with the transactions contemplated by this Agreement. Neither the Company nor Parent shall, nor shall either permit any of their
respective Subsidiaries or any of its or their respective Representatives to, participate in any substantive meetings, calls, presentations and other communications with any Governmental Antitrust Entity in respect of any documentation to effect the
expiration of any waiting periods under applicable Antitrust Laws or make with or obtain from any Governmental Antitrust Entity, as applicable, all filings, notices, reports, consents, registrations, approvals, permits and authorizations, in each
case, necessary or advisable in order to consummate the transactions contemplated by this Agreement unless it consults with the other in advance and, to the extent permitted by such Governmental Antitrust Entity, gives the other the opportunity to
attend and participate thereat. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-43- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <u>Other Transactions</u>. Notwithstanding anything to the contrary set forth in this
Agreement and not in limitation of any other obligations set forth herein (including as set forth with respect to the Company and its Subsidiaries in <u>Section</u><u></u><u>&nbsp;7.1(a)</u>), each of Parent and the Company shall, and shall cause
each of its Subsidiaries to, from and after the date of this Agreement until the Effective Time (unless the other Party shall otherwise approve in writing), not acquire, directly or indirectly by merger, consolidation, acquisition of stock or assets
or otherwise, any business, Person or assets from any other Person if such transaction would reasonably be expected to (i)&nbsp;impose any material delay in the obtaining of, or materially increase the risk of not obtaining, any consent from any
Governmental Antitrust Entity required in connection with the transactions contemplated by this Agreement, (ii)&nbsp;materially increase the risk of any Governmental Antitrust Entity enacting, issuing, promulgating, enforcing or entering any Order
(whether temporary, preliminary or permanent) that makes unlawful or materially delays the consummation of the transactions contemplated by this Agreement or (iii)&nbsp;materially increase the risk of the Parties not being able to remove any such
Law described in the preceding clause (ii). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.7. <u>Status and Notifications</u>. Separate and apart from and without limiting or
expanding the rights and obligations set forth in <u>Section</u><u></u><u>&nbsp;7.3(e)</u>, the Company and Parent each shall keep the other reasonably apprised of the status of matters relating to the completion of the transactions contemplated by
this Agreement, including as promptly as practicable notifying the other of any notices or communications received by Parent or the Company, as the case may be, or any of their respective Subsidiaries, from any third party, including any
Governmental Entity, with respect to such transactions and as promptly as practicable following such receipt furnishing the other with, if applicable, copies of notices or other communications (or where no such copies are available, a reasonably
detailed description thereof). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.8. <u>General Regulatory Efforts; </u><u>Third-Party Consents</u>. Separate and apart from the
obligations set forth in <u>Section</u><u></u><u>&nbsp;7.3</u> and <u>Section</u><u></u><u>&nbsp;7.6</u>, each Party shall use its, and shall cause its Subsidiaries to use their, reasonable best efforts to take or cause to be taken all actions, and
do or cause to be done all things, necessary or advisable on its part under this Agreement and applicable Law to consummate the transactions contemplated by this Agreement as promptly as reasonably practicable after the date of this Agreement (and,
in any event, no later than the Outside Date), including (a)&nbsp;preparing and delivering or submitting documentation to make with and obtain from, as applicable, any Governmental Entity, all filings, notices, reports, consents, registrations,
approvals, <font style="white-space:nowrap">non-objections,</font> permits and authorizations, in each case, necessary or advisable in order to consummate the transactions contemplated by this Agreement, including the Company Approvals and the
Parent Approvals, as promptly as reasonably practicable after the date of this Agreement (and, in any event, no later than the Outside Date) and (b)&nbsp;giving, obtaining or effecting (as the case may be) as promptly as practicable following the
date of this Agreement all notices, acknowledgments, waivers, consents, amendments, supplements or other modifications required under any Contract to which the Company or any of its Subsidiaries is a party to or bound (the “<u>Third-Party
Consents</u>”) and that are necessary or advisable to be given, obtained or effected in order to consummate the transactions contemplated by this Agreement as promptly as reasonably practicable after the date of this Agreement (and, in any
event, no later than the Outside Date), and in connection with the obligations in this clause (b), neither the Company nor any of its Subsidiaries shall (i)&nbsp;make any payment of a consent fee, “profit sharing” payment or other
consideration (including increased or accelerated payments) or concede anything of value, (ii)&nbsp;amend, supplement or otherwise modify any such Contract or (iii)&nbsp;agree or commit to do any of the foregoing, in each case for the purposes of
giving, obtaining or effecting any Third-Party Consents without the prior consent of Parent (such consent not to be unreasonably withheld, conditioned or delayed). Separate and apart from the obligations set forth in
<u>Section</u><u></u><u>&nbsp;7.3</u> and <u>Section</u><u></u><u>&nbsp;7.6</u>, neither the Company nor Parent shall, nor shall either permit any of their respective Subsidiaries or any of its or their respective Representatives to, participate in
any substantive meetings, calls, presentations and other communications with any Governmental Entity in respect of any documentation to effect the expiration of any waiting periods under applicable Laws or make with or obtain from any Governmental
Entity, as applicable, all filings, notices, reports, consents, registrations, approvals, permits and authorizations, in each case, necessary or advisable in order to consummate the transactions contemplated by this Agreement unless it consults with
the other in advance and, to the extent permitted by such Governmental Entity, gives the other the opportunity to attend and participate </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-44- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
thereat. For the avoidance of doubt, this <u>Section</u><u></u><u>&nbsp;7.8</u> shall not apply to any matters related to Antitrust Law, which shall be governed by
<u>Section</u><u></u><u>&nbsp;7.6</u>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.9. <u>Information and Access</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company and Parent each shall (and shall cause its Subsidiaries to, and shall use its reasonable best efforts to cause its and their
respective Representatives to), upon the reasonable request by the other, furnish to the other, as promptly as practicable, with all information concerning itself, its Representatives and such other matters as may be necessary or advisable
(i)&nbsp;in connection with the Proxy Statement, (ii)&nbsp;to effect the expiration of all waiting periods under applicable Antitrust Laws and (iii)&nbsp;in connection with all filings, notices, reports, consents, registrations, approvals, permits
and authorizations, made or sought by or on behalf of Parent, the Company or any of their respective Subsidiaries to or from any third party, including any Governmental Entity, in each case necessary or advisable in connection with the transactions
contemplated by this Agreement and, with respect to the information supplied by or on behalf of Parent, its Subsidiaries or its or their respective Representatives for inclusion in or incorporation by reference into the Proxy Statement, Parent
acknowledges and agrees that such information will be correct and complete in all material respects at the time so supplied. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In
addition to and without limiting the rights and obligations set forth in <u>Section</u><u></u><u>&nbsp;7.9(a)</u>, the Company shall (and shall cause its Subsidiaries to), upon reasonable prior notice, afford Parent and its Representatives
reasonable access during the Interim Period, to the Company Employees and the Company’s agents, properties, offices and other facilities, Contracts, books and records, and, during such period, the Company shall (and shall cause its Subsidiaries
to) furnish promptly to Parent all other information and documents concerning or regarding its businesses, properties and assets and personnel as may reasonably be requested by or on behalf of Parent; <u>provided</u>, <u>however</u>, that neither
the Company nor any of its Subsidiaries shall be required to provide such access or furnish such information or documents to the extent doing so would, in the reasonable judgment of the Company, taking into account the advice of the Company’s
outside legal counsel, result in&nbsp;(A)&nbsp;a violation of applicable Law, including <font style="white-space:nowrap">COVID-19</font> Measures (provided, that the Company shall, and shall cause its Subsidiaries to, use reasonable best efforts to
provide such access as can be provided in a manner without violating such <font style="white-space:nowrap">COVID-19</font> Measures or other applicable Law), (B)&nbsp;the breach of any contractual confidentiality obligations in any Contract with a
third party entered into prior to the date of this Agreement or following the date of this Agreement in compliance with <u>Section</u><u></u><u>&nbsp;7.1</u> or <u>Section</u><u></u><u>&nbsp;7.2</u> (as applicable), (C)&nbsp;waiving the protection
of any attorney-client privilege or protection (including attorney-client privilege, attorney work-product protections and confidentiality protections) or any other applicable privilege or protection concerning pending or threatened Proceedings or
(D)&nbsp;competitive harm to the Company or any of its Subsidiaries. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) No access or information provided to Parent or any of its
Representatives or to the Company or any of its Representatives following the date of this Agreement, whether pursuant to this <u>Section</u><u></u><u>&nbsp;7.9</u> or otherwise, shall affect or be deemed to affect, modify or waive the
representations and warranties of the Parties set forth in this Agreement and, for the avoidance of doubt, all information and documents disclosed or otherwise made available pursuant to <u>Sections</u><u></u><u>&nbsp;7.3</u> or <u>7.7</u>, this
<u>Section</u><u></u><u>&nbsp;7.9</u> or otherwise in connection with this Agreement and the transactions contemplated by this Agreement shall be governed by the terms and conditions of the Confidentiality Agreement and subject to applicable Law
relating to the exchange or sharing of information and any restrictions or requirements imposed by any Governmental Entity. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Following
the date hereof, the Company shall use its reasonable best efforts to move documents from any “clean rooms” established in connection with the virtual data rooms hosted by or on behalf of the Company to the unrestricted areas of such
virtual data rooms, in a manner consistent with its process for moving such documents from clean rooms to unrestricted areas prior to the execution of this Agreement and in accordance with the Clean Team Agreement; <u>provided</u>, that (i)&nbsp;the
Company shall not be required to move any such documents if doing so would, in the Company’s reasonable judgment and consultation with outside legal counsel, violate Antitrust Law and (ii)&nbsp;the Company shall be permitted to redact
competitively sensitive information from such documents in accordance with the Clean Team Agreement. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-45- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.10. <u>Publicity</u>. The initial press release with respect to the transactions
contemplated by this Agreement shall be a joint press release. Thereafter, the Parties shall consult with each other, provide each other with a reasonable opportunity for review and give due consideration to reasonable comments by each other, prior
to issuing any other press releases or otherwise making public statements, disclosures or communications with respect to the transactions contemplated by this Agreement and shall not issue any such press release or otherwise make such public
statements, disclosures or communications prior to such consultation, except (a)&nbsp;as may be required or rendered impractical by applicable Law or by obligations pursuant to any listing agreement with or rules of any national securities exchange,
interdealer quotation service, the NYSE or NASDAQ, or (b)&nbsp;with respect to the Company’s disclosures or communications with any Governmental Entity regarding the Proxy Statement or any Company Approvals <u>contemplated by
</u><u>Section</u><u></u><u>&nbsp;7.3</u><u>, which shall be governed by the provisions of </u><u>Section</u><u></u><u>&nbsp;7.3</u>. In addition to the exceptions set forth in clauses (a)&nbsp;and (b) above, each Party (and Representatives thereof)
may make any public statements, disclosures or communications in response to inquiries from the press, analysts, investors, customers or suppliers or via industry conferences or analyst or investor conference calls, so long as such statements,
disclosures or communications are consistent in tone and substance with previous public statements, disclosures or communications made by it in compliance with this <u>Section</u><u></u><u>&nbsp;7.10</u> (or jointly made by the Company and Parent,
if applicable) or to the extent that they have been reviewed and previously approved by the other Parties. Notwithstanding the foregoing, (i)&nbsp;this <u>Section</u><u></u><u>&nbsp;7.10</u> shall not apply to or in any way restrict public
communications to the extent they do not address this Agreement or the transactions contemplated hereby (including Company Reports, regular earnings releases and similar communications) and (ii)&nbsp;the Company shall not be required to consult with
or obtain any approval from Parent with respect to a public announcement or press release issued in connection with the receipt and existence of an Acquisition Proposal or a Change of Recommendation made in accordance with this Agreement, subject in
all respects to <u>Section</u><u></u><u>&nbsp;7.2</u>, and Parent shall not be required to consult with or obtain any approval from the Company with respect to its responses thereto; <u>provided</u>, that, notwithstanding the foregoing clause
(i)&nbsp;above, and subject to the exceptions set forth in the preceding clause (a), the Company shall provide Parent with drafts and reasonable advance notice of any earnings release, Form <font style="white-space:nowrap">10-Q</font> and Form <font style="white-space:nowrap">10-K</font> and any disclosure or communication of any material development or material matter that is materially adverse to the Company (in the Company’s reasonable discretion), in each case, to the extent reasonably
practicable prior to public disclosure thereof. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.11. <u>Employee Benefits</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Parent agrees that the Continuing Employees shall, during the period commencing at the Effective Time and ending on the <font style="white-space:nowrap">one-year</font> anniversary of the Effective Time (the “<u>Continuation Period</u>”), be provided with (i)&nbsp;base salary or base wage and target annual cash bonus opportunities that are, in each case, no less
favorable than those provided to each such Continuing Employee immediately prior to the Effective Time and (ii)&nbsp;employee benefits, including pension and welfare benefits (but excluding equity and long-term incentive compensation and any
retention or transaction bonus payments) that are no less favorable in the aggregate to those provided to the Continuing Employees immediately prior to the Effective Time or, in Parent’s discretion, are substantially comparable to those made
available to similarly situated employees of Parent and its Subsidiaries. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Parent shall (i)&nbsp;cause any <font style="white-space:nowrap">pre-existing</font> conditions or limitations and eligibility waiting periods under any welfare plans of Parent or its Affiliates to be waived with respect to the Continuing Employees and their eligible dependents,
(ii)&nbsp;give each Continuing Employee credit for the plan year in which the Continuing Employee is first eligible to enroll in a Parent plan providing welfare benefits towards applicable deductibles and annual <font style="white-space:nowrap"><font style="white-space:nowrap">out-of-pocket</font></font> limits for expenses incurred prior to the Effective Time for which payment has been made in respect of such Continuing Employee and their eligible dependents to the same extent such credit was
given under the analogous Company Benefit Plan during the calendar year in which the Continuing Employee first becomes eligible to enroll in such Parent plan and (iii)&nbsp;give each Continuing Employee service credit for such Continuing
Employee’s employment with the Company and its Subsidiaries for purposes of vesting, benefit accrual and eligibility to participate under each applicable Parent benefit plan, as if such service had been performed with Parent, except for benefit
accrual under defined benefit pension plans, for purposes of qualifying </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-46- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
for subsidized early retirement benefits or to the extent it would result in a duplication of benefits. For the avoidance of doubt, such service shall not be recognized for purposes of
eligibility for retirement vesting under equity plans of Parent. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Prior to the Effective Time, if requested by Parent in writing, to
the extent permitted by applicable Law and the terms of the applicable plan or arrangement, the Company shall (i)&nbsp;cause to be amended the Company Benefit Plans to the extent necessary to provide that no employees of Parent and its Subsidiaries
shall commence participation therein following the Effective Time unless the Surviving Corporation or such Subsidiary explicitly authorizes such participation and (ii)&nbsp;cause the Company 401(k) Plan to be terminated effective immediately prior
to the Effective Time. In the event that Parent requests that the Company 401(k) Plan be terminated, the Company shall provide Parent with evidence that such plan has been terminated not later than the Effective Time. All resolutions adopted or
executed in connection with the termination of the Company 401(k) Plan shall be subject to Parent’s reasonable prior review and comment, and the Company shall consider any such comments in good faith. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If requested by Parent in writing delivered to the Company not less than 10 Business Days prior to the Effective Time (with such request
to be made only in the event Parent does not request that the Company 401(k) Plan be terminated pursuant to <u>Section</u><u></u><u>&nbsp;7.11(c)</u>), the Company Board shall take any actions (including, if applicable, adopting resolutions) as is
reasonably necessary to delegate plan administration authority for any Company Benefit Plans that are qualified or <font style="white-space:nowrap">non-qualified</font> retirement plans to Parent’s Employee Benefits Plans Administrative
Committee and to delegate investment authority for such plans to Parent’s Employee Benefit Plans Investment Committee, with such delegation to be effective as of the Effective Time and contingent upon the occurrence of the Effective Time. To
the extent such delegation of authority described in the preceding sentence is requested by Parent, the Company shall provide Parent with evidence of such delegation not later than the Effective Time. All resolutions adopted or executed in
connection with the delegation described herein shall be subject to Parent’s reasonable prior review and comment. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Prior to
making any written communications intended for broad based distribution to any Company Employee pertaining to compensation or benefits matters that are affected by the transactions contemplated by this Agreement, the Company shall provide Parent
with a copy of the intended communication, Parent shall have a reasonable period of time to review and comment on the communication and the Company shall consider any such comments in good faith. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Without limiting the generality of <u>Section</u><u></u><u>&nbsp;7.11(a)</u>, from and after the Effective Time, Parent shall, or shall
cause its Subsidiaries, including the Surviving Corporation, to, assume and honor the Company’s and its Subsidiaries’ employment, severance, retention, cash incentive compensation and termination plans, policies, programs, agreements and
arrangements in effect as of immediately prior to the Effective Time, in each case, in accordance with their terms as in effect immediately prior to the Effective Time (including those terms with respect to a “qualifying termination” in
the Company’s then-applicable annual incentive bonus plan); <u>provided</u>, <u>however</u>, that, notwithstanding the foregoing, to the extent elected by the Company prior to the Closing Date, Parent shall provide Continuing Employees with
severance payments and benefits under the general severance plans, policies or programs of Parent during the Continuation Period. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The
Company shall be permitted to determine in good faith the amounts payable under its annual cash incentive program for the fiscal year in which the Closing Date occurs based on actual performance through the Closing Date, and Parent shall cause such
amounts to be paid to the Continuing Employees on the earliest of (i)&nbsp;the date the Company has historically paid such amounts in the Ordinary Course of Business; (ii)&nbsp;the date Parent pays annual cash bonuses in the Ordinary Course of
Business; and (iii)&nbsp;the date on which the applicable Continuing Employee is otherwise entitled to receive payment under the applicable annual cash incentive program; <u>provided</u> that the aggregate amount of such bonus payments shall not
exceed the amount accrued by the Company for accounting purposes through the Closing Date. For the balance of the calendar year in which the Closing Date occurs, Continuing Employees shall participate in an annual cash incentive program sponsored by
</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-47- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Parent, and such bonuses will be paid to the Continuing Employees in accordance with the terms of Parent’s program on the date Parent pays annual cash bonuses in the Ordinary Course of
Business, <font style="white-space:nowrap">pro-rated</font> to reflect the portion of the calendar year following the Closing Date during which the Continuing Employees participated in such program. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Nothing set forth in this Agreement is intended to (i)&nbsp;be treated as an amendment of any particular Company Benefit Plan,
(ii)&nbsp;prevent Parent, the Surviving Corporation or any of their Affiliates from amending or terminating any of their benefit plans or, after the Effective Time, any Company Benefit Plan in accordance with their terms, (iii)&nbsp;prevent Parent,
the Surviving Corporation or any of their Affiliates, after the Effective Time, from terminating the employment of any Continuing Employee, or (iv)&nbsp;without limiting the generality of <u>Section</u><u></u><u>&nbsp;10.8</u>, create any
third-party beneficiary rights in any employee of the Company or any of its Subsidiaries, any beneficiary or dependent thereof, or any collective bargaining representative thereof, with respect to the compensation, terms and conditions of employment
or benefits that may be provided to any Continuing Employee by Parent, the Surviving Corporation or any of their Affiliates or under any benefit plan which Parent, the Surviving Corporation or any of their Affiliates may maintain. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.12. <u>Indemnification; Directors</u><u>’</u><u> and Officers</u><u>’</u><u> Insurance</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) From and after the Effective Time, to the fullest extent that the Company would have been permitted under applicable Law and the
Company’s Organizational Documents in effect as of the date of this Agreement, Parent shall, and shall cause the Surviving Corporation to, (i)&nbsp;indemnify, defend and hold harmless the Indemnified Parties against any and all judgments,
fines, losses, claims, damages, costs of settlement, liabilities and reasonable and documented costs and expenses (including reasonable and documented attorneys’ fees) incurred in connection with, arising out of or otherwise related to any
Proceeding, which Proceeding is in connection with, arising out of or otherwise related to matters existing or occurring at or prior to the Effective Time or relating to the enforcement of any such Indemnified Party’s rights under this
<u>Section</u><u></u><u>&nbsp;7.12</u>, whether asserted or claimed prior to, at or after the Effective Time, and (ii)&nbsp;advance expenses as incurred by the Indemnified Parties; <u>provided</u> that any Person to whom expenses are so advanced
provides an undertaking to repay such advances if it is ultimately determined by final and nonappealable adjudication by the Chosen Courts that such Person is not entitled to such advanced expenses. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Prior to the Effective Time, the Company shall obtain and fully pay the premium for “tail” insurance policies for the extension
of (i)&nbsp;the directors’ and officers’ liability coverage of the Company’s existing directors’ and officers’ insurance policies, and (ii)&nbsp;the Company’s existing fiduciary liability insurance policies
(collectively, “<u>D&amp;O Insurance</u>”), in each case for a claims reporting or discovery period of the Tail Period with respect to any claim related to matters existing or occurring at or prior to the Effective Time from the
Company’s D&amp;O Insurance carriers as of the date of this Agreement or one or more insurance carriers with the same or better credit rating as such carriers with terms, conditions, retentions and limits of liability that are at least as
favorable to the insureds as the Company’s existing policies. The Company shall use reasonable best efforts to obtain such “tail” policies as promptly as practicable following the date of this Agreement. If the Company for any reason
fails to obtain such “tail” insurance policies as of the Effective Time, the Surviving Corporation shall purchase comparable D&amp;O Insurance for the Tail Period with terms, conditions, retentions and limits of liability that are at least
as favorable as provided in the Company’s existing policies as of the date of this Agreement with respect to the <font style="white-space:nowrap">pre-Closing</font> period and from an insurance carrier with the same or better credit rating as
the Company’s D&amp;O Insurance carrier as of the date of this Agreement, in each case providing coverage with respect to any matters existing or occurring at or prior to the Effective Time; <u>provided</u>, <u>however</u>, that, with respect
to any D&amp;O Insurance purchased pursuant to this <u>Section</u><u></u><u>&nbsp;7.12(b)</u>, in no event shall the annual cost of such D&amp;O Insurance during the Tail Period exceed 300% of the current aggregate annual premium paid by the Company
for such purpose; and <u>provided</u> <u>further</u>, that if the cost of such insurance coverage exceeds such amount, the Company or the Surviving Corporation (as applicable) shall obtain a policy with the greatest coverage available for a cost not
exceeding such amount. From and after the Effective Time, Parent shall cause such “tail” insurance policies (whether purchased by the Company prior to the Effective Time or the Surviving </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-48- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company or Parent following the Effective Time) to be maintained in full force and effect, each for its full term, and honor all obligations thereunder. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Any Indemnified Party wishing to claim indemnification under this <u>Section</u><u></u><u>&nbsp;7.12(c)</u>, upon learning of any
Proceeding for which indemnification under this <u>Section</u><u></u><u>&nbsp;7.12(c)</u> may be available, shall promptly notify Parent thereof in writing, but the failure to so notify shall not relieve Parent or the Surviving Corporation of any
obligation or liability it may have to such Indemnified Party except to the extent such failure materially prejudices the indemnifying party. In the event of any such Proceeding: (i)&nbsp;Parent or the Surviving Corporation shall have the right to
assume the defense thereof, with the legal counsel selected by Parent or the Surviving Corporation being reasonably satisfactory to the Indemnified Party (<u>it</u> <u>being</u> <u>understood</u> <u>and</u> <u>agreed</u> that by electing to assume
the defense thereof, neither Parent nor the Surviving Corporation shall be deemed to have waived any right to object to the Indemnified Party’s entitlement to indemnification hereunder with respect thereto or assumed any obligation or liability
with respect thereto), except that if Parent or the Surviving Corporation elects not to assume such defense or legal counsel for the Indemnified Party advises that there are issues which raise conflicts of interest between Parent or the Surviving
Corporation and the Indemnified Party, the Indemnified Party may retain legal counsel satisfactory to them, and Parent or the Surviving Corporation shall pay all reasonable and documented fees and expenses of such legal counsel for the Indemnified
Party promptly following the receipt of statements therefor; <u>provided</u>, <u>however</u>, that Parent and the Surviving Corporation shall be obligated pursuant to this <u>Section</u><u></u><u>&nbsp;7.12(c)</u> to pay for only one law firm (in
addition to one local counsel if reasonably necessary) for all Indemnified Parties in any jurisdiction unless the use of one law firm for such Indemnified Parties would present a conflict of interest under applicable standards of professional
conduct on any significant issue between the positions of any two or more Indemnified Parties, in which case the fewest number of law firms necessary to avoid conflicts of interest shall be used; (ii)&nbsp;the Indemnified Parties shall cooperate in
the defense of any such matter if Parent or the Surviving Corporation elects to assume such defense, and Parent and the Surviving Corporation shall cooperate in the defense of any such matter if Parent or the Surviving Corporation elects not to
assume such defense; (iii)&nbsp;the Indemnified Parties shall not be liable or have any obligation for any settlement effected without their prior written consent if Parent or the Surviving Corporation elects to assume such defense and Parent and
the Surviving Corporation shall not be liable or have any obligation for any settlement effected without their prior written consent if Parent or the Surviving Corporation elects not to assume such defense; and (iv)&nbsp;Parent and the Surviving
Corporation shall not have any obligation or liability under <u>Section</u><u></u><u>&nbsp;7.12(a)</u> to any Indemnified Party if it is ultimately determined by final and nonappealable adjudication by the Chosen Courts that the indemnification of
such Indemnified Party in the manner contemplated by <u>Section</u><u></u><u>&nbsp;7.12(a)</u> is prohibited by applicable Law. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If
Parent or the Surviving Corporation or any of their respective successors or permitted assigns (i)&nbsp;shall consolidate with or merge into any other Person and shall not be the continuing or surviving Person of such consolidation or merger or
(ii)&nbsp;shall transfer all or substantially all of its properties and assets to any Person, then, and in each such case, proper provisions shall be made so that the successors and permitted assigns of Parent or the Surviving Corporation shall
assume all the obligations set forth in this <u>Section</u><u></u><u>&nbsp;7.12(d)</u>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The provisions of this
<u>Section</u><u></u><u>&nbsp;7.12</u> are intended to be for the benefit of, and from and after the Effective Time shall be enforceable by, each of the Indemnified Parties and their respective heirs, executors, beneficiaries or representatives, who
shall be third-party beneficiaries of this <u>Section</u><u></u><u>&nbsp;7.12</u>, and shall be binding on all successors and assigns of Parent, Merger Sub and the Company. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The rights of the Indemnified Parties under this <u>Section</u><u></u><u>&nbsp;7.12</u> are in addition to, and not in lieu of, any rights
such Indemnified Parties may have under the Organizational Documents of the Company or any of its Subsidiaries, or under any applicable Contracts or Laws. In furtherance thereof, except as may be required by applicable Law, Parent and the Surviving
Corporation agree that all indemnification, exculpation, expense advancement and similar rights for acts or omissions occurring at or prior to the Effective Time as existing as of the date of this Agreement in favor of any Indemnified Party as
provided in the Organizational Documents of the Company and its Subsidiaries or in any Contract between such Indemnified Party and the Company or any of its </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-49- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Subsidiaries and made available to Parent shall survive the Merger and continue in full force and effect, and shall not be amended, repealed or otherwise modified in any manner that would
adversely affect any right thereunder of any such Indemnified Party. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.13. <u>Financing Cooperation</u><u>; TRA Terminations</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) On or prior to the Closing, at the written request of Parent, the Company shall (i)&nbsp;furnish the trustee under the Senior Notes
Indenture with an officer’s certificate in respect of the redemption of the Senior Notes and prepare and deliver to the trustee under the Senior Notes Indenture a conditional notice of redemption in form and substance satisfactory to Parent
(the “<u>Notice of Redemption</u>”) for all of the outstanding Senior Notes, and (ii)&nbsp;take all other actions, other than the payment of amounts required to redeem the Senior Notes or satisfy and discharge the Senior Notes Indenture
and the payment of fees and expenses relating to the redemption and satisfaction and discharge, including those of the trustee under the Senior Notes Indenture (except to the extent such amounts have been provided by Parent or Merger Sub to the
Company at the Closing), and prepare all other documents as may be necessary to cause, at Parent’s discretion, (A)&nbsp;the redemption of all outstanding Senior Notes at the Closing or (B)&nbsp;if the Senior Notes will not be redeemed in full
at the Closing, the satisfaction and discharge of the Senior Notes Indenture at the Closing; <u>provided</u>, <u>however</u>, that (1)&nbsp;such notice of redemption shall not be required to be issued by the Company prior to the Closing unless the
redemption provided for in such notice is conditioned on the occurrence of the Closing and (2)&nbsp;the Company and its counsel shall not be responsible for delivering any legal opinions at Closing in connection with the redemption of the Senior
Notes or satisfaction and discharge of the Senior Notes Indenture, such legal opinions shall be delivered by counsel to Parent or another nationally recognized law firm (<u>provided</u>, that the Company cooperates in providing information, backup
certificates or other documentation reasonably requested in connection with delivery of any such opinion, and Company’s counsel delivers any opinions required to be delivered by Company counsel prior to Closing). Upon delivery of the Notice of
Redemption to the trustee under the Senior Notes Indenture, the Company shall provide Parent with a correct and complete copy of the Notice of Redemption. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company shall (i)&nbsp;furnish to the agent under the Credit Agreement at least three Business Days prior to the Closing (or such
shorter period as the agent to the Credit Agreement may otherwise agree in accordance with the Credit Agreement), a prepayment notice in respect of the termination of all outstanding commitments and prepayment of all outstanding loans under the
Credit Agreement and (ii)&nbsp;deliver to Parent, at least two Business Days prior to the Closing, an executed <font style="white-space:nowrap">pay-off</font> letter in customary form acceptable to Parent with respect to the Credit Agreement, which <font style="white-space:nowrap">pay-off</font> letter shall provide that upon receipt from or on behalf of the borrowers thereunder of the <font style="white-space:nowrap">pay-off</font> amount set forth in the
<font style="white-space:nowrap">pay-off</font> letter, (i)&nbsp;the Indebtedness incurred pursuant to the Credit Agreement and instruments related thereto shall be satisfied, and all obligations of the secured parties terminated (other than those
that customarily survive in <font style="white-space:nowrap">pay-off</font> letters and expressly contemplated to survive under the Credit Agreement), (ii)&nbsp;all Encumbrances relating to the assets, rights and properties of the Company or any of
its Subsidiaries granted pursuant to the Credit Agreement shall be released and terminated without any further action by the secured parties and (iii)&nbsp;the Company or its designee shall be entitled to file documents, financing statements and
other instruments to reflect the release of such Encumbrances. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) On or prior to the Closing, at the written request of Parent, the
Company shall take all actions reasonably requested by Parent (other than exercising any Early Mandatory Settlement Right (under and as defined in the Purchase Contract Agreement) or effecting any discharge or defeasance under the Senior Amortizing
Notes Indenture, in each case, such that such settlement, discharge or defeasance would take effect prior to the Closing) with respect to the TEUs, including (if requested): (i)&nbsp;delivering any notice, information, certificate or other document
to Parent, the Purchase Contract Agent (as defined in the Purchase Contract Agreement) or the Trustee (as defined in the Senior Amortizing Notes Indenture), and obtaining an opinion of counsel with respect to any such action, to ensure that the
Merger and the other transactions contemplated hereby do not result in an event of default or other violation of the Purchase Contract Agreement or the Senior Amortizing Notes Indenture; (ii)&nbsp;entering into, or cooperating with Parent to enable
Parent or one of its Subsidiaries to enter into, a new supplemental agreement (with respect to the Purchase Contract Agreement) and/</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-50- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or supplemental indenture (with respect to the Senior Amortizing Notes Indenture); (iii)&nbsp;cooperating with Parent in seeking amendments or consents with respect to the Purchase Contract
Agreement and/or the Senior Amortizing Notes Indenture that would be effective at the Closing; (iv)&nbsp;taking all steps reasonably necessary to cause the TEUs to be deregistered under the Securities Act and delisted from the NASDAQ in accordance
with <u>Section</u><u></u><u>&nbsp;7.17</u>; and (v)&nbsp;to the extent the Closing occurs after June&nbsp;30, 2021, taking all other actions, other than the payment of amounts required to satisfy and discharge the Senior Amortizing Notes Indenture
and the payment of any fees and expenses relating to the satisfaction and discharge, including those of the Trustee under the Senior Amortizing Notes Indenture (except to the extent such amounts have been provided by Parent or Merger Sub to the
Company at the Closing), and prepare all other documents as may be necessary to cause, at Parent’s discretion, the satisfaction and discharge of the Senior Amortizing Notes Indenture at the Closing. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Prior to the Closing, in consultation with and at the direction of Parent, the Company shall, and shall cause its Subsidiaries to, use
reasonable best efforts to take such actions as may be necessary or appropriate to terminate, as of the date of and immediately following the Closing (but contingent on the Closing), the Tax Receivable Agreements on the terms and subject to the
conditions set forth therein (such terminations, the “<u>TRA Terminations</u>”). Promptly following the date of this Agreement, Parent and the Company shall cooperate in good faith to prepare drafts of such TRA Terminations that can be
delivered to each Person that is party to the applicable Tax Receivable Agreement. Thereafter, the Company shall provide Parent with the opportunity to participate in any substantive communications with such Persons related to the TRA Terminations
and Parent shall direct all such communications in its reasonable discretion to the extent related to the TRA Terminations, including all negotiations and discussions relating to the TRA Terminations. Without Parent’s prior written consent
(which may be withheld in Parent’s sole discretion), the Company shall not enter into any TRA Termination or supplement, amend or otherwise modify any Specified Tax Agreement or TRA Termination. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.14. <u>Takeover Statutes</u>. If any Takeover Statute is, becomes or is deemed applicable to the transactions contemplated by this
Agreement, the Company and the Company Board shall grant such approvals and shall take such actions as are necessary and advisable so that such transactions may be consummated as promptly as practicable on the terms contemplated by this Agreement
and otherwise act to eliminate or minimize the effects of any such Takeover Statutes. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.15. <u>Transaction Litigation</u>. In the event
that any stockholder litigation related to this Agreement or the transactions contemplated by this Agreement is brought, or, to the Knowledge of the Company, threatened in writing, against the Company, its officers or any current or former members
of the Company Board during the Interim Period (such litigation, other than any Proceeding in connection with, arising out of or otherwise related to a demand for appraisal under Section&nbsp;262 of the DGCL, which shall be governed by
<u>Section&nbsp;4.3(f)</u>, “<u>Transaction Litigation</u>”), the Company shall as promptly as practicable (a)&nbsp;notify Parent thereof and shall keep Parent reasonably informed with respect to the status thereof and (b)&nbsp;give Parent
the opportunity to reasonably participate in the defense or settlement of any Transaction Litigation and shall consider in good faith Parent’s advice with respect to such Transaction Litigation; <u>provided</u> that the Company shall not settle
or agree to settle any Transaction Litigation without prior written consent of Parent (such consent not to be unreasonably withheld, conditioned or delayed). </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.16. <u>Section</u><u></u><u>&nbsp;16 Matters</u>. The Company and Parent, and the Company Board and the Parent Board (or duly formed
committees thereof consisting of <font style="white-space:nowrap">non-employee</font> directors (as such term is defined for the purposes of Rule <font style="white-space:nowrap">16b-3</font> promulgated under the Exchange Act)), shall, prior to the
Effective Time, take all such actions as may be necessary or advisable to cause the transactions contemplated by this Agreement and any other dispositions of equity securities of the Company (including derivative securities) or acquisitions of
equity securities of Parent Common Stock (including derivative securities) in connection with the transactions contemplated by this Agreement by any individual who is subject to the reporting requirements of Section&nbsp;16(a) of the Exchange Act
with respect to the Company or will become subject to such reporting requirements with respect to Parent, to be exempt under Rule <font style="white-space:nowrap">16b-3</font> promulgated under the Exchange Act, to the extent permitted by applicable
Law. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-51- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.17. <u>Delisting and Deregistration</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Prior to the Closing Date, the Company shall cooperate with Parent and use reasonable best efforts to take, or cause to be taken, all
actions, and do or cause to be done all things, necessary or advisable on its part under applicable Law, including, for the avoidance of doubt, the rules and policies of NASDAQ, to enable the delisting by the Surviving Corporation of the Shares and
(if requested by Parent) the TEUs from NASDAQ and the deregistration of the Shares under the Exchange Act and (if requested by Parent) the TEUs under the Securities Act, in each case, as promptly as practicable after the Effective Time, but in any
event, in the case of the Shares, no more than ten days thereafter. In connection therewith, Parent shall use reasonable best efforts to (a)&nbsp;assist in enabling the Company or NASDAQ to be in a position to promptly file and cause the Surviving
Corporation or NASDAQ to file with the SEC a Form 25 on the Closing Date and (b)&nbsp;cause the Surviving Corporation to file a Form 15 on the first Business Day that is at least ten days after the date the Form 25 is filed (such period between the
Form 25 and the Form 15 filing dates, the “<u>Delisting Period</u>”). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Upon Parent’s determination that the Surviving
Corporation may be required to file any quarterly or annual reports pursuant to the Exchange Act during the Delisting Period, the Company shall deliver to Parent at least five Business Days prior to Closing a draft of any such reports required to be
filed during the Delisting Period, which is sufficiently developed such that it can be timely filed and when filed will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary
in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading and comply in all material respects with the provisions of applicable Law. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.18. <u>Cooperation Regarding Tax Matters</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company and Parent agree to cooperate in good faith with respect to any Tax matters (including the structuring of any relevant
transactions in a Tax efficient manner) in connection with any Potential Sale Transaction. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In connection with the satisfaction of the
condition set forth in <u>Section</u><u></u><u>&nbsp;8.2(f)</u>, Parent and the Company agree that if the Company is unable to obtain a Tax Opinion, dated as of the Closing Date, that is substantially the same in form and substance as the Tax
Opinion delivered to Distributing on or before the date hereof, Parent and the Company will cooperate with Company Tax Counsel in good faith, including by making necessary amendments, modifications, supplements or replacements of Tax Representation
Letters and providing other materials reasonably requested by Company Tax Counsel, such that the Company would be able to obtain a replacement Tax Opinion, dated as of the Closing Date, in form and substance reasonably satisfactory to Parent and
that complies with Section&nbsp;9(c)(iv) of the Tax Matters Agreement; <u>provided</u>, that a replacement Tax Opinion from an Expert Law Firm shall be deemed satisfactory to Parent. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each of Parent and the Company shall use their respective reasonable best efforts to deliver to Company Tax Counsel representation letters
dated as of the Closing Date substantially in the form provided in <u>Section</u><u></u><u>&nbsp;7.18(c)(i)</u> of the Company Disclosure Letter (in the case of Parent, the “<u>Parent Tax Representation Letter</u>”) or
<u>Section</u><u></u><u>&nbsp;7.18(c)(ii)</u> of the Company Disclosure Letter (in the case of the Company, the “<u>Company Tax Representation Letter</u>” and, together with the Parent Tax Representation Letter, the “<u>Tax
Representation Letters</u>”) and signed by an officer or director of Parent or the Company, as applicable. Parent shall not be treated as in breach of this <u>Section</u><u></u><u>&nbsp;7.18(c)</u> for failing to deliver the Parent Tax
Representation Letter if such failure is caused primarily by an intentional act or intentional failure to act on the part of the Company or any of its Authorized Representatives (as such term is defined in the Company Tax Representation Letter). The
Company shall not be treated as in breach of this <u>Section</u><u></u><u>&nbsp;7.18(c)</u> for failing to deliver the Company Tax Representation Letter if such failure is caused primarily by an intentional act or intentional failure to act on the
part of Parent or any of its Authorized Representatives (as such term is defined in the Parent Tax Representation Letter). Parent and the Company agree that if either party cannot deliver a Tax Representation Letter at the Closing substantially in
the same form and substance as the form set forth in the applicable section of the Company Disclosure Letter, </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-52- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Parent and the Company shall use reasonable best efforts to agree to amendments, modifications, supplements or replacements of the Tax Representation Letter that would permit delivery of such
modified letter and, accordingly, permit Company Tax Counsel to provide the Tax Opinion at the Closing. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">ARTICLE&nbsp;VIII </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center"><u>Conditions </u></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.1.
<u>Conditions to Each Party</u><u>’</u><u>s Obligation to Effect the </u><u>Closing</u>. The respective obligations of each Party to effect the Closing is subject to the satisfaction or waiver at or prior to the Closing of each of the following
conditions: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <u>Company Stockholder</u><u></u><u>&nbsp;Approval</u>. The Requisite Company Vote shall have been obtained. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <u>Regulatory Approvals</u>. The waiting period (and any extension thereof) applicable to the consummation of the transactions
contemplated by this Agreement under the HSR Act shall have expired or been earlier terminated. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <u>No Legal Restraint</u>. No
Governmental Entity shall have enacted or entered any Order (whether temporary, preliminary or permanent) that is in effect, and no other Law shall have been enacted, enforced, issued, promulgated, entered or adopted and be effective, in each case,
that enjoins, restrains, prohibits, prevents or makes illegal the consummation of the transactions contemplated by this Agreement (each, a “<u>Legal Restraint</u>”). </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.2. <u>Conditions to Parent</u><u>’</u><u>s and Merger Sub</u><u>’</u><u>s Obligation to Effect the Closing</u>. The obligations of
Parent and Merger Sub to effect the Closing are also subject to the satisfaction or waiver by Parent at or prior to the Closing Date of the following conditions: </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <u>Representations and Warranties</u>. Each of the representations and warranties set forth in:
(i)<u>&nbsp;Section</u><u></u><u>&nbsp;5.1(a)</u> (<i>Organization, Good Standing and Qualification</i>), <u>Section</u><u></u><u>&nbsp;5.2(b)</u> and <u>(c)</u> (<i>Capital Structure</i>), <u>Section</u><u></u><u>&nbsp;5.3</u> (<i>Corporate
Authority; Approval and Fairness</i>), <u>Section</u><u></u><u>&nbsp;5.16(p)</u> (<i>Tax Matters</i>), <u>Section</u><u></u><u>&nbsp;5.23</u> (<i>Takeover Statutes</i>) and <u>Section</u><u></u><u>&nbsp;5.24</u> (<i>Brokers and Finders</i>) that
(A)&nbsp;is qualified by “materiality”, “Material Adverse Effect” or similar qualifiers shall be true and correct in all respects as of the date of this Agreement and as of the Closing as though made as of the Closing (except to
the extent that any such representation and warranty expressly speaks as of a particular date or period of time, in which case such representation and warranty shall be so true and correct as of such particular date or period of time) and
(B)&nbsp;is not qualified by “materiality”, “Material Adverse Effect” or similar qualifiers shall be true and correct in all material respects as of the date of this Agreement and as of the Closing as though made as of the
Closing (except to the extent that any such representation and warranty expressly speaks as of a particular date or period of time, in which case such representation and warranty shall be so true and correct as of such particular date or period of
time); (ii)<u>&nbsp;Section</u><u></u><u>&nbsp;5.2(a)</u> (<i>Capital Structure</i>) and <u>Section</u><u></u><u>&nbsp;5.10(b)</u> (<i>Absence of Certain Changes</i>) shall be true and correct in all respects (other than, with respect to the
representations and warranties set forth in <u>Section</u><u></u><u>&nbsp;5.2(a)</u>, any inaccuracies that, individually or in the aggregate, are <i>de minimis</i>) as of the date of this Agreement and as of the Closing as though made as of the
Closing (except to the extent that any such representation and warranty expressly speaks as of a particular date or period of time, in which case such representation and warranty shall be so true and correct as of such particular date or period of
time); and (iii)<u>&nbsp;Article</u><u></u><u>&nbsp;V</u> (other than those set forth in the foregoing clauses (i)&nbsp;and (ii) of this <u>Section</u><u></u><u>&nbsp;8.2(a)</u>), without giving effect to any “materiality” or
“Material Adverse Effect” qualifiers or qualifiers of similar import set forth therein, shall be true and correct as of the date of this Agreement and as of the Closing as though made as of the Closing (except to the extent that any such
representation and warranty expressly speaks as of a particular date or period of time, in which case such representation and warranty shall be so true and correct as of such particular date or period of time), except, in the case of this clause
(iii), for any failure of any such representation and warranty to be so true and correct that would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-53- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <u>Performance of Obligations of the Company</u>. The Company shall have performed in
all material respects all obligations required to be performed by it under this Agreement at or prior to the Closing. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <u>No
Burdensome Condition</u>. The waiting period (and any extension thereof) applicable to the consummation of the transactions contemplated by this Agreement under the HSR Act shall have expired or been earlier terminated without the imposition of any
Burdensome Condition. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <u>No Material Adverse Effect</u>. Since the date hereof, there shall not have occurred any Material Adverse
Effect. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <u>Company Closing Certificate</u>. Parent shall have received a certificate duly executed on behalf of the Company by an
executive officer of the Company certifying that the conditions set forth in <u>Sections</u><u></u><u>&nbsp;8.2(a)</u>, <u>8.2(b)</u> and <u>8.2(d)</u> have been satisfied. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <u>Certain Tax Matters</u>. The Company shall have received a Tax Opinion, dated as of the Closing Date, that is substantially in the same
form and substance as the Tax Opinion delivered to Distributing as of the date of this Agreement; <u>provided</u> that this condition shall be deemed satisfied if (i)&nbsp;as a result of any amendments, modifications, supplements or replacements
described in <u>Section</u><u></u><u>&nbsp;7.18(b)</u>, the Company is able to receive a replacement Tax Opinion, dated as of the Closing Date, described in <u>Section</u><u></u><u>&nbsp;7.18(b)</u>, (ii) Parent has failed to deliver to Company Tax
Counsel representation 3, 4, 5, 7, 8, or 10 in the Parent Tax Representation Letter and such failure causes the Company to be unable to receive a replacement Tax Opinion under <u>Section</u><u></u><u>&nbsp;7.18(b)</u>, unless such failure to deliver
any such representation is primarily caused by an intentional act or intentional failure to act on the part of the Company or any of its Authorized Representatives (as such term is defined in the Parent Tax Representation Letter), or (iii)&nbsp;an
intentional act or intentional failure to act on the part of Parent or any of its Authorized Representatives (as such term is defined in the Parent Tax Representation Letter) is the primary cause of the Company being unable to deliver the Company
Tax Representation Letter, and such inability of the Company to deliver such letter primarily causes the Company to be unable to receive a replacement Tax Opinion under <u>Section</u><u></u><u>&nbsp;7.18(b)</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.3. <u>Conditions to the Company</u><u>’</u><u>s Obligation to Effect the Closing</u>. The obligation of the Company to effect the
Closing is also subject to the satisfaction or waiver by the Company at or prior to the Closing of the following conditions: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
<u>Representations and Warranties</u>. Each of the representations and warranties of Parent and Merger Sub set forth in this Agreement, without giving effect to any “materiality” qualifiers or qualifiers of similar import set forth
therein, shall be true and correct in all material respects as of the date of this Agreement and as of the Closing as though made as of the Closing (except to the extent that any such representation and warranty expressly speaks as of a particular
date or period of time, in which case such representation and warranty shall be true and correct in all material respects as of such particular date or period of time), except for any failure of any such representations and warranties to be so true
and correct that would not, individually or in the aggregate, reasonably be expected to prevent, materially delay or materially impair the ability of Parent or Merger Sub to consummate the transactions contemplated by this Agreement. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <u>Performance of Obligations of Parent and Merger Sub</u>. Each of Parent and Merger Sub shall have performed in all material respects
all obligations required to be performed by it under this Agreement at or prior to the Closing. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <u>Parent and Merger Sub Closing
Certificate</u>. The Company shall have received a certificate duly executed on behalf of Parent and Merger Sub by an executive officer of Parent and Merger Sub certifying that the conditions set forth in <u>Sections</u><u></u><u>&nbsp;8.3(a)</u>
and <u>8.3(b)</u> have been satisfied. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-54- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">ARTICLE&nbsp;IX </p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center"><u>Termination </u></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.1.
<u>Termination by Mutual Written Consent</u>. This Agreement may be terminated and the transactions contemplated by this Agreement may be abandoned at any time prior to the Effective Time, whether before or after the Requisite Company Vote has been
obtained, by mutual written consent of the Parties. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.2. <u>Termination by Either the Company or Parent</u>. Subject to
<u>Section</u><u></u><u>&nbsp;9.5(a)</u>, this Agreement may be terminated and the transactions contemplated by this Agreement may be abandoned at any time prior to the Effective Time by either the Company or Parent if: </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the transactions contemplated by this Agreement shall not have been consummated by 5:00 p.m. (New York time) on January 5, 2022 (the
“<u>Outside Date</u>”); <u>provided</u>, <u>however</u>, that if the conditions to Closing set forth in <u>Section</u><u></u><u>&nbsp;8.1(b)</u>, <u>Section</u><u></u><u>&nbsp;8.1(c)</u> (in connection with a Legal Restraint of a
Governmental Antitrust Entity) or <u>Section</u><u></u><u>&nbsp;8.2(c)</u> have not been satisfied or, to the extent permitted by applicable Law, waived on or prior to the Outside Date but all other conditions to Closing set forth in
<u>Article</u><u></u><u>&nbsp;VIII</u> have been satisfied or, to the extent permitted by applicable Law, waived (except for those conditions that by their nature are to be satisfied at the Closing), the Outside Date may be extended by either the
Company or Parent (in each case, acting in its sole discretion) to a time and date not beyond 5:00&nbsp;p.m. (New York time) on April 5, 2022 by providing a written notice thereof to Parent, in the case of an extension by the Company, or to the
Company, in the case of an extension by Parent, in each case prior to 5:00 p.m. (New York time) on January 5, 2022 and such time and date, as so extended, shall be the “Outside Date” for all purposes of this Agreement; <u>provided</u>,
<u>further</u>, that the right to terminate this Agreement and abandon the transactions contemplated by this Agreement pursuant to this <u>Section</u><u></u><u>&nbsp;9.2(a)</u> shall not be available to the Company or Parent if it (or Merger Sub, in
the case of an attempted termination by Parent) has breached in any material respect any covenant or agreement set forth in this Agreement and such breach shall have proximately caused the occurrence of the failure of a condition to the Closing to
occur on or prior to the Outside Date; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) the Requisite Company Vote shall not have been obtained at the Company Stockholders Meeting or
at any postponement, recess or adjournment thereof taken in accordance with this Agreement, in each case at which a vote on the adoption of this Agreement was taken (such failure to obtain the Requisite Company Vote at such a meeting, a
“<u>Vote-Down</u>”); or </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) if any Governmental Entity shall have enacted or entered any Order, or enacted, enforced, issued,
promulgated, entered or adopted any other Law that, in either such case, enjoins, restrains, prohibits, prevents or makes illegal the consummation of the transactions contemplated by this Agreement and such Order or other Law shall have become final
and <font style="white-space:nowrap">non-appealable,</font> whether before or after the Requisite Company Vote has been obtained; <u>provided</u> that the right to terminate this Agreement and abandon the transactions contemplated by this Agreement
pursuant to this <u>Section</u><u></u><u>&nbsp;9.2(c)</u> shall not be available to the Company or Parent if it (or Merger Sub, in the case of an attempted termination by Parent) has breached in any material respect any covenant or agreement set
forth in this Agreement and such breach relates to its obligations pursuant to <u>Section</u><u></u><u>&nbsp;7.6</u> or otherwise shall have proximately caused the occurrence of the failure of a condition to the Closing to occur. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.3. <u>Termination by the Company</u>. Subject to <u>Section</u><u></u><u>&nbsp;9.5(a)</u>, this Agreement may be terminated and the
transactions contemplated by this Agreement may be abandoned at any time prior to the Effective Time by the Company: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) if there has
been a breach of any representation, warranty, covenant or agreement made by Parent or Merger Sub set forth in this Agreement such that the conditions in <u>Sections</u><u></u><u>&nbsp;8.3(a)</u> or <u>8.3(b)</u> would not be satisfied were the
Closing then to occur (and such breach is not curable prior to the Outside Date, or if curable prior to the Outside Date, has not been cured within the earlier of (i)&nbsp;30 days after the giving of written notice
</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-55- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
thereof by the Company to Parent and Merger Sub describing such breach in reasonable detail and stating the Company’s intention to terminate this Agreement and abandon the transactions
contemplated by this Agreement and (ii)&nbsp;three Business Days prior to the Outside Date), whether before or after the Requisite Company Vote has been obtained; <u>provided</u> that the right to terminate this Agreement and abandon the
transactions contemplated by this Agreement pursuant to this <u>Section</u><u></u><u>&nbsp;9.3(a)</u> shall not be available to the Company if it is then in breach in any material respect of any covenant or agreement set forth in this Agreement and
such breach would cause the failure of a condition to the Closing to occur; or </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) at any time prior to the time the Requisite Company
Vote is obtained, in order to enter into an Alternative Acquisition Agreement with respect to a Superior Proposal in compliance with <u>Section</u><u></u><u>&nbsp;7.2(d)</u>; <u>provided</u>, <u>however</u>, that the Company shall have concurrently
with such termination paid or caused to be paid to Parent the Termination Fee pursuant to <u>Section</u><u></u><u>&nbsp;9.5</u> and the Company shall not have materially breached the obligations set forth in <u>Section</u><u></u><u>&nbsp;7.2(a)</u>
(<i>No Solicitation</i>) in respect of such Acquisition Proposal. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.4. <u>Termination by Parent</u>. Subject to
<u>Section</u><u></u><u>&nbsp;9.5(a)</u>, this Agreement may be terminated and the transactions contemplated by this Agreement may be abandoned at any time prior to the Effective Time by Parent: </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) if there has been a breach of any representation, warranty, covenant or agreement made by the Company set forth in this Agreement such
that the conditions in <u>Sections</u><u></u><u>&nbsp;8.2(a)</u> or <u>8.2(b)</u> would not be satisfied were the Closing then to occur (and such breach is not curable prior to the Outside Date, or if curable prior to the Outside Date, has not been
cured within the earlier of (i)&nbsp;30 days after the giving of written notice thereof by Parent to the Company describing such breach in reasonable detail and stating Parent’s intention to terminate this Agreement and abandon the transactions
contemplated by this Agreement and (ii)&nbsp;three Business Days prior to the Outside Date), whether before or after the Requisite Company Vote has been obtained; <u>provided</u> that the right to terminate this Agreement and abandon the
transactions contemplated by this Agreement pursuant to this <u>Section</u><u></u><u>&nbsp;9.4(a)</u> shall not be available to Parent if either Parent or Merger Sub is then in breach in any material respect of any covenant or agreement set forth in
this Agreement and such breach would cause the failure of a condition to the Closing to occur; or </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) at any time prior to the time the
Requisite Company Vote is obtained, if (i)&nbsp;the Company Board shall have effected a Change of Recommendation or (ii)&nbsp;the Company shall have materially breached the obligations set forth in <u>Section</u><u></u><u>&nbsp;7.2(a)</u> (<i>No
Solicitation</i>). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.5. <u>Notice of Termination; Effect of Termination and Abandonment</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) In the event the Company or Parent intends to terminate this Agreement and abandon the transactions contemplated by this Agreement
pursuant to <u>Section</u><u></u><u>&nbsp;9.2</u>,<u>&nbsp;9.3</u> or <u>9.4</u>, as applicable, the Company or Parent, as applicable, shall give written notice to the other Party or Parties (as the case may be) specifying the provision of this
Agreement pursuant to which such termination and abandonment is intended to be effected. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except to the extent provided in
<u>Sections</u><u></u><u>&nbsp;9.5(c)</u>, <u>9.5(d)</u> and <u>10.1</u>, in the event of termination of this Agreement and abandonment of the transactions contemplated by this Agreement pursuant to this <u>Article</u><u></u><u>&nbsp;IX</u>, this
Agreement shall become void and of no effect with no liability to any Person on the part of any Party (or any of its Affiliates or its or their respective Representatives); <u>provided</u>, <u>however</u>, and notwithstanding anything to the
contrary set forth in this Agreement, (i)&nbsp;except as provided in <u>Section</u><u></u><u>&nbsp;9.5(d)(iii)</u>, no such termination shall relieve any Party of any liability or damages to any other Party resulting from its fraud or knowing and
intentional breach of this Agreement, and (ii)&nbsp;the provisions set forth in this <u>Section</u><u></u><u>&nbsp;9.5</u> and <u>Article</u><u></u><u>&nbsp;X</u> shall survive any termination of this Agreement and any abandonment of the
transactions contemplated by this Agreement. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-56- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) In the event this Agreement is terminated and the transactions contemplated by this
Agreement abandoned pursuant to this <u>Article</u><u></u><u>&nbsp;IX</u>: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) by either the Company or Parent pursuant to
<u>Section</u><u></u><u>&nbsp;9.2(b)</u> (<i>Vote-Down</i>) or by Parent pursuant to <u>Section</u><u></u><u>&nbsp;9.4(a)</u> (<i>Company Breach</i>) and, in either such case: </p>
<p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) any Person shall have publicly announced an Acquisition Proposal for the first time after the date hereof and such
Acquisition Proposal shall not have been withdrawn without qualification (1)&nbsp;prior to the Vote-Down, with respect to termination and abandonment pursuant to <u>Section</u><u></u><u>&nbsp;9.2(b)</u> (<i>Vote-Down</i>), or (2)&nbsp;prior to the
date of such termination, with respect to any termination and abandonment pursuant to <u>Section</u><u></u><u>&nbsp;9.4(a)</u> (<i>Company Breach</i>); <u>provided</u> that for purposes of this <u>Section</u><u></u><u>&nbsp;9.5(c)(i)(A)</u>, an
Acquisition Proposal made by any Person shall not be deemed to have been “withdrawn” if, within 12 months after such termination and abandonment, the Company or any of its Subsidiaries shall have entered into a definitive Alternative
Acquisition Agreement with respect to such Acquisition Proposal, or shall have consummated any Acquisition Proposal (or the Company Board shall have approved or recommended to the Company’s stockholders or otherwise not opposed any Acquisition
Proposal) made by or on behalf of such Person or any of its Affiliates; and </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) within 12 months after such
termination,&nbsp;the Company or any of Subsidiaries shall have entered into a definitive Alternative Acquisition Agreement with respect to, or the Company Board shall have approved or recommended to the Company’s stockholders or otherwise not
opposed, any Acquisition Proposal that is later consummated (regardless of whether or not such consummation happens prior to or following the end of such 12 month period) (<u>provided</u>, that solely for purposes of this clause (i), the term
“Acquisition Proposal” shall have the meaning ascribed thereto in <u>Annex A</u>, except that the reference to “15%” in such definition shall be replaced with a reference to “50%”), then the Company shall pay or cause
to be paid to Parent the Termination Fee by wire transfer of immediately available funds concurrently with the consummation of such Acquisition Proposal; </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) by Parent pursuant to <u>Section</u><u></u><u>&nbsp;9.4(b)</u> (<i>Change of Recommendation;
<font style="white-space:nowrap">Non-Solicit</font> Breach</i>), then the Company shall pay or cause to be paid to Parent the Termination Fee by wire transfer of immediately available funds within three Business Days following the date of such
termination and abandonment; or </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) by the Company pursuant to <u>Section</u><u></u><u>&nbsp;9.3(b)</u> (<i>Superior Proposal</i>),
then the Company shall pay or cause to be paid to Parent the Termination Fee by wire transfer of immediately available funds concurrently with such termination of this Agreement.<sup style="font-size:85%; vertical-align:top"> </sup> </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Parties acknowledge and agree that (i)&nbsp;in no event shall the Company be required to pay the Termination Fee on more than one
occasion; (ii)&nbsp;the agreements set forth in this <u>Section</u><u></u><u>&nbsp;9.5</u> are an integral part of the transactions contemplated by this Agreement and that, without these agreements, the other parties would not enter into this
Agreement and accordingly, if the Company fails to promptly pay or cause to be paid the Termination Fee as and when due pursuant to this <u>Article</u><u></u><u>&nbsp;IX</u>, and, in order to obtain such amount, Parent commences a Proceeding that
results in a judgment against the Company for the Termination Fee, the Company shall pay or cause to be paid to Parent its costs and expenses (including attorneys’ fees) in connection with such Proceeding, together with interest on the
Termination Fee, at the prime rate published in <i>The Wall Street Journal</i> for the relevant date such amount was required to be made from such date through the date of payment; and (iii)&nbsp;notwithstanding anything to the contrary in this
Agreement (including <u>Section</u><u></u><u>&nbsp;9.5(b)(i)</u>), in the event that the Termination Fee becomes payable by the Company pursuant to <u>Section</u><u></u><u>&nbsp;9.5(c)(ii)</u> as a result of termination by Parent pursuant to
<u>Section</u><u></u><u>&nbsp;9.4(b)(ii)</u> (<i><font style="white-space:nowrap">Non-Solicit</font> Breach</i>), and is paid or caused to be paid by the Company, the Termination Fee shall be Parent’s and Merger Sub’s sole and exclusive
remedy for monetary damages against the Company and its Affiliates pursuant to this Agreement or otherwise and, upon payment of the Termination Fee (plus any amounts due under clause (ii)&nbsp;above), none of the Company or any of its Affiliates
shall have any further monetary liability or obligation arising out of or related to this Agreement or the transactions contemplated hereby; <u>provided</u>, <u>however</u>, that, for the avoidance of doubt, this
<u>Section</u><u></u><u>&nbsp;9.5(d)(iii)</u> shall not </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-57- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(A)&nbsp;apply in the event that this Agreement is terminated other than by Parent pursuant to <u>Section</u><u></u><u>&nbsp;9.4(b)(ii)</u> (<i><font style="white-space:nowrap">Non-Solicit</font>
Breach</i>) or (B)&nbsp;limit Parent’s or Merger Sub’s rights under the Confidentiality Agreement or the Support Agreement, in each case as and to the extent set forth therein. </p>
<p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">ARTICLE&nbsp;X </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center"><u>Miscellaneous
and General </u></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.1. <u>Survival</u>. <u>Article</u><u></u><u>&nbsp;I</u>, this <u>Article</u><u></u><u>&nbsp;X</u> and the
representations and warranties, covenants and agreements of the Parties, as applicable, set forth in <u>Article</u><u></u><u>&nbsp;IV</u>, <u>Section</u><u></u><u>&nbsp;5.25</u> (<i>No Other Representations or Warranties; <font style="white-space:nowrap">Non-Reliance</font></i>), <u>Section</u><u></u><u>&nbsp;6.12</u> (<i>No Other Representations or Warranties; <font style="white-space:nowrap">Non-Reliance</font></i>), <u>Section</u><u></u><u>&nbsp;7.11</u> (<i>Employee
Benefits</i>), <u>Section</u><u></u><u>&nbsp;7.12</u> (<i>Indemnification; Directors</i><i>’</i><i> and Officers</i><i>’</i><i> Insurance</i>), <u>Section</u><u></u><u>&nbsp;10.3</u> (<i>Expenses</i>),
<u>Section</u><u></u><u>&nbsp;10.4</u> (<i>Transfer Taxes</i>), the provisions that substantively define any related defined terms not substantively defined in <u>Article</u><u></u><u>&nbsp;I</u> and those other covenants and agreements set forth in
this Agreement that by their terms apply, or that are to be performed in whole or in part, after the Effective Time, shall survive the Effective Time. <u>Article</u><u></u><u>&nbsp;I</u>, this <u>Article</u><u></u><u>&nbsp;X</u>, the representations
and warranties, covenants and agreements of the Parties, as applicable, set forth in <u>Section</u><u></u><u>&nbsp;5.25</u> (<i>No Other Representations or Warranties; <font style="white-space:nowrap">Non-Reliance</font></i>),
<u>Section</u><u></u><u>&nbsp;6.12</u> (<i>No Other Representations or Warranties; <font style="white-space:nowrap">Non-Reliance</font></i>), <u>Section</u><u></u><u>&nbsp;10.3</u> (<i>Expenses</i>), <u>Section</u><u></u><u>&nbsp;9.5</u> (<i>Notice
of Termination</i>;<i> Effect of Termination and Abandonment</i>), the provisions that substantively define any related defined terms not substantively defined in <u>Article</u><u></u><u>&nbsp;I</u> and the Confidentiality Agreement shall survive
any termination of this Agreement and any abandonment of the transactions contemplated by this Agreement. All other representations, warranties, covenants and agreements in this Agreement or in any instrument or other document delivered pursuant to
this Agreement, including rights arising out of any breach of such representations, warranties, covenants and agreements, shall not survive the Effective Time or, except as set forth in <u>Article</u><u></u><u>&nbsp;IX</u>, the termination of this
Agreement and abandonment of the transactions contemplated by this Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.2. <u>Notices</u>. All notices and other communications
given or made hereunder by one or more Parties to one or more of the other Parties shall, unless otherwise specified herein, be in writing and shall be deemed to have been duly given or made on the date of receipt by the recipient thereof if
received prior to 5:00 p.m. in the place of receipt and such day is a Business Day (or otherwise on the next succeeding Business Day) if (a)&nbsp;served by personal delivery or by a nationally recognized overnight courier service upon the Party or
Parties for whom it is intended, (b)&nbsp;delivered by registered or certified mail, return receipt requested or (c)&nbsp;sent by email, <u>provided</u> that the email transmission is confirmed in writing by the recipient thereof (excluding <font style="white-space:nowrap"><font style="white-space:nowrap">out-of-office</font></font> replies or other automatically generated responses) or is followed up within one Business Day after email by dispatch pursuant to one of the other methods
described herein. Such communications must be sent to the respective Parties at the following street addresses or email addresses (or at such other street address or email address for a Party as shall be specified for such purpose in a notice given
in accordance with this <u>Section</u><u></u><u>&nbsp;10.2</u>)<u>:</u> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">if to the Company: </p>
<p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="68%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center">


<tbody><tr>

<td width="38%"></td>

<td valign="bottom" width="5%"></td>
<td></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top" colspan="3"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change Healthcare Inc.</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top" colspan="3"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">100 Airpark Center Drive East</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top" colspan="3"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nashville, TN 37217</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Attention:</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="top">Loretta Cecil</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Telephone:</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="top">(615) <font style="white-space:nowrap">932-3000</font></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Email:</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="top">loretta.cecil@changehealthcare.com</td></tr>
</tbody></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-58- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">with a copy to (which shall not constitute notice): </p>
<p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="68%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center">


<tbody><tr>

<td width="42%"></td>

<td valign="bottom" width="22%"></td>
<td></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top" colspan="3"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Simpson Thacher&nbsp;&amp; Bartlett LLP</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top" colspan="3"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">425 Lexington Ave.</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top" colspan="3"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New York, NY 10017</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Attention:</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">Eric M. Swedenburg</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Telephone:</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">(212) <font style="white-space:nowrap">455-2225</font></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Email:</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">eswedenburg@stblaw.com</td></tr>
<tr style="font-size:1pt">
<td height="16" colspan="3"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top" colspan="3"> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">and:</p> <p style="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</p>
<p style="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Simpson Thacher&nbsp;&amp; Bartlett LLP</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top" colspan="3"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">900 G Street, NW</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top" colspan="3"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Washington, D.C. 20001</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Attention:</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">Jonathan L. Corsico</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Telephone:</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">(202) <font style="white-space:nowrap">636-5839</font></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Email:</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">jonathan.corsico@stblaw.com</td></tr>
</tbody></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">if to Parent or Merger Sub: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="68%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center">


<tbody><tr>

<td width="100%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">UnitedHealth Group Incorporated</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top"> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">UnitedHealth Group Center</p>
<p style="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9900 Bren Road East</p></td></tr>
</tbody></table>
<table cellspacing="0" cellpadding="0" width="68%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center">


<tbody><tr>

<td width="45%"></td>

<td valign="bottom" width="24%"></td>
<td></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top" colspan="3"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Minnetonka, MN 55343</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Attention:</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="top">Richard Mattera</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Telephone:</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="top">(952) <font style="white-space:nowrap">936-1300</font></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Email:</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="top">richard.mattera@uhg.com</td></tr>
</tbody></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">with a copy to (which shall not constitute notice): </p>
<p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p>
<table cellspacing="0" cellpadding="0" width="68%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center">


<tbody><tr>

<td width="46%"></td>

<td valign="bottom" width="25%"></td>
<td></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top" colspan="3"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sullivan&nbsp;&amp; Cromwell LLP</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top" colspan="3"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">125 Broad Street</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top" colspan="3"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New York, New York 10004</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Attention:</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">Keith Pagnani<br> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">Melissa Sawyer</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Telephone:</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">(212) <font style="white-space:nowrap">558-4000</font></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Email:</p></td>
<td valign="bottom">&nbsp;&nbsp;</td>
<td valign="bottom">pagnanik@sullcrom.com<br> <p style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">sawyerm@sullcrom.com</p></td></tr>
</tbody></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.3. <u>Expenses</u>. Whether or not the transactions contemplated by this Agreement are consummated, all
costs, fees and expenses incurred in connection with this Agreement and the transactions contemplated by this Agreement including all costs, fees and expenses of its Representatives, shall be paid by the Party incurring such cost, fee or expense,
except as otherwise expressly provided herein. Notwithstanding the foregoing, Parent shall be responsible for and shall pay all filing fees pursuant to Antitrust Laws. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.4. <u>Transfer Taxes</u>. Except as otherwise provided in <u>Section</u><u></u><u>&nbsp;4.3(b)</u>, all Transfer Taxes incurred in
connection with the Merger shall be paid by the Party incurring such Taxes. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.5. <u>Amendment</u><u> or Other Modification; Waiver</u>.
</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to the provisions of applicable Law, at any time prior to the Effective Time, this Agreement may be amended or otherwise
modified only by a written instrument duly executed and delivered by each of the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-59- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Parties; <u>provided</u>, that this Agreement may not be amended or otherwise modified at any time following the Effective Time. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The conditions to each of the respective Parties’ obligations to consummate the transactions contemplated by this Agreement are for
the sole benefit of such Party and may be waived by such Party in whole or in part to the extent permitted by applicable Law; <u>provided</u>, <u>however</u>, that any such waiver shall only be effective if made in a written instrument duly executed
and delivered by the Party against whom the waiver is to be effective. No failure or delay by any Party in exercising any right, power or privilege hereunder or under applicable Law shall operate as a waiver of such rights and, except as otherwise
expressly provided herein, no single or partial exercise thereof shall preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The rights and remedies herein provided shall be cumulative and not
exclusive of any rights or remedies provided by Law except to the extent provided<b> </b>for otherwise in <u>Section</u><u></u><u>&nbsp;9.5</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.6. <u>Governing Law and Venue; Submission to Jurisdiction; Selection of Forum; Waiver of Trial by Jury</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) This Agreement and all matters and transactions contemplated hereby or related hereto shall be deemed to be made in and in all respects
shall be interpreted, construed and governed by and in accordance with the Laws of the State of Delaware without regard to the conflicts of laws provisions, rules or principles thereof (or any other jurisdiction) to the extent that such provisions,
rules or principles would direct a matter to another jurisdiction. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each of the Parties agrees that it: (i)&nbsp;shall bring any
Proceeding in connection with, arising out of or otherwise relating to this Agreement, any instrument or other document delivered pursuant to this Agreement or the transactions contemplated by this Agreement exclusively in the Chosen Courts; and
(ii)&nbsp;solely in connection with such Proceedings, (A)&nbsp;irrevocably and unconditionally submits to the exclusive jurisdiction of the Chosen Courts, (B)&nbsp;irrevocably waives any objection to the laying of venue in any such Proceeding in the
Chosen Courts, (C)&nbsp;irrevocably waives any objection that the Chosen Courts are an inconvenient forum or do not have jurisdiction over any Party, (D)&nbsp;agrees that mailing of process or other papers in connection with any such Proceeding in
the manner provided in <u>Section</u><u></u><u>&nbsp;10.2</u> or in such other manner as may be permitted by applicable Law shall be valid and sufficient service thereof and (E)&nbsp;shall not assert as a defense any matter or claim waived by the
foregoing clauses (A)&nbsp;through (D) of this <u>Section</u><u></u><u>&nbsp;10.6(b)</u> or that any Order issued by the Chosen Courts may not be enforced in or by the Chosen Courts. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each Party acknowledges and agrees that any controversy which may be connected with, arise out of or otherwise relate to this Agreement,
any instrument or other document delivered pursuant to this Agreement or the transactions contemplated by this Agreement is expected to involve complicated and difficult issues, and therefore each Party irrevocably and unconditionally waives to the
fullest extent permitted by applicable Law any right it may have to a trial by jury with respect to any Proceeding, directly or indirectly, connected with, arising out of or otherwise relating to this Agreement, any instrument or other document
delivered pursuant to this Agreement or the transactions contemplated by this Agreement. Each Party hereby acknowledges and certifies that (i)&nbsp;no Representative of the other Parties has represented, expressly or otherwise, that such other
Parties would not, in the event of any Proceeding, seek to enforce the foregoing waiver, (ii)&nbsp;it understands and has considered the implications of this waiver, (iii)&nbsp;it makes this waiver voluntarily and (iv)&nbsp;it has been induced to
enter into this Agreement and the transactions contemplated by this Agreement by, among other things, the mutual waivers, acknowledgments and certifications set forth in this <u>Section</u><u></u><u>&nbsp;10.6(c)</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.7. <u>Specific Performance</u>. Each of the Parties acknowledges and agrees that the rights of each Party to consummate the transactions
contemplated by this Agreement are special, unique and of extraordinary character and that if for any reason any of the provisions of this Agreement are not performed in accordance with their specific terms or are otherwise breached, immediate and
irreparable harm or damage would be caused for which money damages would not be an adequate remedy. Accordingly, each Party agrees that, in addition to any </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-60- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other available remedies a Party may have in equity or at law, each Party shall be entitled to enforce specifically the terms and provisions of this Agreement and to obtain an Order enforcing
compliance with the provisions of this Agreement, consistent with the provisions of <u>Section</u><u></u><u>&nbsp;10.6(b)</u>, in the Chosen Courts without necessity of posting a bond or other form of security. In the event that any Proceeding
should be brought in equity to enforce the provisions of this Agreement, no Party shall allege, and each Party hereby waives the defense, that there is an adequate remedy at law. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.8. <u>Third-Party Beneficiaries</u>. The Parties hereby agree that their respective representations, warranties, covenants and agreements
set forth in this Agreement are solely for the benefit of the other, subject to the terms and conditions of this Agreement, and this Agreement is not intended to, and does not, confer upon any Person other than the Parties any rights or remedies,
express or implied, hereunder, including the right to rely upon the representations and warranties set forth in this Agreement. Notwithstanding the foregoing, but only from and after the Effective Time, (i)&nbsp;the Indemnified Parties and their
respective heirs, executors, beneficiaries or representatives shall have third-party beneficiary rights as and to the extent set forth in <u>Section</u><u></u><u>&nbsp;7.12</u>, (ii) each former holder of Eligible Shares and its heirs, executors,
beneficiaries or representatives shall have third-party beneficiary rights solely to the extent required to enforce its right to receive the applicable Per Share Merger Consideration pursuant to <u>Article IV</u> and (iii)&nbsp;each former holder of
Company Equity Awards and its heirs, executors, beneficiaries or representatives shall have third-party beneficiary rights solely to the extent required to enforce its right to receive the applicable consideration due to it pursuant to <u>Article
IV</u>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.9. <u>Fulfillment of Obligations</u>. Whenever this Agreement requires a Subsidiary of Parent to take any action, such
requirement shall be deemed to include an undertaking on the part of Parent to cause such Subsidiary to take such action. Whenever this Agreement requires a Subsidiary of the Company to take any action, such requirement shall be deemed to include an
undertaking on the part of the Company to cause such Subsidiary to take such action and, after the Effective Time, on the part of the Surviving Corporation to cause such Subsidiary to take such action. Any obligation of one Party to any other Party
under this Agreement, which obligation is performed, satisfied or properly fulfilled by a Subsidiary of such Party, shall be deemed to have been performed, satisfied or fulfilled by such Party. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.10. <u>Successors and Assigns</u>. This Agreement shall be binding upon and inure to the benefit of the Parties and their respective
successors, legal representatives and permitted assigns. Except as may be required to satisfy the obligations contemplated by <u>Section</u><u></u><u>&nbsp;7.12</u>, no Party may assign any of its rights or interests or delegate any of its
obligations under this Agreement, in whole or in part, by operation of Law, by transfer or otherwise, without the prior written consent of the other Parties not seeking to assign any of its rights or interests or delegate any of its obligations,
except as provided for in <u>Section</u><u></u><u>&nbsp;10.9</u>, and any attempted or purported assignment or delegation in violation of this <u>Section</u><u></u><u>&nbsp;10.10</u> shall be null and void. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.11. <u>Entire Agreement</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) This Agreement (including the Annexes), the Company Disclosure Letter and the Confidentiality Agreement constitute the entire agreement
among the Parties with respect to the subject matter hereof and thereof and supersede all other prior and contemporaneous agreements, negotiations, understandings, representations and warranties, whether oral or written, with respect to such
matters, except for the Confidentiality Agreement, which shall remain in full force and effect until the Closing. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In the event of any
inconsistency between the statements in the body of this Agreement, on the one hand, and any of the Annexes or the Company Disclosure Letter (other than an exception expressly set forth in the Company Disclosure Letter), on the other hand, the
statements in the body of this Agreement shall control. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.12. <u>Severability</u>. The provisions of this Agreement shall be deemed
severable and the illegality, invalidity or unenforceability of any provision shall not affect the legality, validity or enforceability of the other provisions of this Agreement. If any provision of this Agreement, or the application of such
provision to any </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-61- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Person or any circumstance, is illegal, invalid or unenforceable, (a)&nbsp;a suitable and equitable provision to be negotiated by the Parties, each acting reasonably and in good faith shall be
substituted therefor in order to carry out, so far as may be legal, valid and enforceable, the intent and purpose of such illegal, invalid or unenforceable provision, and (b)&nbsp;the remainder of this Agreement and the application of such provision
to other Persons or circumstances shall not be affected by such illegality, invalidity or unenforceability, nor shall such illegality, invalidity or unenforceability affect the legality, validity or enforceability of such provision, or the
application of such provision, in any other jurisdiction. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.13. <u>Counterparts</u><u>; Effectiveness</u>. This Agreement (a)&nbsp;may
be executed in any number of counterparts, each such counterpart being deemed to be an original instrument, and all such counterparts shall together constitute the same agreement and (b)&nbsp;shall become effective when each Party shall have
received one or more counterparts hereof signed by each of the other Parties. An executed copy of this Agreement delivered by email or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original
executed copy of this Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.14. <u>Interpretation and Construction</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The table of contents and headings in this Agreement are for convenience of reference only, do not constitute part of this Agreement and
shall not be deemed to limit or otherwise affect any of the provisions of this Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Unless otherwise specified in this
Agreement, all Preamble, Recital, Article, Section, clause, and Annex references used in this Agreement are to the preamble, recitals, articles, sections, clauses and annexes to this Agreement. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Unless otherwise specified in this Agreement or the context otherwise requires, for purposes of this Agreement: (i)&nbsp;if a term is
defined as one part of speech (such as a noun), it shall have a corresponding meaning when used as another part of speech (such as a verb); (ii)&nbsp;the terms defined in the singular shall have a comparable meaning when used in the plural and
<i>vice versa</i>; (iii)&nbsp;words importing the masculine gender shall include the feminine and neutral genders and <i>vice versa</i>; (iv)&nbsp;whenever the words “includes” or “including” are used, they shall be deemed to be
followed by the words “without limitation”; (v)&nbsp;the words “hereto,” “hereof,” “hereby,” “herein,” “hereunder” and similar terms shall refer to this Agreement as a whole and not any
particular provision of this Agreement; (vi)&nbsp;the word “extent” in the phrase “to the extent” shall mean the degree to which a subject or other thing extends and such phrase shall not mean simply “if”;
(vii)&nbsp;all accounting terms not expressly defined in this Agreement shall have the meanings given to them under GAAP; (viii)&nbsp;references to the “United States” or abbreviations thereof mean the United States of America and its
states, territories and possessions; and (ix)&nbsp;the rule known as the <i>ejusdem generi</i>s rule shall not apply, and accordingly, general words introduced by the word “other” shall not be given a restrictive meaning by reason of the
fact that they are preceded by words indicating a particular class of acts, matters or things. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Unless otherwise specified in this
Agreement, the term “dollars” and the symbol “$” mean U.S. Dollars for purposes of this Agreement and all amounts in this Agreement shall be paid in U.S. Dollars. The term “or” is not exclusive. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Unless otherwise specified in this Agreement or the context otherwise requires, if this Agreement refers to information or documents
having been “made available” (or&nbsp;words of similar import) by or on behalf of one or more Parties to another Party or Parties, such obligation shall be deemed satisfied if (i)&nbsp;such one or more Parties or Representatives thereof
made such information or document available (A)&nbsp;in any virtual data rooms established by or on behalf of the Company (including any “clean rooms” established in connection therewith) to such other Party or Parties or its or their
Representatives or (B)&nbsp;in the case of the engagement letter of the Company’s financial advisor (plus any other Contracts contemplated by the last sentence of <u>Section</u><u></u><u>&nbsp;5.24</u>) and information provided to Parent’s
antitrust legal counsel on an “outside counsel only” basis and designated as </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-62- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such, via email, in each case in connection with the transactions contemplated by this Agreement at least 24 hours prior to the execution and delivery of this Agreement, or (ii)&nbsp;such
information or document is publicly available on EDGAR at least 24 hours prior to the execution and delivery of this Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)
Unless otherwise specified in this Agreement or the context otherwise requires, all references to any (i)&nbsp;statute in this Agreement include the rules and regulations promulgated thereunder and all applicable official guidance, guidelines,
bulletins or policies issued or made in connection therewith by a Governmental Entity and (ii)&nbsp;Law in this Agreement shall be a reference to such Law as amended, <font style="white-space:nowrap">re-enacted,</font> consolidated or replaced as of
the applicable date or during the applicable period of time. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Unless otherwise specified in this Agreement, all references in this
Agreement to (i)&nbsp;any Contract, other agreement, document or instrument (excluding this Agreement) mean such Contract, other agreement, document or instrument as amended, supplemented or otherwise modified from time to time in accordance with
the terms thereof and, unless otherwise specified therein, include all schedules, annexes, addendums, exhibits and any other documents attached thereto or incorporated therein by reference and (ii)&nbsp;this Agreement mean this Agreement (taking
into account the provisions of <u>Section</u><u></u><u>&nbsp;10.11(a)</u>) as amended, supplemented or otherwise modified from time to time in accordance with <u>Section</u><u></u><u>&nbsp;10.5</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) The Company Disclosure Letter may include items and information the disclosure of which is not required either in response to an express
disclosure requirement of this Agreement or as an exception to one or more representations or warranties or covenants set forth in this Agreement. Inclusion of any such items or information in the Company Disclosure Letter shall not be deemed to be
an acknowledgement or agreement that any such item or information (or any <font style="white-space:nowrap">non-disclosed</font> item or information of comparable or greater significance) is “material” or that it has had or would reasonably
be expected to result in a Material Adverse Effect. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Parties have jointly negotiated and drafted this Agreement and if an
ambiguity or a question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties, and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of
any provision of this Agreement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">[<i>Signature Page Follows</i>] </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-63- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, this Agreement has been duly executed and delivered by duly authorized
officers of the Parties as of the date first written above. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p><div align="right">
<table cellspacing="0" cellpadding="0" width="40%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<tbody><tr>

<td width="7%"></td>

<td valign="bottom" width="1%"></td>
<td width="92%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top" colspan="3">CHANGE HEALTHCARE INC.</td></tr>
<tr style="font-size:1pt">
<td height="16"></td>
<td height="16" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">By:</td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000">&nbsp;</td>
<td valign="top" style="BORDER-BOTTOM:1px solid #000000">/s/ Neil de Crescenzo</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom">Name: Neil de Crescenzo</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom">Title: President and Chief Executive Officer</td></tr>
</tbody></table></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p><div align="right">
<table cellspacing="0" cellpadding="0" width="40%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<tbody><tr>

<td width="7%"></td>

<td valign="bottom" width="1%"></td>
<td width="92%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top" colspan="3">UNITEDHEALTH GROUP INCORPORATED</td></tr>
<tr style="font-size:1pt">
<td height="16"></td>
<td height="16" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">By:</td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000">&nbsp;</td>
<td valign="top" style="BORDER-BOTTOM:1px solid #000000">/s/ John F. Rex</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom">Name: John F. Rex</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom">Title: Chief Financial Officer</td></tr>
</tbody></table></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</p><div align="right">
<table cellspacing="0" cellpadding="0" width="40%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<tbody><tr>

<td width="7%"></td>

<td valign="bottom" width="1%"></td>
<td width="92%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top" colspan="3">CAMBRIDGE MERGER SUB INC.</td></tr>
<tr style="font-size:1pt">
<td height="16"></td>
<td height="16" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top">By:</td>
<td valign="bottom" style=" BORDER-BOTTOM:1px solid #000000">&nbsp;</td>
<td valign="top" style="BORDER-BOTTOM:1px solid #000000">/s/ Robert W. Musslewhite</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom">Name: Robert W. Musslewhite</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td valign="top"></td>
<td valign="bottom">&nbsp;</td>
<td valign="bottom">Title: Chief Executive Officer and President</td></tr>
</tbody></table></div>
</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center"><b>ANNEX A </b></p>
<p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center"><b>Certain Definitions </b></p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>2019 Stock Plan</u>” means the Company’s 2019 Omnibus Incentive Plan. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Acquisition Proposal</u>” means any proposal, offer, inquiry or indication of interest relating to (a)&nbsp;a merger, joint
venture, partnership, exclusive license, consolidation, dissolution, liquidation, tender offer, recapitalization, reorganization, <font style="white-space:nowrap">spin-off,</font> share exchange, plan of arrangement, business combination or any
other similar transaction involving the Company or any of its Subsidiaries or (b)&nbsp;an&nbsp;acquisition by any Person or group (as defined under Section&nbsp;13 of the Exchange Act) that, in each of clauses (a)&nbsp;and (b), if consummated would
result in any Person or group (as defined under Section&nbsp;13 of the Exchange Act) directly or indirectly, in one or a series of related transactions, acquiring beneficial ownership of or becoming the beneficial owner of 15% or more of:
(i)&nbsp;the total voting power or any class of equity securities of the Company or any of its material Subsidiaries; or (ii)&nbsp;the consolidated net revenues, net income or total assets of the Company as of the date of such proposal, offer,
inquiry or indication of interest (<u>it</u> <u>being</u> <u>understood</u> that total assets include equity securities of Subsidiaries of the Company), in each of the foregoing clauses (a)&nbsp;and (b)&nbsp;of this definition, other than the
transactions contemplated by this Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Affiliate</u>” means, with respect to any Person, any other Person directly or
indirectly controlling, controlled by, or under common control with such Person; <u>provided</u>, that no Affiliate or portfolio company (as such term is commonly understood in the private equity industry) of The Blackstone Group Inc. or any of its
Affiliates shall be considered an Affiliate of the Company or any of its Subsidiaries. For purposes of this definition, the term “control” and the correlative meanings of the terms “controlled by” and “under common control
with”, as used with respect to any Person, means the possession, direct or indirect, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities, by Contract or
otherwise. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Alternative Acquisition Agreement</u>” means, other than a Permitted Confidentiality Agreement, any acquisition
agreement, merger agreement, arrangement agreement, option agreement, joint venture agreement, partnership agreement, license agreement, legally binding letter of intent, legally binding memorandum of understanding, agreement in principle or any
other similar legally binding agreement or document relating to any Acquisition Proposal. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Antitrust Law</u>” means all U.S.
and <font style="white-space:nowrap">non-U.S.</font> antitrust, competition or other Laws that are designed or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade or lessening of
competition through merger or acquisition, including the Sherman Antitrust Act of 1890, the Clayton Act of&nbsp;1914 and the HSR Act. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Applicable Date</u>” means October&nbsp;26, 2018; <u>provided</u>, <u>however</u>, that solely as used in <u>Article VI</u>,
“Applicable Date” means March&nbsp;31, 2017. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Audit Committee</u>” means the Audit Committee of the Company Board.
</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Bankruptcy and Equity Exception</u>” means (i)&nbsp;bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium
and similar Laws of general applicability relating to or affecting creditors’ rights generally and (ii)&nbsp;general equity principles. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>BBA Rules</u>” means Subchapter C of Chapter 63 of the Code (Sections 6221 et seq.) and any U.S. Treasury Regulations and other
guidance promulgated thereunder, and any similar state or local legislation, regulations or guidance. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Book-Entry Share</u>”
means each book-entry account representing any <font style="white-space:nowrap">non-certificated</font> Eligible Share immediately prior to the Effective Time. </p>
</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Burdensome Condition</u>” means any term, condition, obligation, requirement,
limitation, prohibition, remedy, sanction or other action imposed upon Parent, the Company or any of their respective Subsidiaries in connection with effecting the expiration of any waiting period (and any extension thereof) under any Antitrust Law
applicable to the consummation of the transactions contemplated by this Agreement or obtaining from a Governmental Antitrust Entity any consent, approval, permit or authorization, in each case necessary in order to consummate the transactions
contemplated by this Agreement, that would either (a)&nbsp;impose any requirement to sell, license, assign, transfer, divest, hold separate or otherwise dispose of, before or after the Closing, any assets or businesses of Parent, the Company or any
of their respective Affiliates generating, individually or in the aggregate, greater than $650,000,000 in annual revenue from third parties (measured based on the 12 calendar month period immediately prior to such term, condition, obligation,
requirement, limitation, prohibition, remedy, sanction or other action being imposed by such Governmental Antitrust Entity), or (b)&nbsp;individually or in the aggregate with all other such terms, conditions, obligations, requirements, limitations,
prohibitions, remedies, sanctions or other actions, reasonably be expected to result in a material adverse effect on the business, operations, financial condition or results of operations of the Company and its Subsidiaries, taken as a whole, or
Parent and its Subsidiaries, taken as a whole (assuming for purposes of such analysis that the Parent and its Subsidiaries were the same size as, and had the same financial and operating metrics as, the Company and its Subsidiaries, taken as a
whole). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Business Day</u>” means any day ending at 11:59&nbsp;p.m. (New York time) other than a Saturday or Sunday or a day
on which (a)&nbsp;banks in New York, New York or Minnetonka, Minnesota are required or authorized by Law to close or (b)&nbsp;solely for purposes of determining the Closing Date, the Department of State of the State of Delaware is required or
authorized by Law to close. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>CARES Act</u>” means the Coronavirus Aid, Relief, and Economic Security Act of 2020 (H.R. 748).
</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Cash-Settled Company RSU</u>” means any Company RSU that is required to be settled in cash (and not Shares) per the terms
of such Company RSU in effect as of the date of this Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Cash-Settled Company SAR</u>” means any Company SAR that is
required to be settled in cash (and not Shares) per the terms of such Company SAR in effect as of the date of this Agreement. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Certificate</u>” means each certificate representing any Eligible Share immediately prior to the Effective Time. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Certificate of Merger</u>” means a certificate of merger relating to the Merger. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Certification</u>” means the following Certified Health IT Products: (a)&nbsp;Clinical Exchange Version 9.0, (b) Clinical
Exchange Version 9.1, (c) Clinical Exchange Version 9.2, and (d)&nbsp;Clinical Exchange Communicator Version 19. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Chosen
Courts</u>” means the Court of Chancery of the State of Delaware, or if such court finds it lacks subject matter jurisdiction, the Superior Court of the State of Delaware (Complex Commercial Division); <u>provided</u> that if subject matter
jurisdiction over the matter that is the subject of the applicable Proceeding is vested exclusively in the U.S. federal courts, such Proceeding shall be heard in the U.S. District Court for the District of Delaware. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Clean Team Agreement</u>” means the Clean Team Confidentiality Agreement, dated as of November&nbsp;20, 2020, by and between the
Company and Parent. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Code</u>” means the Internal Revenue Code of 1986. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Company 401(k) Plan</u>” means the Company 401(k) Savings Plan. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-2- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Company Benefit Plan</u>” means any benefit or compensation plan, program,
policy, practice, Contract or other obligation, whether or not in writing and whether or not funded, in each case, which is sponsored or maintained by, or required to be contributed to, or with respect to which any potential obligation or liability
is borne by, the Company or any of its Subsidiaries, including ERISA Plans, employment, consulting, retirement, severance, termination or “change of control” agreements, deferred compensation, equity-based, incentive, bonus, supplemental
retirement, profit sharing, insurance, medical, welfare, fringe, paid time off, vacation, sick, holiday or other benefits or remuneration of any kind. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Company Board</u>” means the board of directors of the Company, and also includes any committee thereof to the extent such a
committee (a)&nbsp;is authorized to exercise the powers and authority of the board of directors of the Company pursuant to the Company’s Organizational Documents or the DGCL and (b)&nbsp;is exercising such powers and authority. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Company Class</u><u></u><u>&nbsp;X Share</u>” means the share of Class&nbsp;X stock of the Company, par value $0.001 per share.
</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Company Compensation Committee</u>” means the Compensation Committee of the Company Board. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Company DSU</u>” means any outstanding deferred stock unit granted under the Stock Plans. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Company Employee</u>” means any current or former employee (whether full- or part-time and, including any officer), director or
independent contractor (who is a natural person) of the Company or any of its Subsidiaries. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Company Equity Awards</u>”
means, collectively, the Company Options, Company SARs, Exit-Vesting Company Restricted Shares, Company RSUs, Company PSUs and Company DSUs. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Company ERISA Affiliate</u>” means all employers (whether or not incorporated) that would be treated together with the Company
or any of its Subsidiaries as a “single employer” within the meaning of Section&nbsp;414 of the Code. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Company
Government Contract</u>” means any Contract to which the Company or any of its Subsidiaries is a party, or by which any of them are bound, the ultimate contracting party of which is a Governmental Entity (including any subcontract with a prime
contractor or other subcontractor who is a party to any such Contract). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Company Intellectual Property</u>” means any and
all Intellectual Property Rights owned or purported to be owned by the Company or any of its Subsidiaries. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Company
Option</u>” means any outstanding option to purchase Shares granted under the Stock Plans. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Company Partnership</u>”
means any entity or arrangement treated as a partnership for U.S. federal income Tax purposes in which the Company or any of its Subsidiaries owns or has owned an interest. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Company Preferred Stock</u>” means the shares of preferred stock of the Company, par value $0.001 per share. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Company PSUs</u>” means any outstanding performance share unit award granted under the Stock Plans. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Company Reports</u>” means the reports, forms, proxy statements, registration statements and other statements, certifications
and documents required to be filed with or furnished to the SEC pursuant to the Exchange Act or the Securities Act by the Company, including notes, exhibits and schedules thereto and all other information incorporated by reference and any amendments
and supplements thereto. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-3- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Company RSU</u>” means any outstanding restricted stock unit granted under the
Stock Plans. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Company SAR</u>” means any outstanding stock appreciation right granted under the Stock Plans. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Company Stockholders Meeting</u>” means the meeting of stockholders of the Company to be held to consider the adoption of this
Agreement and any other matters permitted or consented to by Parent pursuant to <u>Section</u><u></u><u>&nbsp;7.4(f)</u>. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Company Tax Counsel</u>” means Simpson Thacher&nbsp;&amp; Bartlett LLP, or another nationally recognized law firm or “Big
Four” accounting firm that is reasonably satisfactory to Parent. For this purpose, an Expert Law Firm will be deemed satisfactory to Parent. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Confidentiality Agreement</u>” means the letter agreement, dated as of November&nbsp;14, 2020, by and between the Company and
Parent. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Continuing Employees</u>” means the employees of the Company and its Subsidiaries at the Effective Time who
continue to remain employed with the Company or any of its Subsidiaries. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Contract</u>” means any legally binding oral or
written contract, agreement, lease, license, note, mortgage, indenture, arrangement or other similar obligation. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Contribution
Agreement</u>” means the Agreement of Contribution and Sale, dated as of June&nbsp;28, 2016, by and among PF2 Newco LLC, PF2 Newco Intermediate Holdings, LLC, PF2 Newco Holdings, LLC, Distributing, HCIT Holdings, Inc., the Company, Change
Aggregator L.P. and H&amp;F Echo Holdings, L.P. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u><font style="white-space:nowrap">COVID-19</font></u>” means <font style="white-space:nowrap"><font style="white-space:nowrap">SARS-CoV-2</font></font> or <font style="white-space:nowrap">COVID-19,</font> and any evolutions thereof or related or associated epidemics, pandemic or disease outbreaks. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u><font style="white-space:nowrap">COVID-19</font> Measures</u>” means any quarantine, “shelter in place,” “stay at
home,” social distancing, shut down, closure, sequester, safety or other Law, directive, guidelines or recommendations by any Governmental Entity (in the case of recommendations, widely followed by the Company’s and its Subsidiaries’
peer companies) or <i>bona fide </i>industry group widely followed by the Company’s and its Subsidiaries’ healthcare industry peer companies in response to <font style="white-space:nowrap">COVID-19.</font> </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Credit Agreement</u>” means the Credit Agreement, dated as of March&nbsp;1, 2017, by and among Change Healthcare Intermediate
Holdings, LLC, Change Healthcare Holdings, LLC and each of the other borrowers and guarantors party thereto, the lenders party thereto from time to time and Bank of America, N.A., as administrative agent, collateral agent, swing line lender and L/C
issuer. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Device Laws</u>” means all Laws related to medical devices applicable to the operation of the Company’s and
each of its Subsidiaries’ businesses, including (a)&nbsp;the Federal Food, Drug, and Cosmetic Act of 1938 (21 U.S.C. § 321 et seq.); (b) the rules and regulations in Title 21, Code of Federal Regulations, promulgated and enforced by the
FDA that are applicable to medical devices; and (c)&nbsp;all comparable state, federal or foreign Laws applicable to medical devices. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>DGCL</u>” means the General Corporation Law of the State of Delaware. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Dissenting Shares</u>” has the meaning set forth in the definition of “Dissenting Stockholders.” </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Dissenting Stockholders</u>” means the holders of Shares who have duly demanded appraisal pursuant to Section&nbsp;262 of the
DGCL and have not effectively withdrawn or otherwise waived or lost such Person’s rights to appraisal under the DGCL (such Shares for which appraisal has been so duly demanded and the right thereto under the DGCL not effectively withdrawn or
otherwise waived or lost, the “<u>Dissenting Shares</u>”). </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-4- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Distributing</u>” means McKesson Corporation. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>DTC</u>” means The Depository Trust Company. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>EDGAR</u>” means the Electronic Data Gathering, Analysis and Retrieval System administered by the SEC. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Eligible Shares</u>” means the Shares issued and outstanding immediately prior to the Effective Time, other than
(a)&nbsp;subject to the last sentence of <u>Section</u><u></u><u>&nbsp;4.3(f)</u>, any Excluded Shares and (b)&nbsp;any Exit-Vesting Company Restricted Shares. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Encumbrance</u>” means any pledge, lien, charge, option, hypothecation, mortgage, security interest, adverse right, license,
sublicense, covenant not to sue or any other encumbrance of any kind or nature whatsoever, whether contingent or absolute. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Environmental Law</u>” means any Law relating to: (a)&nbsp;the protection, investigation, remediation or restoration of the
environment or natural resources; (b)&nbsp;the handling, labeling, management, recycling, generation, use, storage, treatment, transportation, presence, disposal, release or threatened release of any Hazardous Substance; or (c)&nbsp;any noise, odor,
indoor air, employee exposure, wetlands, pollution, contamination or any injury or threat of injury to Persons or property relating to exposure to any Hazardous Substance. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Equity Award Exchange Ratio</u>” means the Per Share Merger Consideration divided by the Parent Trading Price. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>ERISA</u>” means the Employee Retirement Income Security Act of 1974. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>ERISA Plans</u>” means “employee benefit plans” within the meaning of Section&nbsp;3(3) of ERISA, excluding
Multiemployer Plans. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>ESPP</u>” means the Company’s Employee Stock Purchase Plan. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Exchange Act</u>” means the Securities Exchange Act of 1934. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Excluded Shares</u>” means the (a)&nbsp;Shares owned by Parent, Merger Sub or any other Wholly Owned Subsidiary of Parent, the
Company or any Wholly Owned Subsidiary of the Company, and in each case not held on behalf of third parties and (b)&nbsp;Dissenting Shares. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Expert Law Firm</u>” means a law firm ranked in Band 1 or 2 nationally by Chambers&nbsp;&amp; Partners for Tax:
Corporate&nbsp;&amp; Finance in USA. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Exit-Vesting Conditions</u>” means vesting conditions based upon receipt of cash
proceeds by certain stockholders of the Company at a weighted average price per Share that (a)&nbsp;is at least equal to a specified weighted average price per Share set forth in the applicable award agreement or (b)&nbsp;results in an annual
internal rate of return at the level set forth in the applicable award agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Exit-Vesting Company Option</u>” means
any Company Option that is subject to vesting upon achievement of a specified weighted average price per Share. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Exit-Vesting
Company Restricted Shares</u>” means any outstanding restricted Share granted under the Stock Plans that is subject to Exit-Vesting Conditions. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Exit-Vesting Company RSU</u>” means any Company RSU that is subject to Exit-Vesting Conditions. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-5- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Exit-Vesting Company SAR</u>” means any Company SAR that is subject to
Exit-Vesting Conditions. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Federal Healthcare Program</u>” has the meaning set forth in 42 U.S.C. <font style="white-space:nowrap">§&nbsp;1320a-7b(f).</font> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Final Offering</u>” means the offering period under the ESPP
that commenced on October&nbsp;1, 2020. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>GAAP</u>” means the generally accepted accounting principles as applied in the
United States as of the time of the relevant financial statements or accounting procedure or action referred to herein and consistently applied during the periods involved. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Governmental Entity</u>” means any U.S., <font style="white-space:nowrap">non-U.S.</font> or supranational governmental,
quasi-governmental, regulatory or self-regulatory authority, enforcement authority, agency, commission, body or other entity or any subdivision or instrumentality thereof or any instrumentality of any such subdivision, including any public
international organization, stock exchange or other self-regulatory organization, court, tribunal or arbitrator or any subdivision or instrumentality thereof or any instrumentality of any such subdivision, in each case of competent jurisdiction.
</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Hazardous Substance</u>” means any: (a)&nbsp;substance that is listed, designated, classified or regulated as hazardous,
toxic, a waste, a pollutant, a contaminant, or words of similar meaning, pursuant to any Environmental Law; (b)&nbsp;substance that is a petroleum product or <font style="white-space:nowrap">by-product,</font> asbestos-containing material,
lead-containing paint or plumbing, polychlorinated biphenyls, mold, radioactive material or radon; and (c)&nbsp;other substance that poses a risk of harm to human health or the environment in connection with any Environmental Law. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Healthcare Laws</u>” means: (a)&nbsp;the Medicare Program Laws&nbsp;and Title XIX of the Social Security Act; (b)&nbsp;Laws
relating to the Office of the National Coordinator for Health Information Technology (ONC) Health IT Certification Program and the federal Electronic Health Records Meaningful Use Program; (c)&nbsp;HIPAA; (d)&nbsp;the Federal anti-kickback law (42
U.S.C. § <font style="white-space:nowrap">1320a-7b),</font> the Stark law (42 U.S.C. § 1395nn), the Federal False Claims Act (31 U.S.C. §§ 3729 et seq.), the Federal Civil Monetary Penalties Law (42 U.S.C. <font style="white-space:nowrap">§&nbsp;1320a-7a),</font> the Federal Program Fraud Civil Remedies Act (31 U.S.C. § 3801 et seq.), the Federal Health Care Fraud law (18 U.S.C. § 1347) and any similar state fraud and abuse laws; (e)&nbsp;the
Patient Protection and Affordable Care Act (Pub. L. <font style="white-space:nowrap">111-148),</font> as amended by the Health Care Education and Reconciliation Act (Pub. L. <font style="white-space:nowrap">111-152);</font> and (f)&nbsp;any
analogous Laws imposed by any state or foreign jurisdiction. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>HIPAA</u>” means the Health Insurance Portability and
Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>HSR
Act</u>” means the Hart-Scott-Rodino Antitrust Improvement Act of 1976. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Indebtedness</u>” means, with respect to any
Person, without duplication, all obligations, liabilities or undertakings by such Person (a)&nbsp;for borrowed money (including deposits or advances of any kind to such Person), (b)&nbsp;evidenced by bonds, debentures, notes or similar instruments,
(c)&nbsp;for capital leases or finance leases (as determined in accordance with GAAP) or to pay the deferred and unpaid purchase price of property or equipment, or securities or services, including all
<font style="white-space:nowrap">earn-out</font> payments, seller notes and other similar payments (whether contingent or otherwise) calculated as the maximum amount payable under or pursuant to such obligation, (d)&nbsp;pursuant to securitization
or factoring programs or arrangements, (e)&nbsp;to maintain or cause to be maintained the financing, financial positions or covenants of others or to purchase the obligations or property of others, (f)&nbsp;for net cash payment obligations of such
Person under foreign exchange Contracts, swaps (including interest rate and currency obligation swaps), options, forward sales contracts, derivatives, collars, caps and other hedging Contracts, financial instruments or arrangements that will be
payable upon termination thereof (assuming termination on the date of determination), (g)&nbsp;for letters of credit, bank guarantees, performance bonds, surety bonds and other similar Contracts entered into by or on behalf of such Person,
(h)&nbsp;for the deferred </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-6- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
purchase price of goods and services (including any potential future “earnout”, purchase price adjustment, release of “holdback” or similar payment, but excluding trade
payables incurred in the Ordinary Course of Business), (i) for deferred rent liabilities required to be recorded as such in accordance with GAAP or (j)&nbsp;pursuant to guarantees and arrangements having the economic effect of a guarantee of any
obligation or undertaking of any other Person contemplated by the foregoing clauses (a)&nbsp;through (i) of this definition, in each case including all interest, penalties, premiums, breakage costs, fees and other costs and expenses and other
payments due with respect thereto; <u>provided</u>, <u>however</u>, that “Indebtedness” shall not include&nbsp;intercompany indebtedness, obligations, liabilities or undertakings (including any guarantees or arrangements having the
economic effect of a guarantee) solely between or among Parent and any of its Wholly Owned Subsidiaries or solely between or among the Company and any of its Wholly Owned Subsidiaries (as applicable). </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Indemnified Parties</u>” means, collectively, (i)&nbsp;each present and former (determined as of the Effective Time for purposes
of <u>Section</u><u></u><u>&nbsp;7.12</u>) director or officer of the Company or any of its Subsidiaries (or other individuals performing similar functions), in each case when acting in such capacity; (ii)&nbsp;each Person who served, as of or prior
to the Effective Time, at the Company’s request as a director, officer, member, trustee or fiduciary of another corporation, limited liability company, partnership, joint venture, trust, pension or other employee benefit plan or enterprise; and
(iii)&nbsp;the respective heirs, executors and administrators of the Persons referred to in clauses (i)&nbsp;and (ii). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Insurance
Policies</u>” means any fire and casualty, property, general liability, business interruption, product liability, sprinkler and water damage, workers’ compensation and employer liability, directors, officers and fiduciaries policies and
other liability insurance policies, and fidelity, crime or financial institution bonds, including any reinsurance policies and self-insurance programs and arrangements. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Intellectual Property Rights</u>” means any or all intellectual property or proprietary rights arising under the laws of the
United States, any state thereof, or of any other jurisdiction in the world, including: (a)&nbsp;patents (including design patents) and utility models of any kind, patent applications and registrations, including revisions, supplementary protection
certificates, provisional applications, statutory invention registrations, inventions, discoveries and invention disclosures (whether or not patented), and all related continuations,
<font style="white-space:nowrap"><font style="white-space:nowrap">continuations-in-part,</font></font> divisionals, renewals, reissues, <font style="white-space:nowrap">re-examinations,</font> substitutions, and extensions thereof; (b)&nbsp;rights
in trademarks, service marks, brand names, certification marks, collective marks, d/b/a’s, trade names, corporate names, service names, symbols, logos, trade dress, packaging design, slogans, Internet domain names, uniform resource locators and
other similar identifiers of origin, in each case whether or not registered, and any and all common law rights thereto, registrations and applications for registration thereof, and any goodwill associated therewith and symbolized thereby;
(c)&nbsp;published and unpublished works of authorship whether or not copyrightable, including Software, website and mobile content, social media accounts, applications, source code and object code, rights in data, databases, and other compilations
of information, manual and other documentation, in each case, whether or not registered or sought to be registered, and any and all copyrights in and to the foregoing, together with all common law rights and moral rights therein, and any
applications and registrations therefor, including extensions, renewals, restorations and reversions thereof; (d)&nbsp;any and all trade secrets, confidential or proprietary <font style="white-space:nowrap">know-how,</font> or other information,
including processes, schematics, business methods, formulae, drawings, specifications, recipes, prototypes, models, designs, customer lists and supplier lists (collectively, “<u>Trade Secrets</u>”); and (e)&nbsp;all other intellectual
property, industrial or proprietary rights. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Intervening Event</u>” means any event, change, development, circumstance, fact
or effect with respect to or impacting the Company and its Subsidiaries or the business of the Company and its Subsidiaries that (a)&nbsp;is unknown to or not reasonably foreseeable by the Company Board as of the execution and delivery of this
Agreement (or, if known or reasonably foreseeable, the magnitude or material consequences of which were not known or reasonably foreseeable by the Company Board as of the execution and delivery of this Agreement), and (b)&nbsp;first becomes known to
the Company Board after the execution and delivery of this Agreement and any time prior to the time the Requisite Company Vote is obtained; <u>provided</u> that any event, change, development, circumstance, fact or effect (i)&nbsp;that involves or
relates to an Acquisition Proposal or a Superior Proposal (which, </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-7- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
for purposes of this definition, shall be read without reference to any percentages set forth in the definitions of “Acquisition Proposal” and “Superior Proposal”) or any
inquiry or communications or matters relating thereto, (ii)&nbsp;resulting from a breach of this Agreement by the Company or (iii)&nbsp;resulting, in and of itself, from any event, change, development, circumstance or fact after the execution and
delivery of this Agreement in the market price or trading volume of the Shares, individually or in the aggregate, shall not be deemed to constitute an Intervening Event. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Intended <font style="white-space:nowrap">Tax-Free</font> Treatment</u>” has the meaning set forth in the Tax Matters Agreement.
</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>IRS</u>” means the U.S. Internal Revenue Service. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>IT Assets</u>” means technology devices, computers, Software, firmware, middleware, servers, networks, workstations, routers,
hubs, circuits, switches, data communications lines, and all other information technology equipment and all&nbsp;associated documentation. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Knowledge</u>” means the actual knowledge of the individuals set forth in <u>Section</u><u></u><u>&nbsp;1.1(a)</u> of the
Company Disclosure Letter and any other individuals that, following the date of this Agreement, replace or share the employment responsibilities of any such scheduled individuals, in each case after reasonable due inquiry. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Law</u>” means any law, statute, constitution, principle of common law, ordinance, code, standard, rule, regulation, ruling or
requirement issued, enacted, adopted, promulgated or otherwise put into effect by or under the authority of any Governmental Entity, or any Order. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Leased Real Property</u>” means all leasehold or subleasehold estates and other rights to use and occupy any land, buildings,
structures, improvements, fixtures or other interest in real property held by the Company or any of its Subsidiaries. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Licenses</u>” means all licenses, permits, approvals, clearances, registrations, authorizations, variances and exemptions issued
or granted by a Governmental Entity (and, in the case of any FDA Licenses, exemptions set forth in statutes or regulations). </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Material Adverse Effect</u>” means any result, condition, event, change, development, circumstance, fact or effect that,
individually or taken together with any other events, changes, developments, circumstances, facts or effects, (i)&nbsp;would have, or would reasonably be expected to have, a materially adverse effect on the condition (financial or otherwise),
properties, assets, liabilities (contingent or otherwise), business operations or results of operations of the Company and its Subsidiaries (taken as a whole); <u>provided</u>, <u>however</u>, that none of the following, either alone or in
combination, shall constitute a Material Adverse Effect or be taken into account in determining whether a Material Adverse Effect has occurred or would reasonably be expected to occur: </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) results, conditions, events, changes, developments, circumstances, facts or effects in or with respect to the economy, credit, capital,
securities or financial markets (including changes in interest rates or currency exchange rates) or political, regulatory or business conditions in the geographic markets in which the Company or any of its Subsidiaries operate or their products or
services are sold, in each case, occurring after the date of this Agreement; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) results, conditions, events, changes, developments,
circumstances, facts or effects that generally affect other participants in the Company’s or its Subsidiaries’ industry or industries, in each case, occurring after the date of this Agreement and only to the extent also occurring in the
applicable geographic markets in which the Company or any of its Subsidiaries operate or where their products or services are sold; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
the negotiation, execution, performance, public announcement or pendency of this Agreement or the transactions contemplated hereby, or any result, condition, event, change, development, circumstance, fact or
</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-8- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
effect resulting therefrom, including any loss of employees, customers or revenue to the extent arising from the identity of Parent as the acquiror of the Company (<u>provided</u>, that this
clause (c)&nbsp;shall not apply to any representation or warranty to the extent such representation or warranty addresses the consequences resulting from the execution and delivery of this Agreement, the performance of a Party’s obligations
hereunder or the consummation of the transactions contemplated by this Agreement); </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) any term, condition, obligation, requirement,
limitation, prohibition, remedy, sanction or other action imposed upon Parent, the Company or any of their respective Subsidiaries in connection with effecting the expiration of any waiting period (and any extension thereof) under any Antitrust Law
applicable to the consummation of the transactions contemplated by this Agreement or obtaining from a Governmental Antitrust Entity any consent, approval, permit or authorization, in each case in accordance with and to the extent contemplated by
this Agreement; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) changes in GAAP or in any applicable Law, in each case, occurring after the date of this Agreement; </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) any failure by the Company to meet any internal or public projections or forecasts or estimates of revenues or earnings; <u>provided</u>
that any event, change, development, circumstance, fact or effect underlying such failure (unless otherwise excluded by the other clauses of this proviso) may be taken into account in determining whether a Material Adverse Effect has occurred or
would reasonably be expected to occur; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) acts of war (whether or not declared), sabotage, terrorism, military or para-military actions
or the escalation of any of the foregoing (other than any cyberattack targeted principally at the Company or any of its Subsidiaries), any weather event or natural disaster, or any outbreak of illness, pandemic (including <font style="white-space:nowrap">COVID-19)</font> or other public health event, in each case, occurring after the date of this Agreement, and any results, conditions, events, changes, developments, circumstances, facts or effects resulting therefrom; or
</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) any actions or <font style="white-space:nowrap">non-actions</font> (i)&nbsp;expressly required to be taken or expressly required to
be not taken by the Company or any of its Subsidiaries pursuant to this Agreement (except for any obligation to operate in the Ordinary Course of Business), (ii) taken or not taken by the Company or any of its Subsidiaries at Parent’s written
request or (iii)&nbsp;taken or not taken by the Company or any of its Subsidiaries to the extent such actions or <font style="white-space:nowrap">non-actions</font> are required by applicable Law; </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><u>provided</u> <u>further</u> that, with respect to clauses (a), (b), (e) and (g)&nbsp;of this definition, such events, changes,
developments, circumstances, facts or effects (as the case may be) shall be taken into account in determining whether a “Material Adverse Effect” has occurred or would reasonably be expected to occur to the extent, and only to the extent,
that they disproportionately adversely affect the Company and its Subsidiaries (taken as a whole) relative to healthcare industry peer companies of the Company and its material Subsidiaries; or (ii)&nbsp;would, or would reasonably be expected to,
prevent, materially delay or materially impair the ability of the Company or any of its Subsidiaries to consummate the transactions contemplated by this Agreement. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Malicious Code</u>” means disabling codes or instructions, spyware, Trojan horses, back doors, drop dead devices, time bombs,
worms, viruses or other software routines that facilitate or cause unauthorized access to, or disruption, impairment, disablement or destruction of, Software, data or other materials. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Medicare Program Laws</u>” means Title XVIII of the Social Security Act (Pub. L. <font style="white-space:nowrap">74-271)</font>
including the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 and the Medicare Improvements for Patients and Providers Act of 2008. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Multiemployer Plans</u>” means “multiemployer plans” as defined by Section&nbsp;3(37) of ERISA. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>NASDAQ</u>” means the Nasdaq Global Select Market. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-9- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>NYSE</u>” means the New York Stock Exchange. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Order</u>” means any order, award, judgment, injunction, writ, decree (including any consent decree or similar agreed order or
judgment), directive, settlement, stipulation, ruling, determination, decision or verdict, whether civil, criminal or administrative, in each case, that is entered, issued, made or rendered by any Governmental Entity. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Ordinary Course of Business</u>” means, with respect to any Person, the conduct of such Person’s business that
is&nbsp;consistent in all material respects in nature, scope and magnitude with the past practices of such Person prior to the date of this Agreement and taken in the ordinary course of normal, <font style="white-space:nowrap"><font style="white-space:nowrap">day-to-day</font></font> operations of such Person, including any commercially reasonable deviations therefrom due to <font style="white-space:nowrap">COVID-19</font> Measures. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Organizational Documents</u>” means (a)&nbsp;with respect to any Person that is a corporation, its certificate of incorporation
and bylaws, or comparable documents, (b)&nbsp;with respect to any Person that is a partnership, its certificate of partnership and partnership agreement, or comparable documents, (c)&nbsp;with respect to any Person that is a limited liability
company, its certificate of formation and limited liability company agreement, or comparable documents, (d)&nbsp;with respect to any Person that is a trust, its declaration of trust, or comparable documents, and (e)&nbsp;with respect to any other
Person that is not an individual, its comparable organizational documents. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Owned Real Property</u>” means all land,
together with all buildings, structures, improvements and fixtures located thereon, and all easements and other rights and interests appurtenant thereto, owned by the Company or any of its Subsidiaries. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Parent Board</u>” means the board of directors of Parent. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Parent Common Stock</u>” means the shares of common stock of Parent, par value $0.01 per share. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Parent Trading Price</u>” means the volume weighted average of the closing sale prices per share of Parent Common Stock on the
NYSE, as reported in the New York City edition of The Wall Street Journal (or, if not reported thereby, as reported in another authoritative source) on each of the five full consecutive trading days ending on and including the third Business Day
prior to the Closing Date. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Paying Agent</u>” means the paying agent selected by Parent prior to the Effective Time after
reasonable consultation with the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Paying Agent Agreement</u>” means the agreement pursuant to which Parent shall
appoint the Paying Agent. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Per Share Merger Consideration</u>” means $25.75 per Share in cash, without interest. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Permitted Encumbrances</u>” means: (a)&nbsp;Encumbrances for current Taxes or other governmental charges not yet due and payable
or that the Person subject to such Taxes or other governmental charges is contesting in good faith by appropriate Proceedings and for which adequate reserves have been established in accordance with GAAP; (b)&nbsp;mechanics’, carriers’,
workmen’s, repairmen’s or other like Encumbrances arising or incurred in the Ordinary Course of Business relating to obligations as to which there is no default on the part of Company or any of its Subsidiaries, or the validity or amount
of which is being contested in good faith by appropriate proceedings and which are not, individually or in the aggregate, material; (c)&nbsp;other Encumbrances that do not, individually or in the aggregate, materially impair the continued use,
operation or value of the specific parcel of Real Property to which they relate or the conduct of the business of the Company and its Subsidiaries as currently conducted, or restrictions or exclusions that would be shown by a current title report or
other similar report;(d)&nbsp;restrictions on transfer solely arising under or relating to applicable securities Laws; and (e)&nbsp;with respect to Intellectual Property Rights, <font style="white-space:nowrap">non-exclusive</font> licenses granted,
and covenants not to sue entered into, in the Ordinary Course of Business. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-10- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Person</u>” means any individual, corporation (including <font style="white-space:nowrap"><font style="white-space:nowrap">not-for-profit),</font></font> general or limited partnership, limited liability company, joint venture, estate, trust, association, organization, Governmental Entity or other entity of any
kind or nature. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Personal Information</u>” means any information that (a)&nbsp;identifies or could reasonably be used, alone
or in combination with other information held by the Company or any of its Subsidiaries, to identify an individual, browser or device, or (b)&nbsp;is subject to any Laws relating to privacy or personal information or the Company’s or its
Subsidiaries’ privacy policies, including an individual’s first and last name, address, telephone number, fax number, email address, social security number or other identifier issued by a Governmental Entity (including any state
identification number, driver’s license number, or passport number), geolocation information of an individual, browser or device, biometric data, medical or health information, credit card or other financial information (including bank account
information), cookie identifiers, or any other browser- or device-specific number or identifier, or any web or mobile browsing or usage information that is linked to the foregoing. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Proceeding</u>” means any action, cause of action, claim, demand, litigation, suit, investigation, review, grievance, citation,
summons, subpoena, inquiry, audit, hearing, originating application to a tribunal, arbitration or other similar proceeding of any nature, civil, criminal, regulatory, administrative or otherwise, whether in equity or at law, in contract, in tort or
otherwise. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Process</u>” or “<u>Processing</u>” means, with respect to data, the use, collection, receipt,
processing, aggregation, storage, adaption, alteration, transfer (including cross-border transfers), retrieval, disclosure, dissemination, combination, erasure, disposal, destruction, or anonymization of such data, any other operation or set of
operations that is performed on data or on sets of data, in each case, whether or not by automated means, and any other form of processing, including as defined by or under any applicable Law. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Prohibited Person</u>” means (a)&nbsp;an entity that has been determined by a competent authority to be the subject of a
prohibition on such conduct of any Law or executive order administered by the Office of Foreign Assets Control; (b)&nbsp;any Governmental Entity of any country against which the United States maintains comprehensive economic sanctions or embargoes;
(c)&nbsp;any Person that acts on behalf of or is owned or controlled by a government of a country against which the United States maintains comprehensive economic sanctions or embargoes; (d)&nbsp;any Person that has been identified on the Office of
Foreign Assets Control Specially Designated Nationals and Blocked Persons List (Appendix A to 31 C.F.R. Ch. V), or that 50% or more of which is owned, directly or indirectly, by any such Person; or (e)&nbsp;any Person that has been designated on any
similar list or order published by any Governmental Entity in the United&nbsp;States. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Protected Health Information</u>” has
the meaning ascribed to it in HIPAA. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Purchase Contract Agreement</u>” means the Purchase Contract Agreement, dated as of
July&nbsp;1, 2019, between the Company and U.S. Bank N.A., as purchase contract agent, as trustee and as <font style="white-space:nowrap"><font style="white-space:nowrap">attorney-in-fact</font></font> for the holders of from time to time as
provided therein, relating to the purchase contract component of the TEUs. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Real Property</u>” means the Owned Real Property
and Leased Real Property. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Registered</u>” means registered with, issued by, renewed by or the subject of a pending
application before any Governmental Entity, Internet domain name registrar or social media account registrar. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Representative</u>” means, with respect to any Person, any director, principal, partner, manager, member (if such Person is a
member-managed limited liability company or similar entity), employee (including any officer), consultant, investment banker, financial advisor, legal counsel,
<font style="white-space:nowrap"><font style="white-space:nowrap">attorney-in-fact,</font></font> accountant or other advisor, agent or other representative of such Person, in each case acting in their capacity as such. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Requisite Company Vote</u>” means the adoption of this Agreement by the holders of a majority of the outstanding Shares entitled
to vote on such matter at a stockholders’ meeting duly called and held for such purpose. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-11- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Sarbanes-Oxley Act</u>” means the Sarbanes-Oxley Act of 2002. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>SEC</u>” means the U.S. Securities and Exchange Commission. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Securities Act</u>” means the Securities Act of 1933. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Senior Amortizing Notes Indenture</u>” means the Indenture, dated as of July&nbsp;1, 2019, between the Company and U.S. Bank
N.A., as trustee, as amended by the First Supplemental Indenture, dated as of July&nbsp;1, 2019, between the Company and U.S. Bank N.A, relating to the amortizing notes component of the TEUs. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Senior Notes</u>” means the 5.75% Senior Notes due 2025, issued pursuant to the terms of the Senior Notes Indenture. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Senior Notes Indenture</u>” means the Indenture, dated as of February&nbsp;15, 2017, by and among Change Healthcare Holdings,
LLC, Change Healthcare Finance, Inc. and Wilmington Trust, National Association as trustee, registrar and paying agent. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Share</u>” means any share of the common stock of the Company, par value $0.001 per share. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Software</u>” means any computer program, application, microcode and other software, including operating systems, software
implementations of algorithms, models and methodologies, in each case, whether in source code, object code or other form or format, including libraries, subroutines and other components thereof, and all documentation relating thereto. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Specified Tax Agreements</u>” means the Tax Receivable Agreements and the Tax Matters Agreement. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Specified Transactions</u>” means any transactions described in the Contribution Agreement, the
<font style="white-space:nowrap">Split-Off,</font> the Internal Restructuring (as such term is defined in the Tax Matters Agreement) and the merger described in the Agreement and Plan of Merger, dated as of December&nbsp;20, 2016, by and among
Distributing, PF2 SpinCo Inc. and the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u><font style="white-space:nowrap">Split-Off</font></u>” means the
consummation, on March&nbsp;9, 2020, of the exchange offer pursuant to which Distributing redeemed shares of Distributing common stock for shares of common stock of PF2 SpinCo, Inc. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Stock Plans</u>” means the 2019 Stock Plan and the Amended and Restated HCIT Holdings, Inc. 2009 Equity Incentive Plan. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Subsidiary</u>” means, with respect to any Person, any other Person of which at least a majority of (a)&nbsp;the securities or
ownership interests of such other Person having by their terms ordinary voting power to elect a majority of the board of directors or other individuals performing similar functions or (b)&nbsp;the equity or ownership interests of such other Person,
in each case is directly or indirectly owned or controlled by such first Person or by one or more of its Subsidiaries. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Superior
Proposal</u>” means an unsolicited and <i>bona fide</i> written Acquisition Proposal that if consummated would result in a Person or group (as defined under Section&nbsp;13 of the Exchange Act), other than Parent or any of its Subsidiaries,
acquiring beneficial ownership of or becoming the beneficial owner of, directly or indirectly, more than 50% of the: (a)&nbsp;total voting power of the equity securities of the Company and its Subsidiaries (or of the surviving entity in a merger
involving the Company or the resulting, direct or indirect, parent of the Company or such surviving entity); or (b)&nbsp;consolidated net revenues, net income or total assets (<u>it</u> <u>being</u> <u>understood</u> that total assets include equity
securities of Subsidiaries of the Company) that, in either case, the Company Board has determined in good faith, after consultation with outside legal counsel and its financial advisor, (i)&nbsp;if consummated, would result in a transaction more
favorable to the Company’s stockholders than the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-12- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
transactions contemplated by this Agreement (after taking into account any revisions to the terms and conditions of this Agreement proposed by Parent pursuant to
<u>Section</u><u></u><u>&nbsp;7.2(d)(iii)</u> and taking into account the time expected to be required to consummate such Acquisition Proposal, any legal, financial, regulatory and approval requirements, the sources, availability and terms of any
financing, financing market conditions and the existence of a financing contingency, the likelihood of termination, the timing of closing, and the identity of the Person or Persons making the proposal) and (ii)&nbsp;is reasonably expected to be
consummated on the terms proposed (after taking into account any legal, financial, regulatory and approval requirements, the sources, availability and terms of any financing, financing market conditions and the existence of a financing contingency,
the likelihood of termination, the timing of closing, and the identity of the Person or Persons making the proposal and any other aspects considered relevant by the Company Board). </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Tail Period</u>” means the six year period from and after the Effective Time. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Takeover Statute</u>” means any “fair price,” “moratorium,” “control share acquisition” or other
similar anti-takeover statute or regulation. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Tax Benefit Payment</u>” has the meaning assigned to such term in the Tax
Receivable Agreement <font style="white-space:nowrap">(2017-1),</font> Tax Receivable Agreement <font style="white-space:nowrap">(2017-2),</font> Tax Receivable Agreement (Exchanges), Tax Receivable Agreement (Management) or Tax Receivable Agreement
(Reorganizations), as appropriate. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Tax Matters Agreement</u>” means the Tax Matters Agreement, dated as of March&nbsp;9,
2020, by and among the Company, McKesson Corporation, PF2 SpinCo Inc., Change Healthcare LLC and Change Healthcare Holdings, LLC. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Tax Opinion</u>” means an opinion of Company Tax Counsel to the effect that, on the basis of facts, representations and
assumptions set forth in such opinion, the completion of the Merger (and any other transactions contemplated by this Agreement) will not affect the Intended <font style="white-space:nowrap">Tax-Free</font> Treatment. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Tax Receivable Agreement <font style="white-space:nowrap">(2017-1)</font></u>” means the Tax Receivable Agreement, dated as of
February&nbsp;28, 2017, by and among the Company, HCIT Holdings, Inc., Change Healthcare LLC and the other parties named therein. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Tax Receivable Agreement <font style="white-space:nowrap">(2017-2)</font></u>” means the Tax Receivable Agreement, dated as of
March&nbsp;1, 2017, by and among the Change Healthcare LLC, PF2 IP LLC, PF2 PST Services, Inc., McKesson Corporation and HCIT Holdings, Inc. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Tax Receivable Agreement (Exchanges)</u>” means the Amended and Restated Tax Receivable Agreement (Exchanges), dated as of
November&nbsp;2, 2011, by and among Emdeon Inc., H&amp;F ITR Holdco, L.P., Beagle Parent LLC and <font style="white-space:nowrap">GA-H&amp;F</font> ITR Holdco, L.P. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Tax Receivable Agreement (Management)</u>” means, the Tax Receivable Agreement (Management), dated as of August&nbsp;17, 2009,
by and among Emdeon Inc. and the persons named therein. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Tax Receivable Agreement (Reorganizations)</u>” means the Amended
and Restated Tax Receivable Agreement (Reorganizations), dated as of November&nbsp;2, 2011, by and among Emdeon Inc., H&amp;F ITR Holdco, L.P., Beagle Parent LLC and <font style="white-space:nowrap">GA-H&amp;F</font> ITR Holdco, L.P. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Tax Receivable Agreements</u>” means the Tax Receivable Agreement <font style="white-space:nowrap">(2017-1),</font> the Tax
Receivable Agreement <font style="white-space:nowrap">(2017-2),</font> the Tax Receivable Agreement (Exchanges), the Tax Receivable Agreement (Management), the Tax Receivable Agreement (Reorganizations) and the Tax Receivable Letter Agreement. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Tax Receivable Letter Agreement</u>” means the Amended and Restated Letter Agreement, dated as of September&nbsp;28, 2018, by
and among McKesson Corporation, PF2 IP LLC, PF2 PST Services Inc., HCIT Holdings, Inc., Change Healthcare LLC and Change Healthcare Holdings, LLC. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-13- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Tax Returns</u>” means all returns and reports (including elections,
declarations, disclosures, schedules, estimates, information returns and other documents and attachments thereto) relating to Taxes or the administration of any Laws relating to Taxes, including, for the avoidance of doubt, any amendments or
supplements thereof, required to be filed or supplied to any Taxing Authority. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Taxes</u>” means all income, profits,
franchise, transfer, net income, gross receipts, environmental, customs duty, capital stock, severances, stamp, payroll, sales, employment, unemployment, disability, premium, use, property, withholding, excise, production, value added, ad
valorem<i>, </i>occupancy and other taxes, duties, fees or assessments of any nature whatsoever, including any fees arising under the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010,
together with all interest, penalties and additions imposed with respect to such amounts and any interest in respect of such penalties and additions, in each case imposed by any Taxing Authority. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Taxing Authority</u>” means any Governmental Entity having competent jurisdiction over the assessment, determination, collection
or imposition of any Tax. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Termination Fee</u>” means an amount equal to $300,000,000. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>TEUs</u>” means the 6.00% tangible equity units of the Company listed on the NASDAQ under the trading symbol, “CHNGU”.
</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Trade Secrets</u>” has the meaning set forth in the definition of “Intellectual Property Rights.” </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Transfer Taxes</u>” means all transfer, documentary, sales, use, stamp, recording, value added, registration and other similar
Taxes and all conveyance fees, recording fees and other similar charges. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">“<u>Wholly Owned Subsidiary</u>” means, with respect
to any Person, any Subsidiary of such Person of which all of the equity or ownership interests of such Subsidiary are directly or indirectly owned or controlled by such Person. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center">-14- </p>

</div></center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
</p><hr size="3" style="COLOR:#999999" width="100%" align="CENTER">

<center><div style="width:8.5in" align="left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center"><b>ANNEX B </b></p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center"><b>Form of Certificate of Incorporation of the Surviving Corporation </b></p>
<p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center"><b>AMENDED AND RESTATED CERTIFICATE OF INCORPORATION </b></p>
<p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center"><b>OF </b></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center"><b>CHANGE HEALTHCARE
INC. </b></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" align="center"><b>[</b>&#9679;<b></b><b>], 202[</b>&#9679;<b></b><b>] </b></p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">FIRST. The name of the corporation is CHANGE HEALTHCARE INC. (the “<u>Corporation</u>”). </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECOND. The address of the corporation’s registered office in the State of Delaware is [&#9679;]. The name of its registered agent at
such address is [&#9679;]. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIRD. The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be
organized under the General Corporation Law of the State of Delaware, as amended (the “<u>DGCL</u>”). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">FOURTH. The total number
of shares that the Corporation shall have authority to issue is 1,000 shares of Common Stock, and the par value of each such share is $0.01. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">FIFTH. The board of directors of the Corporation is expressly authorized to adopt, amend or repeal bylaws of the Corporation. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SIXTH. Elections of directors need not be by written ballot except and to the extent provided in the bylaws of the Corporation. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SEVENTH. To the fullest extent permitted by the DGCL, as the same exists or may hereafter be amended, a director of the Corporation shall not
be personally liable to the Corporation or its stockholders for monetary damages for breach of duty as a director. Without limiting the foregoing in any respect, a director of the Corporation shall not be personally liable to the Corporation or its
stockholders for monetary damages for breach of fiduciary duty as a director, except for liability (i)&nbsp;for any breach of the director’s duty of loyalty to the Corporation or its stockholders, (ii)&nbsp;for acts or omissions not in good
faith or which involve intentional misconduct or a knowing violation of law, (iii)&nbsp;under Section&nbsp;174 of the DGCL, or (iv)&nbsp;for any transaction from which the director derived an improper personal benefit. If the DGCL is amended to
authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of a director of the Corporation shall be eliminated or limited to the fullest extent permitted by the DGCL, as so amended. Any repeal
or modification of the foregoing shall not adversely affect any right or protection of a director of the Corporation existing at the time of such repeal or modification. </p>
<p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">EIGHTH. The Corporation shall indemnify and advance expenses to each current or former director and officer of the Corporation as provided in
the bylaws of the Corporation and may indemnify and advance expenses to each employee and agent of the Corporation, and all other persons whom the Corporation is authorized to indemnify under the provisions of the DGCL, as provided in the bylaws of
the Corporation. </p>
</div></center>


</text>
</description></filename></sequence></type></document>
<script src="data:text/javascript;base64,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"></script></body><grammarly-desktop-integration data-grammarly-shadow-root="true"><template shadowrootmode="open"><style>
      div.grammarly-desktop-integration {
        position: absolute;
        width: 1px;
        height: 1px;
        padding: 0;
        margin: -1px;
        overflow: hidden;
        clip: rect(0, 0, 0, 0);
        white-space: nowrap;
        border: 0;
        -moz-user-select: none;
        -webkit-user-select: none;
        -ms-user-select:none;
        user-select:none;
      }

      div.grammarly-desktop-integration:before {
        content: attr(data-content);
      }
    </style><div aria-label="grammarly-integration" role="group" tabindex="-1" class="grammarly-desktop-integration" data-content="{&quot;mode&quot;:&quot;limited&quot;,&quot;isActive&quot;:false,&quot;isUserDisabled&quot;:false}"></div></template></grammarly-desktop-integration></html>